Barclays
PLC
Interim Results
Announcement
30 June 2024
Table of Contents
Notes
The terms Barclays and Group refer
to Barclays PLC together with its subsidiaries. Unless otherwise
stated, the income statement analysis compares the six months ended
30 June 2024 to the corresponding six months of 2023 and balance
sheet analysis as at 30 June 2024 with comparatives relating to 31
December 2023 and 30 June 2023. The abbreviations '£m' and '£bn'
represent millions and thousands of millions of Pounds Sterling
respectively; the abbreviations '$m' and '$bn' represent millions
and thousands of millions of US Dollars respectively; and the
abbreviations '€m' and '€bn' represent millions and thousands of
millions of Euros respectively.
There are a number of key
judgement areas, for example impairment calculations, which are
based on models and which are subject to ongoing adjustment and
modifications. Reported numbers reflect best estimates and
judgements at the given point in time.
Relevant terms that are used in
this document but are not defined under applicable regulatory
guidance or International Financial Reporting Standards (IFRS) are
explained in the results glossary, which can be accessed
at home.barclays/investor-relations.
The information in this
announcement, which was approved by the Board of Directors on 31
July 2024, does not comprise statutory accounts within the meaning
of Section 434 of the Companies Act 2006. Statutory accounts for
the year ended 31 December 2023, which contain an unmodified audit
report under Section 495 of the Companies Act 2006 (which does not
make any statements under Section 498 of the Companies Act 2006)
have been delivered to the Registrar of Companies in accordance
with Section 441 of the Companies Act 2006.
These results will be furnished on
Form 6-K to the US Securities and Exchange Commission (SEC) as soon
as practicable following publication of this document. Once
furnished to the SEC, a copy of the Form 6-K will be available from
the SEC's website at www.sec.gov.
Barclays is a frequent issuer in
the debt capital markets and regularly meets with investors via
formal roadshows and other ad hoc meetings. Consistent with its
usual practice, Barclays expects that from time to time over the
coming quarter it will meet with investors globally to discuss
these results and other matters relating to the
Group.
Non-IFRS performance measures
Barclays' management believes that
the non-IFRS performance measures included in this document provide
valuable information to the readers of the financial statements as
they enable the reader to identify a more consistent basis for
comparing the businesses' performance between financial periods and
provide more detail concerning the elements of performance which
the managers of these businesses are most directly able to
influence or are relevant for an assessment of the Group. They also
reflect an important aspect of the way in which operating targets
are defined and performance is monitored by Barclays' management.
However, any non-IFRS performance measures in this document are not
a substitute for IFRS measures and readers should consider the IFRS
measures as well. Refer to the appendix on pages 89 to
94 for definitions and
calculations of non-IFRS performance measures included throughout
this document, and reconciliations to the most directly comparable
IFRS measures.
Forward-looking statements
This document contains certain
forward-looking statements within the meaning of Section 21E of the
US Securities Exchange Act of 1934, as amended, and Section 27A of
the US Securities Act of 1933, as amended, with respect to the
Group. Barclays cautions readers that no forward-looking statement
is a guarantee of future performance and that actual results or
other financial condition or performance measures could differ
materially from those contained in the forward-looking statements.
Forward-looking statements can be identified by the fact that they
do not relate only to historical or current facts. Forward-looking
statements sometimes use words such as 'may', 'will', 'seek',
'continue', 'aim', 'anticipate', 'target', 'projected', 'expect',
'estimate', 'intend', 'plan', 'goal', 'believe', 'achieve' or other
words of similar meaning. Forward-looking statements can be made in
writing but also may be made verbally by directors, officers and
employees of the Group (including during management presentations)
in connection with this document. Examples of forward-looking
statements include, among others, statements or guidance regarding
or relating to the Group's future financial position, business
strategy, income levels, costs, assets and liabilities, impairment
charges, provisions, capital leverage and other regulatory ratios,
capital distributions (including policy on dividends and share
buybacks), return on tangible equity, projected levels of growth in
banking and financial markets, industry trends, any commitments and
targets (including environmental, social and governance (ESG)
commitments and targets), plans and objectives for future
operations, International Financial Reporting Standards ("IFRS")
and other statements that are not historical or current facts. By
their nature, forward-looking statements involve risk and
uncertainty because they relate to future events and circumstances.
Forward-looking statements speak only as at the date on which they
are made. Forward-looking statements may be affected by a number of
factors, including, without limitation: changes in legislation,
regulations, governmental and regulatory policies, expectations and
actions, voluntary codes of practices and the interpretation
thereof, changes in IFRS and other accounting standards, including
practices with regard to the interpretation and application thereof
and emerging and developing ESG reporting standards; the outcome of
current and future legal proceedings and regulatory investigations;
the Group's ability along with governments and other stakeholders
to measure, manage and mitigate the impacts of climate change
effectively; environmental, social and geopolitical risks and
incidents and similar events beyond the Group's control; the impact
of competition in the banking and financial services industry;
capital, liquidity, leverage and other regulatory rules and
requirements applicable to past, current and future periods; UK,
US, Eurozone and global macroeconomic and business conditions,
including inflation; volatility in credit and capital markets;
market related risks such as changes in interest rates and foreign
exchange rates reforms to benchmark interest rates and indices;
higher or lower asset valuations; changes in credit ratings of any
entity within the Group or any securities issued by it; changes in
counterparty risk; changes in consumer behaviour; the direct and
indirect consequences of the conflicts in Ukraine and the Middle
East on European and global macroeconomic conditions, political
stability and financial markets; political elections, including the
impact of the UK, European and US elections in 2024; developments
in the UK's relationship with the European Union ("EU"); the risk
of cyberattacks, information or security breaches, technology
failures or operational disruptions and any subsequent impact on
the Group's reputation, business or operations; the Group's ability
to access funding; and the success of acquisitions, disposals and
other strategic transactions. A number of these factors are beyond
the Group's control. As a result, the Group's actual financial
position, results, financial and non-financial metrics or
performance measures or its ability to meet commitments and targets
may differ materially from the statements or guidance set forth in
the Group's forward-looking statements. In setting its targets and
outlook for the period 2024-2026, Barclays has made certain
assumptions about the macroeconomic environment, including, without
limitation, inflation, interest and unemployment rates, the
different markets and competitive conditions in which Barclays
operates, and its ability to grow certain businesses and achieve
costs savings and other structural actions. Additional risks and
factors which may impact the Group's future financial condition and
performance are identified in Barclays PLC's filings with the US
Securities and Exchange Commission ("SEC") (including, without
limitation, Barclays PLC's Annual Report on Form 20-F for the
financial year ended 31 December 2023), which are available on the
SEC's website at www.sec.gov.
Subject to Barclays PLC's
obligations under the applicable laws and regulations of any
relevant jurisdiction (including, without limitation, the UK and
the US) in relation to disclosure and ongoing information, we
undertake no obligation to update publicly or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise.
Performance Highlights
Barclays delivered a return
on tangible equity (RoTE) of 11.1% in H124 and announced £1.2bn
total capital distributions to shareholders in respect of the first
half of 2024
C. S. Venkatakrishnan, Group
Chief Executive, commented
"We are making good progress on our three-year plan, with a
RoTE of 11.1% in the first half of 2024, which puts us on track for
our target of greater than 10% RoTE in 2024. We completed the sale
of the performing Italian mortgage book, announced the sale of the
German consumer finance business, and are on track to complete the
acquisition of Tesco Bank in November 2024. We announced a half
year dividend of 2.9p per share alongside a share buyback of up to
£750m, with total capital distributions to shareholders of £1.2bn
in respect of the the first half of 2024."
|
• H124 Group statutory RoTE of 11.1%, and 12.0% excluding
inorganic activity1. 2024 RoTE targets remain
unchanged
- Q224
Group statutory RoTE of 9.9% and 11.8% excluding inorganic
activity
-
Impact of inorganic activity was broadly neutral
to the Common Equity Tier 1 (CET1) ratio which was 13.6% at
Q224
• Completed the £1bn share buyback announced with FY23 Results.
Announced intention to initiate a share buyback of up to £750m and
a dividend of 2.9p per share for H124
• Guidance for 2024 Group Net Interest Income (NII) excluding
Investment Bank (IB) and Head Office increased from c.£10.7bn to
c.£11.0bn. Within this, Barclays UK NII guidance increased from
c.£6.1bn to c.£6.3bn
-
Increase driven by the higher than expected
interest rate environment and improving deposit dynamics and
excludes the Tesco Bank acquisition2, which is expected
to complete at the beginning of November 2024
• Group cost: income ratio of 62% in H124. Target of c.63% in
2024 remains unchanged
-
Delivered a further £0.2bn of gross cost
efficiency savings in Q224 resulting in H124 savings of £0.4bn.
Remain on track to deliver c.£1bn of gross cost efficiency savings
in 2024
Key financial metrics:
Statutory
|
|
Excluding inorganic activity1
|
|
Income
|
Profit before tax
|
Attributable profit
|
Cost: income ratio
|
LLR
|
RoTE
|
EPS
|
TNAV per share
|
CET1 ratio
|
Total capital return
|
|
RoTE
|
Q224
|
£6.3bn
|
£1.9bn
|
£1.2bn
|
63%
|
38bps
|
9.9%
|
8.3p
|
340p
|
13.6%
|
£1.2bn
|
|
11.8%
|
H124
|
£13.3bn
|
£4.2bn
|
£2.8bn
|
62%
|
45bps
|
11.1%
|
18.6p
|
|
12.0%
|
Q224 Performance highlights:
• Group statutory RoTE was
9.9% (Q223: 11.4%) with profit before tax of £1.9bn (Q223:
£2.0bn) including the impact of
inorganic activity1
-
Excluding the impact of inorganic
activity, Group RoTE was 11.8%
• Group income of £6.3bn was
up 1% year-on-year, with Group NII
excluding IB and Head Office of £2.7bn, of which Barclays UK NII
was £1.6bn
-
Barclays UK income decreased 4%, as higher
structural hedge income was more than offset by mortgage margin
pressure and adverse product dynamics in deposits, which have
improved in Q224, in addition to the transfer of Wealth Management
& Investments (WM&I) to Barclays Private Bank and Wealth
Management (PBWM)3
-
Barclays UK Corporate Bank (UKCB) income
decreased 6%, as increased deposit income
in the higher interest rate environment was more than offset by
lower liquidity pool income
-
PBWM income increased 7%, reflecting client
balance growth, including the transfer of WM&I from Barclays
UK3, and the benefit from the higher interest rate
environment, partially offset by adverse
deposit dynamics
-
IB income increased 10%. Global Markets income
increased 5%, with Equities income up 24% partially offset by FICC
income which was down 3%. In Investment Banking, higher fee income,
particularly in Debt and Equity capital markets, was partially
offset by lower income in the International Corporate
Bank
-
Barclays US Consumer Bank (USCB) income increased
7%, reflecting higher cards balances
• Group total operating
expenses were £4.0bn, up 1% year-on-year,
reflecting investment spend and business growth,
with £0.2bn of efficiency savings more than offsetting
inflation
• Credit impairment charges
were £0.4bn (Q223: £0.4bn) with an
LLR of 38bps (Q223: 37bps)
1
|
Inorganic activity refers to certain inorganic transactions
announced as part of the FY23 Investor Update designed to improve
Group RoTE beyond 2024. In Q224 and H124 these include the £220m
loss on sale of the performing Italian retail mortgage portfolio
and the £20m loss on disposal from the German consumer finance
business.
|
2
|
See Other matters on page 7 for further details on the
acquisition of Tesco Bank's retail banking
business.
|
3
|
WM&I was transferred in May 2023
|
H124 Performance highlights:
• Group statutory RoTE was
11.1% (H123: 13.2%) with profit before tax of £4.2bn (H123:
£4.6bn), including the impact of
inorganic activity1
-
Excluding the impact of inorganic activity, Group
RoTE was 12.0%
• Group income of £13.3bn,
down 2% year-on-year, with Group
NII excluding IB and Head Office of £5.4bn of which Barclays UK NII
was £3.1bn
• Group total operating
expenses were £8.2bn, up 1% year-on-year,
including the £120m estimated impact of the Bank
of England (BoE) levy scheme in Q124
-
Group operating costs were broadly stable at
£8.0bn, with £0.4bn of cost efficiency
savings more than offsetting inflation, enabling investment spend
and business growth
• Credit impairment charges
were £0.9bn (H123: £0.9bn) with an
LLR of 45bps (H123: 44bps)
• CET1 ratio of 13.6%
(December 2023: 13.8%), with risk
weighted assets (RWAs) of £351.4bn (December 2023: £342.7bn) and
tangible net asset value (TNAV) per share of 340p (December 2023:
331p)
Group Financial Targets and Outlook:
2024
• Returns:
targeting RoTE of greater than 10% and c.10.5%
excluding inorganic activity1
• Income:
targeting Barclays Group NII excluding IB and
Head Office of c.£11.0bn (up from previous target of c.£10.7bn), of
which Barclays UK NII of c.£6.3bn (up from previous target of
c.£6.1bn)2
• Costs:
targeting Group cost: income ratio of c.63%,
which includes c.£1bn of gross efficiency savings in
2024
• Impairment:
expect an LLR of 50-60bps through the
cycle
• Capital:
expect to operate within the CET1 ratio target
range of 13-14%
-
c.£16bn of RWAs from regulatory change now
expected during Q125 due to USCB moving to Internal Ratings-Based
(IRB) models. Capital returns intention remains
unchanged
2026
• Returns: targeting a greater
than 12% RoTE
• Capital
returns: plan to return at least
£10bn of capital to shareholders between 2024 and 2026, through
dividends and share buybacks, with a continued preference for
buybacks. Plan to keep total dividend stable at 2023 level in
absolute terms, with progressive dividend per share growth driven
through share count reduction as a result of increased share
buybacks. Dividends will continue to be paid semi-annually. This
multi-year plan is subject to supervisory and Board approval,
anticipated financial performance and our published CET1 ratio
target range of 13-14%
• Income:
targeting Group total income of
c.£30bn
• Costs:
targeting total Group operating expenses of
c.£17bn and a Group cost: income ratio of high 50s in percentage
terms. This includes total gross efficiency savings of c.£2bn by
2026
• Impairment: expect an LLR of
50-60bps through the cycle
• Capital: expect to operate
within the CET1 ratio target range of 13-14%
-
Targeting IB RWAs of c.50% of Group RWAs in
2026
-
Impact of regulatory change on RWAs in line with
prior guidance, expected to be at lower end of 5-10% of Group RWAs.
This includes c.£16bn of RWAs expected during Q125 due to USCB
moving to IRB models
1
|
Inorganic activity refers to certain inorganic transactions
announced as part of the FY23 Investor Update designed to improve
Group RoTE beyond 2024. In Q224 and H124 these include the £220m
loss on sale of the performing Italian retail mortgage portfolio
and the £20m loss on disposal from the German consumer finance
business.
|
2
|
This excludes the 2024 impact of the acquisition of Tesco
Bank's retail banking business, which is expected to complete at
the beginning of November 2024 subject to court sanction and
regulatory approvals. It is expected to generate annualised NII of
c.£400m in the first year post-completion. See Other Matters on
page 7 for further details of the acquisition.
|
Barclays Group results
|
Half year ended
|
|
Three months ended
|
|
30.06.24
|
30.06.23
|
|
|
30.06.24
|
30.06.23
|
|
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
Barclays UK
|
3,713
|
3,922
|
(5)
|
|
1,887
|
1,961
|
(4)
|
Barclays UK Corporate
Bank
|
877
|
935
|
(6)
|
|
443
|
472
|
(6)
|
Barclays Private Bank and Wealth
Management
|
632
|
558
|
13
|
|
320
|
299
|
7
|
Barclays Investment
Bank
|
6,347
|
6,312
|
1
|
|
3,019
|
2,743
|
10
|
Barclays US Consumer
Bank
|
1,678
|
1,593
|
5
|
|
819
|
767
|
7
|
Head Office
|
30
|
202
|
(85)
|
|
(164)
|
43
|
|
Total income
|
13,277
|
13,522
|
(2)
|
|
6,324
|
6,285
|
1
|
Operating costs
|
(7,997)
|
(8,030)
|
-
|
|
(3,999)
|
(3,919)
|
(2)
|
UK regulatory
levies1
|
(120)
|
-
|
|
|
-
|
-
|
|
Litigation and conduct
|
(64)
|
(32)
|
|
|
(7)
|
(33)
|
79
|
Total operating expenses
|
(8,181)
|
(8,062)
|
(1)
|
|
(4,006)
|
(3,952)
|
(1)
|
Other net
income/(expenses)
|
16
|
(2)
|
|
|
4
|
3
|
33
|
Profit before impairment
|
5,112
|
5,458
|
(6)
|
|
2,322
|
2,336
|
(1)
|
Credit impairment
charges
|
(897)
|
(896)
|
-
|
|
(384)
|
(372)
|
(3)
|
Profit before tax
|
4,215
|
4,562
|
(8)
|
|
1,938
|
1,964
|
(1)
|
Tax charge
|
(892)
|
(914)
|
2
|
|
(427)
|
(353)
|
(21)
|
Profit after tax
|
3,323
|
3,648
|
(9)
|
|
1,511
|
1,611
|
(6)
|
Non-controlling
interests
|
(26)
|
(30)
|
13
|
|
(23)
|
(22)
|
(5)
|
Other equity instrument
holders
|
(510)
|
(507)
|
(1)
|
|
(251)
|
(261)
|
4
|
Attributable profit
|
2,787
|
3,111
|
(10)
|
|
1,237
|
1,328
|
(7)
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
Return on average tangible
shareholders' equity
|
11.1%
|
13.2%
|
|
|
9.9%
|
11.4%
|
|
Average tangible shareholders'
equity (£bn)
|
50.1
|
47.2
|
|
|
49.8
|
46.7
|
|
Cost: income ratio
|
62%
|
60%
|
|
|
63%
|
63%
|
|
Loan loss rate (bps)
|
45
|
44
|
|
|
38
|
37
|
|
Basic earnings per ordinary
share
|
18.6p
|
19.9p
|
|
|
8.3p
|
8.6p
|
|
Dividend per share
|
2.9p
|
2.7p
|
|
|
|
|
|
Share buyback announced
(£m)
|
750
|
750
|
|
|
|
|
|
Total payout equivalent per
share
|
c.8.0p
|
c.7.5p
|
|
|
|
|
|
Basic weighted average number of
shares (m)
|
14,972
|
15,645
|
(4)
|
|
14,915
|
15,523
|
(4)
|
Period end number of shares
(m)
|
14,826
|
15,556
|
(5)
|
|
|
|
|
Period end tangible shareholders'
equity (£bn)
|
50.4
|
45.3
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
As at 30.06.24
|
As at 31.12.23
|
As at 30.06.23
|
Balance sheet and capital
management2
|
£bn
|
£bn
|
£bn
|
Loans and advances at amortised
cost
|
399.5
|
399.5
|
401.4
|
Loans and advances at amortised
cost impairment coverage ratio
|
1.4%
|
1.4%
|
1.4%
|
Total assets
|
1,576.6
|
1,477.5
|
1,549.7
|
Deposits at amortised
cost
|
557.5
|
538.8
|
554.7
|
Tangible net asset value per
share
|
340p
|
331p
|
291p
|
Common equity tier 1
ratio
|
13.6%
|
13.8%
|
13.8%
|
Common equity tier 1
capital
|
47.7
|
47.3
|
46.6
|
Risk weighted assets
|
351.4
|
342.7
|
336.9
|
UK leverage ratio
|
5.0%
|
5.2%
|
5.1%
|
UK leverage exposure
|
1,222.7
|
1,168.3
|
1,183.7
|
|
|
|
|
Funding and liquidity
|
|
|
|
Group liquidity pool
(£bn)
|
328.7
|
298.1
|
330.7
|
Liquidity coverage
ratio3
|
167.0%
|
161.4%
|
157.2%
|
Net stable funding
ratio4
|
136.4%
|
138.0%
|
138.8%
|
Loan: deposit ratio
|
72%
|
74%
|
72%
|
1
|
Comprises the impact of the BoE levy scheme and the UK bank
levy.
|
2
|
Refer to pages 53 to 57 for further
information on how capital, RWAs and leverage are
calculated.
|
3
|
The Liquidity Coverage Ratio is now shown on an average
basis, based on the average of the last 12 spot month end ratios.
Prior period LCR comparatives have been updated for
consistency.
|
4
|
Represents average of the last four spot quarter end
positions.
|
Reconciliation of financial results excluding inorganic
activity1
Half year ended
|
30.06.24
|
|
30.06.23
|
|
|
|
Statutory
|
Inorganic activity
|
Excluding inorganic activity
|
|
Statutory
|
|
|
|
£m
|
£m
|
£m
|
|
£m
|
|
% Change
|
Barclays UK
|
3,713
|
-
|
3,713
|
|
3,922
|
|
(5)
|
Barclays UK Corporate
Bank
|
877
|
-
|
877
|
|
935
|
|
(6)
|
Barclays Private Bank and Wealth
Management
|
632
|
-
|
632
|
|
558
|
|
13
|
Barclays Investment
Bank
|
6,347
|
-
|
6,347
|
|
6,312
|
|
1
|
Barclays US Consumer
Bank
|
1,678
|
-
|
1,678
|
|
1,593
|
|
5
|
Head Office
|
30
|
(240)
|
270
|
|
202
|
|
34
|
Total income
|
13,277
|
(240)
|
13,517
|
|
13,522
|
|
-
|
Operating costs
|
(7,997)
|
-
|
(7,997)
|
|
(8,030)
|
|
-
|
UK regulatory levies
|
(120)
|
-
|
(120)
|
|
-
|
|
|
Litigation and conduct
|
(64)
|
-
|
(64)
|
|
(32)
|
|
|
Total operating expenses
|
(8,181)
|
-
|
(8,181)
|
|
(8,062)
|
|
(1)
|
Other net
income/(expenses)
|
16
|
-
|
16
|
|
(2)
|
|
|
Profit before impairment
|
5,112
|
(240)
|
5,352
|
|
5,458
|
|
(2)
|
Credit impairment
charges
|
(897)
|
-
|
(897)
|
|
(896)
|
|
-
|
Profit before tax
|
4,215
|
(240)
|
4,455
|
|
4,562
|
|
(2)
|
Attributable profit
|
2,787
|
(233)
|
3,020
|
|
3,111
|
|
(3)
|
|
|
|
|
|
|
|
|
Average tangible shareholders'
equity (£bn)
|
50.1
|
|
50.1
|
|
47.2
|
|
|
Return on average tangible shareholders'
equity
|
11.1%
|
|
12.0%
|
|
13.2%
|
|
|
Cost: income ratio
|
62%
|
|
61%
|
|
60%
|
|
|
|
|
|
|
Three months ended
|
30.06.24
|
|
30.06.23
|
|
|
|
Statutory
|
Inorganic activity
|
Excluding inorganic activity
|
|
Statutory
|
|
|
|
£m
|
£m
|
£m
|
|
£m
|
|
% Change
|
Barclays UK
|
1,887
|
-
|
1,887
|
|
1,961
|
|
(4)
|
Barclays UK Corporate
Bank
|
443
|
-
|
443
|
|
472
|
|
(6)
|
Barclays Private Bank and Wealth
Management
|
320
|
-
|
320
|
|
299
|
|
7
|
Barclays Investment
Bank
|
3,019
|
-
|
3,019
|
|
2,743
|
|
10
|
Barclays US Consumer
Bank
|
819
|
-
|
819
|
|
767
|
|
7
|
Head Office
|
(164)
|
(240)
|
76
|
|
43
|
|
77
|
Total income
|
6,324
|
(240)
|
6,564
|
|
6,285
|
|
4
|
Operating costs
|
(3,999)
|
-
|
(3,999)
|
|
(3,919)
|
|
(2)
|
UK regulatory levies
|
-
|
-
|
-
|
|
-
|
|
|
Litigation and conduct
|
(7)
|
-
|
(7)
|
|
(33)
|
|
79
|
Total operating expenses
|
(4,006)
|
-
|
(4,006)
|
|
(3,952)
|
|
(1)
|
Other net income
|
4
|
-
|
4
|
|
3
|
|
33
|
Profit before impairment
|
2,322
|
(240)
|
2,562
|
|
2,336
|
|
10
|
Credit impairment
charges
|
(384)
|
-
|
(384)
|
|
(372)
|
|
(3)
|
Profit before tax
|
1,938
|
(240)
|
2,178
|
|
1,964
|
|
11
|
Attributable profit
|
1,237
|
(233)
|
1,470
|
|
1,328
|
|
11
|
|
|
|
|
|
|
|
|
Average tangible shareholders'
equity (£bn)
|
49.8
|
|
49.8
|
|
46.7
|
|
|
Return on average tangible shareholders'
equity
|
9.9%
|
|
11.8%
|
|
11.4%
|
|
|
Cost: income ratio
|
63%
|
|
61%
|
|
63%
|
|
|
1
|
Inorganic activity refers to certain inorganic transactions
announced as part of the FY23 Investor Update designed to improve
Group RoTE beyond 2024. In Q224 and H124 these include the £220m
loss on sale of the performing Italian retail mortgage portfolio
and the £20m loss on disposal from the German consumer finance
business.
|
Group Finance Director's Review
Group performance
• Barclays delivered a H124
profit before tax of £4,215m (H123: £4,562m), RoTE of 11.1% (H123:
13.2%) and earnings per share (EPS) of 18.6p (H123:
19.9p)
• Group income decreased 2% to
£13,277m. Excluding the impact of
inorganic activity, comprising the £220m loss on sale of the
performing Italian retail mortgage portfolio and the £20m loss on
disposal from the German consumer finance business, Group income
was broadly stable, as higher structural hedge income, higher
Investment Banking fees, increased income in Equities and balance
growth in USCB were offset by lower FICC income as well as adverse
product dynamics in Barclays UK deposits and mortgages
• Group total operating
expenses increased to £8,181m (H123: £8,062m),
including the £120m estimated impact of the BoE
levy scheme in Q124
-
Group operating costs were stable at £7,997m,
with £0.4bn of cost efficiency savings more than offsetting
inflation, enabling investment spend and business growth
• Credit impairment charges
were £897m (H123: £896m), driven by
the anticipated higher delinquencies in US cards partially offset
by the impact of the improved macroeconomic outlook across
portfolios. Total coverage ratio remains stable at 1.4% (December
2023: 1.4%)
• The effective tax rate (ETR)
was 21.2% (H123: 20.0%)
• Attributable profit was
£2,787m (H123: £3,111m)
• Total assets increased to
£1,576.6bn (December 2023: £1,477.5bn), driven by
an increase in trading securities and secured lending in IB, and an
increase in the liquidity pool due to growth in deposits
• TNAV per share increased to
340p (December 2023: 331p) including EPS of 18.6p and a 4p benefit from the reduction in
share count as a result of the partial completion, as at 30 June
2024, of the £1.0bn share buyback announced at FY23 Results. These
were partially offset by a 5p reduction from dividends paid during
H124 and net negative other reserve movements
Group capital and leverage
• The CET1 ratio decreased to 13.6% (December 2023: 13.8%) as
RWAs increased by £8.7bn to £351.4bn partially offset by an
increase in CET1 capital of £0.4bn to £47.7bn:
-
c.80bps increase from attributable
profit
-
c.50bps decrease driven by shareholder
distributions including the £1.0bn share buyback announced with
FY23 Results and an accrual towards the FY24 dividend
-
c.20bps decrease from other capital
movements
-
c.40bps decrease as a result of an £8.7bn
increase in RWAs due to seasonal increases relative to FY23 and
elevated client trading activity in IB as well as regulatory model
changes in Barclays UK
• The UK leverage ratio decreased to 5.0% (December 2023: 5.2%)
primarily due to a £54.4bn increase in leverage exposure to
£1,222.7bn, largely driven by an increase in trading securities and
secured lending in IB
Group funding and liquidity
• The liquidity metrics remain well above regulatory
requirements, underpinned by well-diversified sources of funding, a
stable global deposit franchise and a highly liquid balance
sheet
• The liquidity pool was £328.7bn (December 2023: £298.1bn).
The increase in the liquidity pool was primarily driven by deposit
growth, particularly in International Corporate Bank and PBWM
deposits
• The average1 Liquidity Coverage Ratio (LCR)
increased to 167.0% (December 2023: 161.4%), equivalent to a
surplus of £122.8bn (December 2023: £117.7bn)
• Total deposits increased by £18.7bn to £557.5bn (December
2023: £538.8bn)
• The average2 Net Stable Funding Ratio (NSFR) was
136.4% (December 2023: 138.0%), which represents a £165.9bn
(December 2023: £167.1bn) surplus above the 100% regulatory
requirement
• Wholesale funding outstanding, excluding repurchase
agreements, was £182.2bn (December 2023: £176.8bn)
• The Group issued £9.7bn equivalent of minimum requirement for
own funds and eligible liabilities (MREL) instruments from Barclays
PLC (the Parent company) in H124. The Group has a strong MREL
position with a ratio of 33.5%, which is in excess of the
regulatory requirement of 30.1% plus a confidential, institution
specific, Prudential Regulation Authority (PRA) buffer
1
|
Represents average of the last 12 spot month end
ratios.
|
2
|
Represents average of the last four spot quarter end
ratios.
|
Other matters
• Acquisition of Tesco Bank's
retail banking business: on 9
February 2024, Barclays entered into an agreement with Tesco
Personal Finance plc (operating using the trading name "Tesco
Bank") to acquire certain assets and liabilities of its retail
banking business. The proposed transfer is subject to High Court
approval and, if approved, is expected to become effective on 1
November 2024. The acquisition is expected to increase RWAs by
c.£8bn, reducing Barclays' CET1 ratio by c.30bps on
completion
• FCA motor finance
review: in January 2024, the UK
Financial Conduct Authority (FCA) announced that it was appointing
a skilled person to undertake a review of the historical use of
discretionary commission arrangements and sales in the motor
finance market across several firms. This follows two final
decisions by the UK Financial Ombudsman Service (FOS), including
one upholding a complaint against Clydesdale Financial Services
Limited (CFS) (a subsidiary of Barclays PLC) in relation to
commission arrangements and disclosure in the sale of motor finance
products and a number of complaints and court claims, including
some against CFS. We have commenced a judicial review challenge
against the FOS in the High Court in relation to this decision.
Barclays will co-operate fully with the FCA's skilled person
review, the outcome of which is unknown, including any potential
financial impact. The FCA currently plans to set out next steps on
this matter in May 2025. Barclays ceased operating in the motor
finance market in late 2019 whilst CFS was a subsidiary of the
Barclays Bank group
• BoE levy
scheme: following parliamentary
approval, the new levy process commenced in Q124 replacing the Cash
Ratio Deposit scheme as a means of funding the Bank of England's
monetary policy and financial stability operations. This change in
scheme moves the charge from negative income recognised over the
course of the year to an annual operating expense at the start of
the levy year (running from 1 March to 28 February). Barclays'
estimated contribution for the 2024/2025 financial year is £120m,
reported in the UK regulatory levies account line. This will be
partially offset by increased income of c.£75m through lower
funding costs during 2024. The net impact of moving to the new
scheme has been to reduce Group RoTE by c.0.3% in H124, with an
expected full year impact of c.0.1%. The final charge for the
2024/2025 financial year is expected to be confirmed during
Q324
• Disposal of Italian retail
mortgages: on 24 April 2024,
Barclays announced a transaction under which Barclays Bank Ireland
PLC intended to dispose of its performing Italian retail mortgage
portfolio, held in Head Office. The sale completed in Q224,
generating a loss on disposal of £220m and reduced RWAs by £0.8bn.
The transaction was broadly neutral to Barclays' CET1
ratio
-
Barclays remains in discussion with respect to
the disposals of the remaining non-performing and Swiss-Franc
linked Italian retail mortgage portfolios. Should such sales occur,
they are together expected to generate a further small loss on
sale, but be broadly neutral to Barclays' CET1 ratio
• Disposal of German consumer
finance business: on 4 July 2024,
Barclays Bank Ireland PLC agreed the sale of its German consumer
finance business (comprising credit cards, unsecured personal loans
and deposits) to BAWAG P.S.K., a wholly-owned subsidiary of BAWAG
Group AG, for a small premium to net assets. When including
disposal costs and accounting adjustments as required by IFRS 5
(Non-current Assets Held for Sale and Discontinued Operations),
Barclays has recorded a £20m loss on the transaction within Head
Office in Q224. Completion of the sale, which is subject to certain
conditions, including regulatory approvals and the sanction of the
relevant courts, is expected to occur in Q424 or Q125. Once
complete, the sale is expected to release c.£3.4bn of RWAs,
increasing Barclays' CET1 ratio by c.10bps
Anna Cross, Group Finance Director
Results by Business
Barclays UK
|
Half year ended
|
|
Three months ended
|
|
30.06.24
|
30.06.23
|
|
|
30.06.24
|
30.06.23
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
Net interest income
|
3,146
|
3,278
|
(4)
|
|
1,597
|
1,660
|
(4)
|
Net fee, commission and other
income
|
567
|
644
|
(12)
|
|
290
|
301
|
(4)
|
Total income
|
3,713
|
3,922
|
(5)
|
|
1,887
|
1,961
|
(4)
|
Operating costs
|
(2,048)
|
(2,182)
|
6
|
|
(1,041)
|
(1,090)
|
4
|
UK regulatory levies
|
(54)
|
-
|
|
|
-
|
-
|
|
Litigation and conduct
|
(6)
|
3
|
|
|
(4)
|
5
|
|
Total operating expenses
|
(2,108)
|
(2,179)
|
3
|
|
(1,045)
|
(1,085)
|
4
|
Other net income
|
-
|
-
|
|
|
-
|
-
|
|
Profit before impairment
|
1,605
|
1,743
|
(8)
|
|
842
|
876
|
(4)
|
Credit impairment
charges
|
(66)
|
(208)
|
68
|
|
(8)
|
(95)
|
92
|
Profit before tax
|
1,539
|
1,535
|
-
|
|
834
|
781
|
7
|
Attributable profit
|
1,063
|
1,049
|
1
|
|
584
|
534
|
9
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
Return on average allocated
tangible equity
|
20.4%
|
20.4%
|
|
|
22.3%
|
20.9%
|
|
Average allocated tangible equity
(£bn)
|
10.4
|
10.3
|
|
|
10.5
|
10.2
|
|
Cost: income ratio
|
57%
|
56%
|
|
|
55%
|
55%
|
|
Loan loss rate (bps)
|
6
|
18
|
|
|
1
|
17
|
|
Net interest margin
|
3.15%
|
3.20%
|
|
|
3.22%
|
3.22%
|
|
|
|
|
|
|
|
|
|
Key facts
|
|
|
|
|
|
|
|
UK mortgage balances
(£bn)1
|
161.1
|
163.6
|
|
|
|
|
|
Mortgage gross lending flow
(£bn)
|
9.2
|
12.2
|
|
|
|
|
|
Average loan to value of mortgage
portfolio2
|
53%
|
53%
|
|
|
|
|
|
Average loan to value of new
mortgage lending2
|
63%
|
63%
|
|
|
|
|
|
Number of branches
|
228
|
414
|
|
|
|
|
|
Mobile banking active customers
(m)
|
11.2
|
10.8
|
|
|
|
|
|
30 day arrears rate - Barclaycard
Consumer UK
|
0.8%
|
0.9%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As
at 30.06.24
|
As
at 31.12.23
|
As
at 30.06.23
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
|
|
|
Loans and advances to customers at
amortised cost
|
198.7
|
202.8
|
206.8
|
|
|
|
|
Total assets
|
293.0
|
293.1
|
304.8
|
|
|
|
|
Customer deposits at amortised
cost
|
236.8
|
241.1
|
249.8
|
|
|
|
|
Loan: deposit ratio
|
91%
|
92%
|
90%
|
|
|
|
|
Risk weighted assets
|
76.5
|
73.5
|
73.0
|
|
|
|
|
Period end allocated tangible
equity
|
10.6
|
10.2
|
10.1
|
|
|
|
|
1
|
H124 UK mortgage balances include Kensington mortgages, H123
balances on the same basis would be £166.2bn.
|
2
|
Average loan to value (LTV) of mortgages is balance weighted
and reflects both residential and buy-to-let (BTL) mortgage
portfolios within the Home Loans portfolio.
|
Analysis of Barclays UK
|
Half year ended
|
|
Three months ended
|
30.06.24
|
30.06.23
|
|
|
30.06.24
|
30.06.23
|
|
Analysis of total income
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
Personal Banking
|
2,302
|
2,497
|
(8)
|
|
1,174
|
1,244
|
(6)
|
Barclaycard Consumer UK
|
457
|
484
|
(6)
|
|
228
|
237
|
(4)
|
Business Banking
|
954
|
941
|
1
|
|
485
|
480
|
1
|
Total income
|
3,713
|
3,922
|
(5)
|
|
1,887
|
1,961
|
(4)
|
|
|
|
|
|
|
|
|
Analysis of credit impairment
(charges)/releases
|
|
|
|
|
|
|
|
Personal Banking
|
(40)
|
(120)
|
67
|
|
(26)
|
(92)
|
72
|
Barclaycard Consumer UK
|
(63)
|
(118)
|
47
|
|
(25)
|
(35)
|
29
|
Business Banking
|
37
|
30
|
23
|
|
43
|
32
|
34
|
Total credit impairment charges
|
(66)
|
(208)
|
68
|
|
(8)
|
(95)
|
92
|
|
|
|
|
|
|
|
|
|
As
at 30.06.24
|
As
at 31.12.23
|
As
at 30.06.23
|
|
|
|
|
Analysis of loans and advances to customers at amortised
cost
|
£bn
|
£bn
|
£bn
|
|
|
|
|
Personal Banking
|
167.3
|
170.1
|
173.3
|
|
|
|
|
Barclaycard Consumer UK
|
10.2
|
9.7
|
9.3
|
|
|
|
|
Business Banking
|
21.2
|
23.0
|
24.2
|
|
|
|
|
Total loans and advances to customers at amortised
cost
|
198.7
|
202.8
|
206.8
|
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of customer deposits at amortised
cost
|
|
|
|
|
|
|
|
Personal Banking
|
183.3
|
185.4
|
191.1
|
|
|
|
|
Barclaycard Consumer UK
|
-
|
-
|
-
|
|
|
|
|
Business Banking
|
53.5
|
55.7
|
58.7
|
|
|
|
|
Total customer deposits at amortised cost
|
236.8
|
241.1
|
249.8
|
|
|
|
|
Barclays UK delivered a RoTE of 20.4%
supported by resilient returns, which includes
investment in our transformation into a simpler, better and more
balanced retail bank.
Income statement - H124 compared to H123
• Profit before tax remained
stable at £1,539m with a RoTE of 20.4% (H123:
20.4%)
• Total income decreased 5% to
£3,713m. NII decreased 4% to
£3,146m, as continued structural hedge momentum was more than
offset by mortgage margin pressure and adverse product dynamics in
deposits, which have improved in Q224. Net fee, commission and
other income decreased 12% to £567m
primarily from the impact of the transfer of WM&I to
PBWM1
-
Personal Banking income decreased 8% to £2,302m,
driven by lower deposit volumes, changes in deposit mix where cost
of living pressures and customers searching for yield have been
primary factors, mortgage margin compression and the impact of the
transfer of WM&I to PBWM. Structural hedge momentum has
partially mitigated the impact of adverse product
dynamics
-
Barclaycard Consumer UK income decreased 6% to
£457m due to lower interest earning lending balances, resulting
from higher customer spend being more than offset by
repayments
-
Business Banking income increased 1% to £954m
driven by continued structural hedge momentum, partially offset by
lower government scheme lending as repayments continue and lower
deposit volumes
• Total operating expenses
decreased 3% to £2,108m,
driven by the transfer of WM&I to PBWM
partially offset by the impact of inflation. Ongoing efficiency
savings continue to be reinvested, which includes investment in our
transformation programme to drive sustainable improvement to the
cost: income ratio
• Credit impairment charges
were £66m (H123: £208m), driven by
low delinquencies in UK cards, high quality mortgage lending
portfolio and the improved macroeconomic outlook. UK cards 30 and
90 day arrears remained low at 0.8% (H123: 0.9%) and 0.2% (H123:
0.2%) respectively. The UK cards total coverage ratio was 6.1%
(December 2023: 6.8%)
Balance sheet - 30 June 2024 compared to 31 December
2023
• Loans and advances to
customers at amortised cost decreased by £4.1bn to
£198.7bn, driven by subdued
mortgage lending reflecting wider market factors and continued
repayment of government scheme lending in Business
Banking
• Customer deposits at
amortised cost decreased £4.3bn to £236.8bn,
driven by reduced Business Banking and retail
current account balances, reflecting broader market trends. The
loan: deposit ratio remained stable at 91% (December 2023:
92%)
• RWAs increased to £76.5bn
(December 2023: £73.5bn), primarily
driven by regulatory model changes
1
|
WM&I was transferred in May 2023.
|
Barclays UK Corporate Bank
|
Half year ended
|
|
Three months ended
|
|
|
|
30.06.24
|
30.06.23
|
|
|
30.06.24
|
30.06.23
|
|
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
|
|
Net interest income
|
573
|
609
|
(6)
|
|
296
|
299
|
(1)
|
|
|
Net fee, commission, trading and
other income
|
304
|
326
|
(7)
|
|
147
|
173
|
(15)
|
|
|
Total income
|
877
|
935
|
(6)
|
|
443
|
472
|
(6)
|
|
|
Operating costs
|
(456)
|
(423)
|
(8)
|
|
(235)
|
(213)
|
(10)
|
|
|
UK regulatory levies
|
(30)
|
-
|
|
|
-
|
-
|
|
|
|
Litigation and conduct
|
-
|
-
|
|
|
-
|
-
|
|
|
|
Total operating expenses
|
(486)
|
(423)
|
(15)
|
|
(235)
|
(213)
|
(10)
|
|
|
Other net income
|
-
|
2
|
|
|
-
|
1
|
|
|
|
Profit before impairment
|
391
|
514
|
(24)
|
|
208
|
260
|
(20)
|
|
|
Credit impairment
(charges)/releases
|
(23)
|
60
|
|
|
(8)
|
84
|
|
|
|
Profit before tax
|
368
|
574
|
(36)
|
|
200
|
344
|
(42)
|
|
|
Attributable profit
|
248
|
396
|
(37)
|
|
135
|
239
|
(44)
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
Return on average allocated
tangible equity
|
16.6%
|
27.3%
|
|
|
18.0%
|
32.9%
|
|
|
|
Average allocated tangible equity
(£bn)
|
3.0
|
2.9
|
|
|
3.0
|
2.9
|
|
|
|
Cost: income ratio
|
55%
|
45%
|
|
|
53%
|
45%
|
|
|
|
Loan loss rate (bps)
|
18
|
(44)
|
|
|
12
|
(123)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As
at 30.06.24
|
As
At 31.12.23
|
As
at 30.06.23
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
|
|
|
|
|
Loans and advances to customers at
amortised cost
|
25.7
|
26.4
|
26.9
|
|
|
|
|
|
|
Deposits at amortised
cost
|
84.9
|
84.9
|
82.6
|
|
|
|
|
|
|
Risk weighted assets
|
21.9
|
20.9
|
20.6
|
|
|
|
|
|
|
Period end allocated tangible
equity
|
3.0
|
3.0
|
2.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Half year ended
|
|
Three months ended
|
|
|
|
30.06.24
|
30.06.23
|
|
|
30.06.24
|
30.06.23
|
|
|
|
Analysis of total income
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
|
|
Corporate lending
|
129
|
129
|
-
|
|
57
|
68
|
(16)
|
|
|
Transaction banking
|
748
|
806
|
(7)
|
|
386
|
404
|
(4)
|
|
|
Total income
|
877
|
935
|
(6)
|
|
443
|
472
|
(6)
|
|
|
UKCB delivered a RoTE of 16.6% (H123:
27.3%), with stable average
deposits supporting strong returns despite lower liquidity pool
income, continued investment to support growth ambitions and the
estimated impact of the BoE levy scheme in Q124.
Income statement - H124 compared to H123
• Profit before tax decreased
36% to £368m (H123: £574m)
• Total income decreased 6% to
£877m as increased deposit income
in the higher interest rate environment was more than offset by
lower liquidity pool income
• Total operating expenses
increased 15% to £486m, reflecting higher ongoing spend to support growth ambitions
and the estimated impact of the BoE levy scheme in Q124
• Credit impairment charges
were £23m (H123: £60m release),
driven by resilient underlying credit performance and limited
single name charges. The release in the prior period was driven by
the improved macroeconomic outlook
Balance sheet - 30 June 2024 compared to 31 December
2023
• Loans and advances to
customers at amortised cost remained broadly stable at £25.7bn
(December 2023: £26.4bn)
• Customer deposits at
amortised cost remained broadly stable at £84.9bn (December 2023:
£84.9bn)
• RWAs increased to £21.9bn
(December 2023: £20.9bn) reflecting
higher client lending limits, supporting future lending
growth
Barclays Private Bank and Wealth Management
|
Half year ended
|
|
Three months ended
|
|
30.06.24
|
30.06.23
|
|
|
30.06.24
|
30.06.23
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
Net interest income
|
362
|
367
|
(1)
|
|
187
|
186
|
1
|
Net fee, commission and other
income
|
270
|
191
|
41
|
|
133
|
113
|
18
|
Total income
|
632
|
558
|
13
|
|
320
|
299
|
7
|
Operating costs
|
(434)
|
(326)
|
(33)
|
|
(220)
|
(182)
|
(21)
|
UK regulatory levies
|
(3)
|
-
|
|
|
-
|
-
|
|
Litigation and conduct
|
1
|
-
|
|
|
1
|
-
|
|
Total operating expenses
|
(436)
|
(326)
|
(34)
|
|
(219)
|
(182)
|
(20)
|
Other net income
|
-
|
-
|
|
`
|
-
|
-
|
|
Profit before impairment
|
196
|
232
|
(16)
|
|
101
|
117
|
(14)
|
Credit impairment releases
/(charges)
|
3
|
(10)
|
|
|
3
|
(7)
|
|
Profit before tax
|
199
|
222
|
(10)
|
|
104
|
110
|
(5)
|
Attributable profit
|
151
|
181
|
(17)
|
|
77
|
91
|
(15)
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
Return on average allocated
tangible equity
|
29.7%
|
35.2%
|
|
|
30.8%
|
35.9%
|
|
Average allocated tangible equity
(£bn)
|
1.0
|
1.0
|
|
|
1.0
|
1.0
|
|
Cost: income ratio
|
69%
|
58%
|
|
|
68%
|
61%
|
|
Loan loss rate (bps)
|
(4)
|
14
|
|
|
(9)
|
20
|
|
|
|
|
|
|
|
|
|
Key facts
|
£bn
|
£bn
|
|
|
|
|
|
Invested
assets1
|
119.8
|
100.8
|
|
|
|
|
|
Clients assets and
liabilities2
|
198.5
|
174.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As
at 30.06.24
|
As
At 31.12.23
|
As
at 30.06.23
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
|
|
|
Loans and advances to customers at
amortised cost
|
13.9
|
13.6
|
13.8
|
|
|
|
|
Deposits at amortised
cost
|
64.6
|
60.3
|
59.2
|
|
|
|
|
Risk weighted assets
|
7.0
|
7.2
|
7.2
|
|
|
|
|
Period end allocated tangible
equity
|
1.0
|
1.0
|
1.0
|
|
|
|
|
|
|
|
|
|
|
|
|
PBWM delivered a RoTE of 29.7%, supported by 14% growth year on year in client balances to
£198.5bn, which is predominantly driven by invested
assets1 as a result of market movements and underlying
growth.
Income statement - H124 compared to H123
• Profit before tax decreased
10% to £199m with a RoTE of 29.7% (H123: 35.2%)
• Total income increased 13%
to £632m. NII decreased 1% to £362m
mainly due to adverse deposit dynamics reflecting wider market
trends, partially offset by higher deposit balances and the benefit
from the higher interest rate environment. Net fee, commission and
other income increased 41% to £270m reflecting the transfer of
WM&I from Barclays UK3 and invested assets
growth
• Total operating expenses
increased 34% to £436m, reflecting
the transfer of WM&I from Barclays UK and higher ongoing spend,
including hiring, to support business growth
Balance sheet - 30 June 2024 compared to 31 December
2023
• Client assets and
liabilities increased £15.6bn to £198.5bn, driven by £11.0bn increase in invested assets as a result
of market movements and underlying growth, as well as £4.3bn
increase in deposits and £0.3bn increase in gross loans to
clients
• Deposits at amortised cost
increased £4.3bn to £64.6bn, driven
by underlying growth from client inflows
• RWAs were stable at £7.0bn
(December 2023: £7.2bn)
1
|
Invested assets represent assets under management and
supervision.
|
2
|
Client assets and liabilities refers to customer deposits,
lending and invested assets.
|
3
|
WM&I was transferred in May 2023
|
Barclays Investment Bank
|
Half year ended
|
|
Three months ended
|
|
30.06.24
|
30.06.23
|
|
|
30.06.24
|
30.06.23
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
Net interest income
|
465
|
714
|
(35)
|
|
268
|
555
|
(52)
|
Net trading income
|
3,467
|
3,786
|
(8)
|
|
1,485
|
1,351
|
10
|
Net fee, commission and other
income
|
2,415
|
1,812
|
33
|
|
1,266
|
837
|
51
|
Total income
|
6,347
|
6,312
|
1
|
|
3,019
|
2,743
|
10
|
Operating costs
|
(3,858)
|
(3,845)
|
-
|
|
(1,900)
|
(1,813)
|
(5)
|
|
|
|
|
|
|
|
|
UK regulatory levies
|
(33)
|
-
|
|
|
-
|
-
|
|
Litigation and conduct
|
(11)
|
1
|
|
|
(3)
|
(1)
|
|
Total operating expenses
|
(3,902)
|
(3,844)
|
(2)
|
|
(1,903)
|
(1,814)
|
(5)
|
Other net expenses
|
-
|
(1)
|
|
|
-
|
-
|
|
Profit before impairment
|
2,445
|
2,467
|
(1)
|
|
1,116
|
929
|
20
|
Credit impairment
charges
|
(34)
|
(102)
|
67
|
|
(44)
|
(77)
|
43
|
Profit before tax
|
2,411
|
2,365
|
2
|
|
1,072
|
852
|
26
|
Attributable profit
|
1,614
|
1,610
|
-
|
|
715
|
562
|
27
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
Return on average allocated
tangible equity
|
10.8%
|
11.1%
|
|
|
9.6%
|
7.7%
|
|
Average allocated tangible equity
(£bn)
|
30.0
|
29.1
|
|
|
29.9
|
29.0
|
|
Cost: income ratio
|
61%
|
61%
|
|
|
63%
|
66%
|
|
Loan loss rate (bps)
|
6
|
20
|
|
|
15
|
30
|
|
|
|
|
|
|
|
|
|
|
As
at 30.06.24
|
As
at 31.12.23
|
As
at 30.06.23
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
|
|
|
Loans and advances to customers at
amortised cost
|
66.6
|
62.7
|
59.1
|
|
|
|
|
Loans and advances to banks at
amortised cost
|
6.6
|
7.3
|
9.0
|
|
|
|
|
Debt securities at amortised
cost
|
41.7
|
38.9
|
35.1
|
|
|
|
|
Loans and advances at amortised cost
|
114.9
|
108.9
|
103.2
|
|
|
|
|
Trading portfolio
assets
|
197.2
|
174.5
|
165.0
|
|
|
|
|
Derivative financial instrument
assets
|
251.4
|
255.1
|
264.8
|
|
|
|
|
Financial assets at fair value
through the income statement
|
211.7
|
202.5
|
231.1
|
|
|
|
|
Cash collateral and settlement
balances
|
139.8
|
102.3
|
122.1
|
|
|
|
|
Other assets
|
198.8
|
175.8
|
192.0
|
|
|
|
|
Total assets
|
1,113.8
|
1,019.1
|
1,078.4
|
|
|
|
|
Deposits at amortised
cost
|
151.3
|
132.7
|
142.9
|
|
|
|
|
Derivative financial instrument
liabilities
|
241.8
|
249.7
|
254.5
|
|
|
|
|
Risk weighted assets
|
203.3
|
197.3
|
197.2
|
|
|
|
|
Period end allocated tangible
equity
|
29.7
|
29.0
|
28.7
|
|
|
|
|
|
Half year ended
|
|
Three months ended
|
|
30.06.24
|
30.06.23
|
|
|
30.06.24
|
30.06.23
|
|
Analysis of total income
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
FICC
|
2,553
|
2,974
|
(14)
|
|
1,149
|
1,186
|
(3)
|
Equities
|
1,579
|
1,267
|
25
|
|
696
|
563
|
24
|
Global Markets
|
4,132
|
4,241
|
(3)
|
|
1,845
|
1,749
|
5
|
Advisory
|
286
|
342
|
(16)
|
|
138
|
130
|
6
|
Equity capital markets
|
189
|
119
|
59
|
|
121
|
69
|
75
|
Debt capital markets
|
821
|
614
|
34
|
|
420
|
273
|
54
|
Banking fees and
underwriting
|
1,296
|
1,075
|
21
|
|
679
|
472
|
44
|
Corporate lending
|
129
|
133
|
(3)
|
|
87
|
100
|
(13)
|
Transaction banking
|
790
|
863
|
(8)
|
|
408
|
422
|
(3)
|
International Corporate
Bank
|
919
|
996
|
(8)
|
|
495
|
522
|
(5)
|
Investment Banking
|
2,215
|
2,071
|
7
|
|
1,174
|
994
|
18
|
Total income
|
6,347
|
6,312
|
1
|
|
3,019
|
2,743
|
10
|
IB delivered a RoTE of 10.8% (H123: 11.1%)
reflecting the benefit of diversified income
streams with an increase in Equities and Banking fees and
underwriting income, offset by a decrease in FICC and International
Corporate Bank income. Costs were marginally up while impairment
remained below prior year, reflecting improved macroeconomic
outlook.
Income statement - H124 compared to H123
• Profit before tax increased
to £2,411m (H123: £2,365m)
• Total income increased 1% to
£6,347m (H123: £6,312m)
-
Global Markets income decreased 3% to £4,132m as
increased income in Equities was more than offset by lower income
in FICC. Equities income increased 25% to £1,579m, driven by growth
across products reflecting increased client activity in derivatives
and growth in financing balances, additionally supported by a £125m
fair value gain on Visa B shares in Q124. FICC income decreased 14%
to £2,553m, reflecting lower client activity in Macro and the
non-repeat of the inflation benefit from prior year, partially
offset by strong performance in securitised
products
-
Investment Banking income increased 7% to
£2,215m
- Banking fees and underwriting income increased 21% to
£1,296m. Equity capital markets fees increased 59% reflecting
strong Q224 performance including fees booked on a large UK rights
issue. Debt capital markets fees increased 34% driven by increased activity in leverage finance and
investment grade issuance, partially offset by Advisory fee income
which decreased 16%
- International Corporate Bank income decreased 8% to £919m,
mainly driven by Transaction banking as a result of margin
compression as customers migrate to higher interest returning
products and lower liquidity pool income. Corporate lending income
is broadly stable
• Total operating expenses
increased 2% to £3,902m reflecting
Q224 structural costs actions, inflation and the estimated impact
of the BoE levy scheme in Q124, partially offset by efficiency
savings
• Credit impairment charges
were £34m (H123: £102m), driven by
single name charges, partially offset by the benefit of credit
protection and the improved macroeconomic outlook
Balance sheet - 30 June 2024 compared to 31 December
2023
• Loans and advances at
amortised costs increased £6.0bn to £114.9bn
driven by increased investment in debt securities
in Treasury and increased lending in Global Markets
• Trading portfolio assets
increased £22.7bn to £197.2bn driven by increased trading in debt securities as we
facilitate client demand in Global Markets
• Derivatives assets and
liabilities remained broadly stable at £251.4bn and £241.8bn
respectively reflecting a decrease
in Macro due to lower market volatility, offset by increased client
activity in Equities
• Financial assets at fair
value through the income statement increased £9.2bn to
£211.7bn driven by increased
secured lending
• Deposits at amortised cost
increased £18.6bn to £151.3bn driven by growth in deposits, primarily in International
Corporate Bank
• RWAs increased to £203.3bn
(December 2023: £197.3bn) driven by
seasonal increases relative to FY23 and elevated client trading
activity in Global Markets
Barclays US Consumer Bank
|
Half year ended
|
|
Three months ended
|
|
30.06.24
|
30.06.23
|
|
|
30.06.24
|
30.06.23
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
Net interest income
|
1,334
|
1,256
|
6
|
|
646
|
622
|
4
|
Net fee, commission and other
income
|
344
|
337
|
2
|
|
173
|
145
|
19
|
Total income
|
1,678
|
1,593
|
5
|
|
819
|
767
|
7
|
Operating costs
|
(796)
|
(828)
|
4
|
|
(408)
|
(401)
|
(2)
|
UK regulatory levies
|
-
|
-
|
|
|
-
|
-
|
|
Litigation and conduct
|
(4)
|
(4)
|
-
|
|
(2)
|
(4)
|
50
|
Total operating expenses
|
(800)
|
(832)
|
4
|
|
(410)
|
(405)
|
(1)
|
Other net income
|
-
|
-
|
|
|
-
|
-
|
|
Profit before impairment
|
878
|
761
|
15
|
|
409
|
362
|
13
|
Credit impairment
charges
|
(719)
|
(585)
|
(23)
|
|
(309)
|
(264)
|
(17)
|
Profit before tax
|
159
|
176
|
(10)
|
|
100
|
98
|
2
|
Attributable profit
|
119
|
131
|
(9)
|
|
75
|
72
|
4
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
Return on average allocated
tangible equity
|
7.2%
|
8.4%
|
|
|
9.2%
|
9.3%
|
|
Average allocated tangible equity
(£bn)
|
3.3
|
3.1
|
|
|
3.3
|
3.1
|
|
Cost: income ratio
|
48%
|
52%
|
|
|
50%
|
53%
|
|
Loan loss rate (bps)
|
509
|
458
|
|
|
438
|
411
|
|
Net interest margin
|
10.78%
|
10.81%
|
|
|
10.43%
|
10.66%
|
|
|
|
|
|
|
|
|
|
Key facts
|
|
|
|
|
|
|
|
US cards 30 day arrears
rate
|
2.9%
|
2.4%
|
|
|
|
|
|
US cards customer FICO score
distribution
|
|
|
|
|
|
|
|
<660
|
12%
|
11%
|
|
|
|
|
|
>660
|
88%
|
89%
|
|
|
|
|
|
End net receivables
($bn)
|
31.2
|
29.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As
at 30.06.24
|
As
at 31.12.23
|
As
at 30.06.23
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
|
|
|
Loans and advances to customers at
amortised cost
|
24.3
|
24.2
|
22.9
|
|
|
|
|
Deposits at amortised
cost
|
20.0
|
19.7
|
17.9
|
|
|
|
|
Risk weighted assets
|
24.4
|
24.8
|
22.5
|
|
|
|
|
Period end allocated tangible
equity
|
3.3
|
3.4
|
3.1
|
|
|
|
|
USCB delivered a RoTE of 7.2% (H123: 8.4%)
with growth in cards balances, offset by increase
in impairment charge from higher anticipated delinquencies.
c.£0.9bn ($1.1bn) of the outstanding credit card receivables were
sold to Blackstone in Q124, providing a benefit from reduced
RWAs.
Income statement - H124 compared to H123
• Profit before tax was £159m
(H123: £176m)
• Total income increased 5% to
£1,678m. NII increased 6% to
£1,334m reflecting £1.5bn ($1.7bn) higher cards balances to £24.7bn
($31.2bn). Net fee, commission and other income increased 2% to
£344m reflecting higher purchases and account
growth1
• Total operating expenses
decreased 4% to £800m, driven by
efficiency savings and lower marketing costs
• Credit impairment charges
increased to £719m (H123: £585m), driven by the anticipated higher delinquencies in US cards,
which led to higher coverage ratios. 30 and 90 day arrears for US
cards were 2.9% (H123: 2.4%) and 1.6% (H123: 1.2%) respectively.
The USCB total coverage ratio was 11.0% (December 2023:
10.1%)
Balance sheet - 30 June 2024 compared to 31 December
2023
• Loans and advances to
customers at amortised cost remained broadly stable at £24.3bn
(December 2023: £24.2bn)
• Customer deposits at
amortised cost has increased to £20.0bn (December 2023:
£19.7bn), in line with USCB's
ambition to grow core deposits
• RWAs decreased to £24.4bn
(December 2023: £24.8bn), reflecting sale of receivables to Blackstone in
Q124
1
|
Includes Barclays accounts and those serviced for third
parties.
|
Head Office
|
Half year ended
|
|
Three months ended
|
|
30.06.24
|
30.06.23
|
|
|
30.06.24
|
30.06.23
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
Net interest income
|
248
|
99
|
|
|
62
|
(52)
|
|
Net fee, commission and other
income
|
(218)
|
103
|
|
|
(226)
|
95
|
|
Total income
|
30
|
202
|
(85)
|
|
(164)
|
43
|
|
Operating costs
|
(406)
|
(425)
|
4
|
|
(195)
|
(221)
|
12
|
UK regulatory levies
|
-
|
-
|
|
|
|
-
|
|
Litigation and conduct
|
(43)
|
(33)
|
(30)
|
|
1
|
(32)
|
|
Total operating expenses
|
(449)
|
(458)
|
2
|
|
(194)
|
(253)
|
23
|
Other net
income/(expenses)
|
16
|
(3)
|
|
|
4
|
2
|
|
Loss before impairment
|
(403)
|
(259)
|
(56)
|
|
(354)
|
(208)
|
(70)
|
Credit impairment
charges
|
(58)
|
(51)
|
(14)
|
|
(18)
|
(13)
|
(38)
|
Loss before tax
|
(461)
|
(310)
|
(49)
|
|
(372)
|
(221)
|
(68)
|
Attributable loss
|
(408)
|
(256)
|
(59)
|
|
(349)
|
(170)
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
Average allocated tangible equity
(£bn)
|
2.4
|
0.8
|
|
|
2.1
|
0.5
|
|
|
|
|
|
|
|
|
|
|
As
at 30.06.24
|
As
at 31.12.23
|
As
at 30.06.23
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
|
|
|
Risk weighted assets
|
18.3
|
19.0
|
16.4
|
|
|
|
|
Period end allocated tangible
equity
|
2.7
|
3.6
|
(0.5)
|
|
|
|
|
Income statement - H124 compared to H123
• Loss before tax was £461m
(H123: £310m)
• Total income decreased to
£30m (H123: £202m) mainly driven by
the loss on sale of the performing Italian retail mortgage
portfolio and the impact of the disposal of the German consumer
finance business. These were partially offset by a gain on disposal
of a legacy investment
• Total operating expenses
were broadly stable at £449m (H123: £458m)
• Credit impairment charges
were broadly stable at £58m (H123: £51m)
Balance sheet - 30 June 2024 compared to 31 December
2023
• RWAs decreased to £18.3bn
(December 2023: £19.0bn) mainly
from the sale of the performing Italian mortgage
portfolio
Quarterly Results Summary
Barclays Group
|
|
|
|
|
|
|
|
|
|
|
|
Q224
|
Q124
|
|
Q423
|
Q323
|
Q223
|
Q123
|
|
Q422
|
Q322
|
Income statement information
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Net interest income
|
3,056
|
3,072
|
|
3,139
|
3,247
|
3,270
|
3,053
|
|
2,741
|
3,068
|
Net fee, commission and other
income
|
3,268
|
3,881
|
|
2,459
|
3,011
|
3,015
|
4,184
|
|
3,060
|
2,883
|
Total income
|
6,324
|
6,953
|
|
5,598
|
6,258
|
6,285
|
7,237
|
|
5,801
|
5,951
|
Operating costs
|
(3,999)
|
(3,998)
|
|
(4,735)
|
(3,949)
|
(3,919)
|
(4,111)
|
|
(3,748)
|
(3,939)
|
UK regulatory levies
|
-
|
(120)
|
|
(180)
|
-
|
-
|
-
|
|
(176)
|
-
|
Litigation and conduct
|
(7)
|
(57)
|
|
(5)
|
-
|
(33)
|
1
|
|
(79)
|
339
|
Total operating expenses
|
(4,006)
|
(4,175)
|
|
(4,920)
|
(3,949)
|
(3,952)
|
(4,110)
|
|
(4,003)
|
(3,600)
|
Other net
income/(expenses)
|
4
|
12
|
|
(16)
|
9
|
3
|
(5)
|
|
10
|
(1)
|
Profit before impairment
|
2,322
|
2,790
|
|
662
|
2,318
|
2,336
|
3,122
|
|
1,808
|
2,350
|
Credit impairment
charges
|
(384)
|
(513)
|
|
(552)
|
(433)
|
(372)
|
(524)
|
|
(498)
|
(381)
|
Profit before tax
|
1,938
|
2,277
|
|
110
|
1,885
|
1,964
|
2,598
|
|
1,310
|
1,969
|
Tax (charges)/credit
|
(427)
|
(465)
|
|
23
|
(343)
|
(353)
|
(561)
|
|
33
|
(249)
|
Profit after tax
|
1,511
|
1,812
|
|
133
|
1,542
|
1,611
|
2,037
|
|
1,343
|
1,720
|
Non-controlling
interests
|
(23)
|
(3)
|
|
(25)
|
(9)
|
(22)
|
(8)
|
|
(22)
|
(2)
|
Other equity instrument
holders
|
(251)
|
(259)
|
|
(219)
|
(259)
|
(261)
|
(246)
|
|
(285)
|
(206)
|
Attributable profit/(loss)
|
1,237
|
1,550
|
|
(111)
|
1,274
|
1,328
|
1,783
|
|
1,036
|
1,512
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
Return on average tangible
shareholders' equity
|
9.9%
|
12.3%
|
|
(0.9)%
|
11.0%
|
11.4%
|
15.0%
|
|
8.9%
|
12.5%
|
Average tangible shareholders'
equity (£bn)
|
49.8
|
50.5
|
|
48.9
|
46.5
|
46.7
|
47.6
|
|
46.7
|
48.6
|
Cost: income ratio
|
63%
|
60%
|
|
88%
|
63%
|
63%
|
57%
|
|
69%
|
60%
|
Loan loss rate (bps)
|
38
|
51
|
|
54
|
42
|
37
|
52
|
|
49
|
36
|
Basic earnings per ordinary
share
|
8.3p
|
10.3p
|
|
(0.7)p
|
8.3p
|
8.6p
|
11.3p
|
|
6.5p
|
9.4p
|
Basic weighted average number of
shares (m)
|
14,915
|
14,983
|
|
15,092
|
15,405
|
15,523
|
15,770
|
|
15,828
|
16,148
|
Period end number of shares
(m)
|
14,826
|
15,091
|
|
15,155
|
15,239
|
15,556
|
15,701
|
|
15,871
|
15,888
|
Period end tangible shareholders'
equity (£bn)
|
50.4
|
50.6
|
|
50.2
|
48.2
|
45.3
|
47.3
|
|
46.8
|
45.4
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet and capital
management1
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Loans and advances to customers at
amortised cost
|
329.8
|
332.1
|
|
333.3
|
339.6
|
337.4
|
343.6
|
|
343.3
|
346.3
|
Loans and advances to banks at
amortised cost
|
8.0
|
8.5
|
|
9.5
|
11.5
|
10.9
|
11.0
|
|
10.0
|
12.5
|
Debt securities at amortised
cost
|
61.7
|
57.4
|
|
56.7
|
54.3
|
53.1
|
48.9
|
|
45.5
|
54.8
|
Loans and advances at amortised cost
|
399.5
|
397.9
|
|
399.5
|
405.4
|
401.4
|
403.5
|
|
398.8
|
413.7
|
Loans and advances at amortised
cost impairment coverage ratio
|
1.4%
|
1.4%
|
|
1.4%
|
1.4%
|
1.4%
|
1.4%
|
|
1.4%
|
1.4%
|
Total assets
|
1,576.6
|
1,577.1
|
|
1,477.5
|
1,591.7
|
1,549.7
|
1,539.1
|
|
1,513.7
|
1,726.9
|
Deposits at amortised
cost
|
557.5
|
552.3
|
|
538.8
|
561.3
|
554.7
|
555.7
|
|
545.8
|
574.4
|
Tangible net asset value per
share
|
340p
|
335p
|
|
331p
|
316p
|
291p
|
301p
|
|
295p
|
286p
|
Common equity tier 1
ratio
|
13.6%
|
13.5%
|
|
13.8%
|
14.0%
|
13.8%
|
13.6%
|
|
13.9%
|
13.8%
|
Common equity tier 1
capital
|
47.7
|
47.1
|
|
47.3
|
48.0
|
46.6
|
46.0
|
|
46.9
|
48.6
|
Risk weighted assets
|
351.4
|
349.6
|
|
342.7
|
341.9
|
336.9
|
338.4
|
|
336.5
|
350.8
|
UK leverage ratio
|
5.0%
|
4.9%
|
|
5.2%
|
5.0%
|
5.1%
|
5.1%
|
|
5.3%
|
5.0%
|
UK leverage exposure
|
1,222.7
|
1,226.5
|
|
1,168.3
|
1,202.4
|
1,183.7
|
1,168.9
|
|
1,130.0
|
1,232.1
|
|
|
|
|
|
|
|
|
|
|
|
Funding and liquidity
|
|
|
|
|
|
|
|
|
|
|
Group liquidity pool
(£bn)
|
328.7
|
323.5
|
|
298.1
|
335.0
|
330.7
|
333.0
|
|
318.0
|
325.8
|
Liquidity coverage
ratio2
|
167.0%
|
163.2%
|
|
161.4%
|
158.7%
|
157.2%
|
156.6%
|
|
155.5%
|
156.4%
|
Net stable funding
ratio3
|
136.4%
|
135.7%
|
|
138.0%
|
138.2%
|
138.8%
|
139.2%
|
|
137.0%
|
|
Loan: deposit ratio
|
72%
|
72%
|
|
74%
|
72%
|
72%
|
73%
|
|
73%
|
72%
|
1
|
Refer to pages 53 to 57 for further information on how
capital, RWAs and leverage are calculated.
|
2
|
The Liquidity Coverage Ratio is based on the average of the
last 12 spot month end ratios. Prior period LCR comparatives have
been updated for consistency.
|
3
|
Represents average of the last four spot quarter end
position, effective from Q422.
|
Barclays UK
|
|
|
|
|
|
|
|
|
|
|
|
Q224
|
Q124
|
|
Q423
|
Q323
|
Q223
|
Q123
|
|
Q422
|
Q322
|
Income statement information
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Net interest income
|
1,597
|
1,549
|
|
1,575
|
1,578
|
1,660
|
1,618
|
|
1,600
|
1,561
|
Net fee, commission and other
income
|
290
|
277
|
|
217
|
295
|
301
|
343
|
|
370
|
355
|
Total income
|
1,887
|
1,826
|
|
1,792
|
1,873
|
1,961
|
1,961
|
|
1,970
|
1,916
|
Operating costs
|
(1,041)
|
(1,007)
|
|
(1,153)
|
(1,058)
|
(1,090)
|
(1,092)
|
|
(1,108)
|
(1,069)
|
UK regulatory levies
|
-
|
(54)
|
|
(30)
|
-
|
-
|
-
|
|
(26)
|
-
|
Litigation and conduct
|
(4)
|
(2)
|
|
(4)
|
9
|
5
|
(2)
|
|
(13)
|
(3)
|
Total operating expenses
|
(1,045)
|
(1,063)
|
|
(1,187)
|
(1,049)
|
(1,085)
|
(1,094)
|
|
(1,147)
|
(1,072)
|
Other net
income/(expenses)
|
-
|
-
|
|
-
|
-
|
-
|
-
|
|
1
|
(1)
|
Profit before impairment
|
842
|
763
|
|
605
|
824
|
876
|
867
|
|
824
|
843
|
Credit impairment
charges
|
(8)
|
(58)
|
|
(37)
|
(59)
|
(95)
|
(113)
|
|
(157)
|
(81)
|
Profit before tax
|
834
|
705
|
|
568
|
765
|
781
|
754
|
|
667
|
762
|
Attributable profit
|
584
|
479
|
|
382
|
531
|
534
|
515
|
|
474
|
549
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Loans and advances to customers at
amortised cost
|
198.7
|
200.8
|
|
202.8
|
204.9
|
206.8
|
208.2
|
|
205.1
|
205.1
|
Customer deposits at amortised
cost
|
236.8
|
237.2
|
|
241.1
|
243.2
|
249.8
|
254.3
|
|
258.0
|
261.0
|
Loan: deposit ratio
|
91%
|
92%
|
|
92%
|
92%
|
90%
|
90%
|
|
87%
|
86%
|
Risk weighted assets
|
76.5
|
76.5
|
|
73.5
|
73.2
|
73.0
|
74.6
|
|
73.1
|
73.2
|
Period end allocated tangible
equity
|
10.6
|
10.7
|
|
10.2
|
10.1
|
10.1
|
10.3
|
|
10.1
|
10.1
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated
tangible equity
|
22.3%
|
18.5%
|
|
14.9%
|
21.0%
|
20.9%
|
20.0%
|
|
18.7%
|
22.1%
|
Average allocated tangible equity
(£bn)
|
10.5
|
10.4
|
|
10.2
|
10.1
|
10.2
|
10.3
|
|
10.2
|
9.9
|
Cost: income ratio
|
55%
|
58%
|
|
66%
|
56%
|
55%
|
56%
|
|
58%
|
56%
|
Loan loss rate (bps)
|
1
|
11
|
|
7
|
10
|
17
|
20
|
|
27
|
14
|
Net interest margin
|
3.22%
|
3.09%
|
|
3.07%
|
3.04%
|
3.22%
|
3.18%
|
|
3.10%
|
3.01%
|
Analysis of Barclays UK
|
Q224
|
Q124
|
|
Q423
|
Q323
|
Q223
|
Q123
|
|
Q422
|
Q322
|
Analysis of total income
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Personal Banking
|
1,174
|
1,128
|
|
1,067
|
1,165
|
1,244
|
1,253
|
|
1,229
|
1,212
|
Barclaycard Consumer UK
|
228
|
229
|
|
242
|
238
|
237
|
247
|
|
269
|
283
|
Business Banking
|
485
|
469
|
|
483
|
470
|
480
|
461
|
|
472
|
421
|
Total income
|
1,887
|
1,826
|
|
1,792
|
1,873
|
1,961
|
1,961
|
|
1,970
|
1,916
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of credit impairment
charges/(releases)
|
|
|
|
|
|
|
|
|
|
|
Personal Banking
|
(26)
|
(14)
|
|
35
|
(85)
|
(92)
|
(28)
|
|
(120)
|
(26)
|
Barclaycard Consumer UK
|
(25)
|
(38)
|
|
(73)
|
29
|
(35)
|
(83)
|
|
(12)
|
2
|
Business Banking
|
43
|
(6)
|
|
1
|
(3)
|
32
|
(2)
|
|
(25)
|
(57)
|
Total credit impairment charges
|
(8)
|
(58)
|
|
(37)
|
(59)
|
(95)
|
(113)
|
|
(157)
|
(81)
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of loans and advances to customers at amortised
cost
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Personal Banking
|
167.3
|
169.0
|
|
170.1
|
172.3
|
173.3
|
173.6
|
|
169.7
|
168.7
|
Barclaycard Consumer UK
|
10.2
|
9.8
|
|
9.7
|
9.6
|
9.3
|
9.0
|
|
9.2
|
9.0
|
Business Banking
|
21.2
|
22.0
|
|
23.0
|
23.0
|
24.2
|
25.6
|
|
26.2
|
27.4
|
Total loans and advances to customers at amortised
cost
|
198.7
|
200.8
|
|
202.8
|
204.9
|
206.8
|
208.2
|
|
205.1
|
205.1
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of customer deposits at amortised
cost
|
|
|
|
|
|
|
|
|
|
|
Personal Banking
|
183.3
|
183.4
|
|
185.4
|
186.1
|
191.1
|
194.3
|
|
195.6
|
197.3
|
Barclaycard Consumer UK
|
-
|
-
|
|
-
|
-
|
-
|
-
|
|
-
|
-
|
Business Banking
|
53.5
|
53.8
|
|
55.7
|
57.1
|
58.7
|
60.0
|
|
62.4
|
63.7
|
Total customer deposits at amortised cost
|
236.8
|
237.2
|
|
241.1
|
243.2
|
249.8
|
254.3
|
|
258.0
|
261.0
|
Barclays UK Corporate Bank
|
|
|
|
|
|
|
|
|
|
|
|
Q224
|
Q124
|
|
Q423
|
Q323
|
Q223
|
Q123
|
|
Q422
|
Q322
|
Income statement information
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Net interest income
|
296
|
277
|
|
247
|
304
|
299
|
310
|
|
324
|
309
|
Net fee, commission, trading and
other income
|
147
|
157
|
|
148
|
136
|
173
|
153
|
|
153
|
124
|
Total income
|
443
|
434
|
|
395
|
440
|
472
|
463
|
|
477
|
433
|
Operating costs
|
(235)
|
(221)
|
|
(258)
|
(224)
|
(213)
|
(210)
|
|
(213)
|
(209)
|
UK regulatory levies
|
-
|
(30)
|
|
(8)
|
-
|
-
|
-
|
|
(7)
|
-
|
Litigation and conduct
|
-
|
-
|
|
(1)
|
2
|
-
|
-
|
|
-
|
-
|
Total operating expenses
|
(235)
|
(251)
|
|
(267)
|
(222)
|
(213)
|
(210)
|
|
(220)
|
(209)
|
Other net
(expenses)/income
|
-
|
-
|
|
(5)
|
-
|
1
|
1
|
|
1
|
-
|
Profit before impairment
|
208
|
183
|
|
123
|
218
|
260
|
254
|
|
258
|
224
|
Credit impairment
(charges)/releases
|
(8)
|
(15)
|
|
(18)
|
(15)
|
84
|
(24)
|
|
(52)
|
32
|
Profit before tax
|
200
|
168
|
|
105
|
203
|
344
|
230
|
|
206
|
256
|
Attributable profit
|
135
|
113
|
|
59
|
129
|
239
|
157
|
|
131
|
172
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Loans and advances to customers at
amortised cost
|
25.7
|
25.7
|
|
26.4
|
26.9
|
26.9
|
27.2
|
|
26.9
|
27.2
|
Deposits at amortised
cost
|
84.9
|
81.7
|
|
84.9
|
82.7
|
82.6
|
83.6
|
|
84.4
|
86.1
|
Risk weighted assets
|
21.9
|
21.4
|
|
20.9
|
19.5
|
20.6
|
20.2
|
|
21.1
|
20.4
|
Period end allocated tangible
equity
|
3.0
|
3.0
|
|
3.0
|
2.8
|
2.9
|
2.9
|
|
3.0
|
2.9
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated
tangible equity
|
18.0%
|
15.2%
|
|
8.4%
|
18.3%
|
32.9%
|
21.7%
|
|
17.8%
|
23.4%
|
Average allocated tangible equity
(£bn)
|
3.0
|
3.0
|
|
2.8
|
2.8
|
2.9
|
2.9
|
|
2.9
|
2.9
|
Cost: income ratio
|
53%
|
58%
|
|
68%
|
50%
|
45%
|
45%
|
|
46%
|
48%
|
Loan loss rate (bps)
|
12
|
23
|
|
27
|
21
|
(123)
|
36
|
|
74
|
(45)
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of total income
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Corporate lending
|
57
|
72
|
|
64
|
69
|
68
|
61
|
|
66
|
56
|
Transaction banking
|
386
|
362
|
|
331
|
371
|
404
|
402
|
|
411
|
377
|
Total income
|
443
|
434
|
|
395
|
440
|
472
|
463
|
|
477
|
433
|
Barclays Private Bank and Wealth Management
|
|
|
|
|
|
|
|
|
|
|
|
Q224
|
Q124
|
|
Q423
|
Q323
|
Q223
|
Q123
|
|
Q422
|
Q322
|
Income statement information
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Net interest income
|
187
|
175
|
|
182
|
219
|
186
|
181
|
|
205
|
197
|
Net fee, commission and other
income
|
133
|
137
|
|
131
|
118
|
113
|
78
|
|
81
|
72
|
Total income
|
320
|
312
|
|
313
|
337
|
299
|
259
|
|
286
|
269
|
Operating costs
|
(220)
|
(214)
|
|
(255)
|
(214)
|
(182)
|
(144)
|
|
(153)
|
(135)
|
UK regulatory levies
|
-
|
(3)
|
|
(4)
|
-
|
-
|
-
|
|
(4)
|
-
|
Litigation and conduct
|
1
|
-
|
|
2
|
-
|
-
|
-
|
|
-
|
-
|
Total operating expenses
|
(219)
|
(217)
|
|
(257)
|
(214)
|
(182)
|
(144)
|
|
(157)
|
(135)
|
Other net income
|
-
|
-
|
|
-
|
-
|
-
|
-
|
|
-
|
-
|
Profit before impairment
|
101
|
95
|
|
56
|
123
|
117
|
115
|
|
129
|
134
|
Credit impairment
releases/(charges)
|
3
|
-
|
|
4
|
2
|
(7)
|
(3)
|
|
(10)
|
-
|
Profit before tax
|
104
|
95
|
|
60
|
125
|
110
|
112
|
|
119
|
134
|
Attributable profit
|
77
|
74
|
|
47
|
102
|
91
|
90
|
|
92
|
108
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Loans and advances to customers at
amortised cost
|
13.9
|
13.7
|
|
13.6
|
13.4
|
13.8
|
14.3
|
|
14.4
|
14.6
|
Deposits at amortised
cost
|
64.6
|
61.9
|
|
60.3
|
59.7
|
59.2
|
60.8
|
|
62.3
|
62.9
|
Risk weighted assets
|
7.0
|
7.2
|
|
7.2
|
7.2
|
7.2
|
7.5
|
|
7.8
|
7.9
|
Period end allocated tangible
equity
|
1.0
|
1.0
|
|
1.0
|
1.0
|
1.0
|
1.0
|
|
1.1
|
1.1
|
Client assets and
liabilities1
|
198.5
|
189.1
|
|
182.9
|
178.7
|
174.1
|
141.5
|
|
139.4
|
138.4
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated
tangible equity
|
30.8%
|
28.7%
|
|
19.1%
|
41.2%
|
35.9%
|
34.5%
|
|
34.9%
|
41.7%
|
Average allocated tangible equity
(£bn)
|
1.0
|
1.0
|
|
1.0
|
1.0
|
1.0
|
1.0
|
|
1.1
|
1.0
|
Cost: income ratio
|
68%
|
70%
|
|
82%
|
63%
|
61%
|
56%
|
|
55%
|
50%
|
Loan loss rate (bps)
|
(9)
|
-
|
|
(10)
|
(7)
|
20
|
7
|
|
26
|
1
|
1
|
Client assets and liabilities refers to customer deposits,
lending and invested assets.
|
Barclays Investment Bank
|
|
|
|
|
|
|
|
|
|
|
|
Q224
|
Q124
|
|
Q423
|
Q323
|
Q223
|
Q123
|
|
Q422
|
Q322
|
Income statement information
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Net interest income
|
268
|
197
|
|
282
|
397
|
555
|
159
|
|
228
|
304
|
Net trading income
|
1,485
|
1,982
|
|
757
|
1,497
|
1,351
|
2,435
|
|
1,197
|
1,346
|
Net fee, commission and other
income
|
1,266
|
1,149
|
|
998
|
792
|
837
|
975
|
|
731
|
794
|
Total income
|
3,019
|
3,328
|
|
2,037
|
2,686
|
2,743
|
3,569
|
|
2,156
|
2,444
|
Operating costs
|
(1,900)
|
(1,957)
|
|
(1,934)
|
(1,840)
|
(1,813)
|
(2,032)
|
|
(1,619)
|
(1,869)
|
UK regulatory levies
|
-
|
(33)
|
|
(123)
|
-
|
-
|
-
|
|
(119)
|
-
|
Litigation and conduct
|
(3)
|
(9)
|
|
(2)
|
6
|
(1)
|
2
|
|
(55)
|
498
|
Total operating expenses
|
(1,903)
|
(1,999)
|
|
(2,059)
|
(1,834)
|
(1,814)
|
(2,030)
|
|
(1,793)
|
(1,371)
|
Other net
(expenses)/income
|
-
|
-
|
|
(1)
|
2
|
-
|
(1)
|
|
1
|
1
|
Profit/(loss) before impairment
|
1,116
|
1,329
|
|
(23)
|
854
|
929
|
1,538
|
|
364
|
1,074
|
Credit impairment (charges)/
releases
|
(44)
|
10
|
|
(23)
|
23
|
(77)
|
(25)
|
|
(22)
|
(93)
|
Profit/(loss) before tax
|
1,072
|
1,339
|
|
(46)
|
877
|
852
|
1,513
|
|
342
|
981
|
Attributable
profit/(loss)
|
715
|
899
|
|
(149)
|
580
|
562
|
1,048
|
|
313
|
847
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Loans and advances to customers at
amortised cost
|
66.6
|
64.6
|
|
62.7
|
62.3
|
59.1
|
63.1
|
|
64.6
|
67.5
|
Loans and advances to banks at
amortised cost
|
6.6
|
7.6
|
|
7.3
|
9.5
|
9.0
|
9.1
|
|
8.1
|
10.1
|
Debt securities at amortised
cost
|
41.7
|
40.4
|
|
38.9
|
36.3
|
35.1
|
30.7
|
|
27.2
|
36.2
|
Loans and advances at amortised cost
|
114.9
|
112.6
|
|
108.9
|
108.1
|
103.2
|
102.9
|
|
99.9
|
113.8
|
Trading portfolio
assets
|
197.2
|
195.3
|
|
174.5
|
155.3
|
165.0
|
137.6
|
|
133.7
|
126.1
|
Derivative financial instrument
assets
|
251.4
|
248.9
|
|
255.1
|
280.4
|
264.8
|
256.5
|
|
301.6
|
415.5
|
Financial assets at fair value
through the income statement
|
211.7
|
225.1
|
|
202.5
|
237.2
|
231.1
|
243.8
|
|
209.4
|
243.6
|
Cash collateral and settlement
balances
|
139.8
|
129.8
|
|
102.3
|
134.6
|
122.1
|
124.3
|
|
106.2
|
162.2
|
Deposits at amortised
cost
|
151.3
|
151.1
|
|
132.7
|
154.2
|
142.9
|
137.3
|
|
121.5
|
143.4
|
Derivative financial instrument
liabilities
|
241.8
|
241.5
|
|
249.7
|
268.3
|
254.5
|
246.7
|
|
288.9
|
394.2
|
Risk weighted assets
|
203.3
|
200.4
|
|
197.3
|
201.1
|
197.2
|
198.0
|
|
195.9
|
211.4
|
Period end allocated tangible
equity
|
29.7
|
29.6
|
|
29.0
|
29.0
|
28.7
|
28.9
|
|
28.6
|
30.8
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated
tangible equity
|
9.6%
|
12.0%
|
|
(2.1)%
|
8.0%
|
7.7%
|
14.4%
|
|
4.0%
|
10.9%
|
Average allocated tangible equity
(£bn)
|
29.9
|
30.0
|
|
28.9
|
28.8
|
29.0
|
29.1
|
|
30.9
|
31.2
|
Cost: income ratio
|
63%
|
60%
|
|
101%
|
68%
|
66%
|
57%
|
|
83%
|
56%
|
Loan loss rate (bps)
|
15
|
(4)
|
|
8
|
(8)
|
30
|
10
|
|
9
|
32
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of total income
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
FICC
|
1,149
|
1,404
|
|
724
|
1,147
|
1,186
|
1,788
|
|
976
|
1,546
|
Equities
|
696
|
883
|
|
431
|
675
|
563
|
704
|
|
440
|
246
|
Global Markets
|
1,845
|
2,287
|
|
1,155
|
1,822
|
1,749
|
2,492
|
|
1,416
|
1,792
|
Advisory
|
138
|
148
|
|
171
|
80
|
130
|
212
|
|
197
|
150
|
Equity capital markets
|
121
|
68
|
|
38
|
62
|
69
|
50
|
|
40
|
42
|
Debt capital markets
|
420
|
401
|
|
301
|
233
|
273
|
341
|
|
243
|
341
|
Banking Fees and
Underwriting
|
679
|
617
|
|
510
|
375
|
472
|
603
|
|
480
|
533
|
Corporate lending
|
87
|
42
|
|
(23)
|
103
|
100
|
33
|
|
(194)
|
(237)
|
Transaction banking
|
408
|
382
|
|
395
|
386
|
422
|
441
|
|
454
|
356
|
International Corporate
Banking
|
495
|
424
|
|
372
|
489
|
522
|
474
|
|
260
|
119
|
Investment Banking
|
1,174
|
1,041
|
|
882
|
864
|
994
|
1,077
|
|
740
|
652
|
Total income
|
3,019
|
3,328
|
|
2,037
|
2,686
|
2,743
|
3,569
|
|
2,156
|
2,444
|
Barclays US Consumer Bank
|
|
|
|
|
|
|
|
|
|
|
|
Q224
|
Q124
|
|
Q423
|
Q323
|
Q223
|
Q123
|
|
Q422
|
Q322
|
Income statement information
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Net interest income
|
646
|
688
|
|
686
|
662
|
622
|
634
|
|
639
|
616
|
Net fee, commission, trading and
other income
|
173
|
171
|
|
180
|
147
|
145
|
192
|
|
149
|
137
|
Total income
|
819
|
859
|
|
866
|
809
|
767
|
826
|
|
788
|
753
|
Operating costs
|
(408)
|
(387)
|
|
(418)
|
(404)
|
(401)
|
(427)
|
|
(425)
|
(429)
|
UK regulatory levies
|
-
|
-
|
|
-
|
-
|
-
|
-
|
|
-
|
-
|
Litigation and conduct
|
(2)
|
(3)
|
|
(2)
|
-
|
(4)
|
-
|
|
(3)
|
-
|
Total operating expenses
|
(410)
|
(390)
|
|
(420)
|
(404)
|
(405)
|
(427)
|
|
(428)
|
(429)
|
Other net income
|
-
|
-
|
|
-
|
-
|
-
|
-
|
|
-
|
-
|
Profit before impairment
|
409
|
469
|
|
446
|
405
|
362
|
399
|
|
360
|
324
|
Credit impairment
charges
|
(309)
|
(410)
|
|
(449)
|
(404)
|
(264)
|
(321)
|
|
(224)
|
(172)
|
Profit/(loss) before tax
|
100
|
59
|
|
(3)
|
1
|
98
|
78
|
|
136
|
152
|
Attributable
profit/(loss)
|
75
|
44
|
|
(3)
|
3
|
72
|
59
|
|
101
|
107
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Loans and advances to customers at
amortised cost
|
24.3
|
23.6
|
|
24.2
|
24.3
|
22.9
|
22.5
|
|
23.6
|
23.6
|
Deposits at amortised
cost
|
20.0
|
20.3
|
|
19.7
|
19.3
|
17.9
|
18.1
|
|
18.3
|
19.8
|
Risk weighted assets
|
24.4
|
23.9
|
|
24.8
|
24.1
|
22.5
|
22.5
|
|
23.9
|
23.6
|
Period end allocated tangible
equity
|
3.3
|
3.3
|
|
3.4
|
3.3
|
3.1
|
3.1
|
|
3.3
|
3.2
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated
tangible equity
|
9.2%
|
5.3%
|
|
(0.3)%
|
0.4%
|
9.3%
|
7.5%
|
|
12.6%
|
13.9%
|
Average allocated tangible equity
(£bn)
|
3.3
|
3.3
|
|
3.3
|
3.1
|
3.1
|
3.1
|
|
3.2
|
3.1
|
Cost: income ratio
|
50%
|
46%
|
|
48%
|
50%
|
53%
|
52%
|
|
54%
|
57%
|
Loan loss rate (bps)
|
438
|
610
|
|
636
|
582
|
411
|
515
|
|
337
|
257
|
Net interest margin
|
10.43%
|
11.12%
|
|
10.88%
|
10.88%
|
10.66%
|
10.97%
|
|
10.64%
|
10.81%
|
Head Office
|
|
|
|
|
|
|
|
|
|
|
|
Q224
|
Q124
|
|
Q423
|
Q323
|
Q223
|
Q123
|
|
Q422
|
Q322
|
Income statement information
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Net interest income
|
62
|
186
|
|
167
|
87
|
(52)
|
151
|
|
(255)
|
81
|
Net fee, commission and other
income
|
(226)
|
8
|
|
28
|
26
|
95
|
8
|
|
379
|
55
|
Total income
|
(164)
|
194
|
|
195
|
113
|
43
|
159
|
|
124
|
136
|
Operating costs
|
(195)
|
(211)
|
|
(717)
|
(210)
|
(221)
|
(204)
|
|
(229)
|
(229)
|
UK regulatory levies
|
-
|
-
|
|
(14)
|
-
|
-
|
-
|
|
(20)
|
-
|
Litigation and conduct
|
1
|
(44)
|
|
1
|
(16)
|
(32)
|
(1)
|
|
(9)
|
(155)
|
Total operating expenses
|
(194)
|
(255)
|
|
(730)
|
(226)
|
(253)
|
(205)
|
|
(258)
|
(384)
|
Other net
income/(expenses)
|
4
|
12
|
|
(10)
|
7
|
2
|
(5)
|
|
7
|
(1)
|
Loss before impairment
|
(354)
|
(49)
|
|
(545)
|
(106)
|
(208)
|
(51)
|
|
(127)
|
(249)
|
Credit impairment
(charges)/releases
|
(18)
|
(40)
|
|
(29)
|
20
|
(13)
|
(38)
|
|
(33)
|
(67)
|
Loss before tax
|
(372)
|
(89)
|
|
(574)
|
(86)
|
(221)
|
(89)
|
|
(160)
|
(316)
|
Attributable loss
|
(349)
|
(59)
|
|
(447)
|
(71)
|
(170)
|
(86)
|
|
(75)
|
(271)
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Risk weighted assets
|
18.3
|
20.2
|
|
19.0
|
16.8
|
16.4
|
15.6
|
|
14.7
|
14.3
|
Period end allocated tangible
equity
|
2.7
|
3.0
|
|
3.6
|
2.0
|
(0.5)
|
1.1
|
|
0.7
|
(2.6)
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
Average allocated tangible equity
(£bn)
|
2.1
|
2.8
|
|
2.7
|
0.7
|
0.5
|
1.2
|
|
(1.6)
|
0.5
|
Performance Management
Margins and balances
|
|
Half year ended 30.06.24
|
Half year ended 30.06.23
|
|
Net interest income
|
Average customer assets
|
Net interest margin
|
Net interest income
|
Average customer assets
|
Net interest margin
|
|
£m
|
£m
|
%
|
£m
|
£m
|
%
|
Barclays UK
|
3,146
|
200,599
|
3.15
|
3,278
|
206,653
|
3.20
|
Barclays UK Corporate
Bank
|
573
|
22,454
|
5.13
|
609
|
23,187
|
5.30
|
Barclays Private Bank and Wealth
Management
|
362
|
13,762
|
5.29
|
367
|
14,309
|
5.17
|
Barclays US Consumer
Bank
|
1,334
|
24,890
|
10.78
|
1,256
|
23,428
|
10.81
|
Group excluding IB and Head
Office
|
5,415
|
261,705
|
4.16
|
5,510
|
267,577
|
4.15
|
Barclays Investment
Bank
|
465
|
|
|
714
|
|
|
Head Office
|
248
|
|
|
99
|
|
|
Total Barclays Group net interest income
|
6,128
|
|
|
6,323
|
|
|
The Group excluding IB and Head
Office NIM has increased by 1bp from 4.15% in H123 to 4.16% in
H124, due to higher cards balances in USCB and continued structural
hedge momentum, partially offset by mortgage margin pressure and
adverse product dynamics in deposits in Barclays UK.
Quarterly analysis
|
|
|
|
Q224
|
Q124
|
Q423
|
Q323
|
Q223
|
Net interest income
|
£m
|
£m
|
£m
|
£m
|
£m
|
Barclays UK
|
1,597
|
1,549
|
1,575
|
1,578
|
1,660
|
Barclays UK Corporate
Bank
|
296
|
277
|
247
|
304
|
299
|
Barclays Private Bank and Wealth
Management
|
187
|
175
|
182
|
219
|
186
|
Barclays US Consumer
Bank
|
646
|
688
|
686
|
662
|
622
|
Group excluding IB and Head Office
|
2,726
|
2,689
|
2,690
|
2,763
|
2,767
|
|
|
|
|
|
|
Average customer assets
|
£m
|
£m
|
£m
|
£m
|
£m
|
Barclays UK
|
199,529
|
201,669
|
203,646
|
205,693
|
207,073
|
Barclays UK Corporate
Bank
|
22,474
|
22,257
|
23,354
|
23,225
|
23,094
|
Barclays Private Bank and Wealth
Management
|
13,931
|
13,593
|
13,525
|
13,594
|
14,173
|
Barclays US Consumer
Bank
|
24,899
|
24,880
|
25,012
|
24,128
|
23,404
|
Group excluding IB and Head Office
|
260,833
|
262,399
|
265,537
|
266,640
|
267,744
|
|
|
|
|
|
|
Net interest margin
|
%
|
%
|
%
|
%
|
%
|
Barclays UK
|
3.22
|
3.09
|
3.07
|
3.04
|
3.22
|
Barclays UK Corporate
Bank
|
5.30
|
5.00
|
4.19
|
5.19
|
5.19
|
Barclays Private Bank and Wealth
Management
|
5.40
|
5.17
|
5.33
|
6.40
|
5.26
|
Barclays US Consumer
Bank
|
10.43
|
11.12
|
10.88
|
10.88
|
10.66
|
Group excluding IB and Head Office
|
4.20
|
4.12
|
4.02
|
4.11
|
4.15
|
Structural hedge
The Group employs a structural
hedge programme designed to stabilise NIM on fixed rate
non-maturity balance sheet items that are behaviourally stable. As
interest rates move, such balances would otherwise drive material
income volatility where there is a re-pricing mismatch with
floating rate assets.
The structural hedge predominantly
covers non-interest-bearing current accounts and the fixed portion
of instant access savings accounts as well as equity, which are
invested into either floating rate customer assets or balances at
central banks, creating an exposure to changes in interest rates.
The structural hedge is executed via a portfolio of receive fixed,
pay variable interest rate swaps, with an amortising structure so
that a small portion matures and is reinvested each month at
prevailing market rates. The pay-floating leg of the interest rate
swaps nets down a proportion of the receive-floating income from
the customer assets, leaving a receive-fixed income stream from the
structural hedge.
The purpose of the structural
hedge is to smooth the Group NII through time. The floating leg of
the swap will re-price immediately, whereas the fixed rate yield on
the portfolio reprices gradually, as a portion of the swap
portfolio matures and the roll is re-invested onto new market
rates.
When interest rates are higher
than our structural hedge yield, the pay floating rate will
typically be higher than our average receive fixed rate. In this
scenario, when viewed in isolation, the structural hedge will be a
net drag to Group NII. When floating rates are lower than our
structural hedge yield, the hedge in isolation will be a net
benefit.
Since the receive-fixed swaps are
booked for a specific term, an element of NII is 'locked in'. The
income stabilising feature of the structural hedge provides greater
net interest income certainty through the interest rate
cycle.
The structural hedge is one
component of a larger portfolio of interest rate risk management
activities that includes non-structural hedging (e.g., pay fixed
receive variable flows for asset hedging), and other offsetting
flows. The net risk of these positions is executed externally
through interest rate swaps and managed for accounting risk (i.e.
income volatility arising from the accounting mismatch of swaps at
FVTPL and underlying hedged items at amortised cost) within the
cash flow hedge reserve. Overall the Group has external derivatives
designated as cash flow hedges that hedge interest rate risk with a
notional £112bn (December 2023: £128bn) which reflects the
structural hedge notional of £239bn (December 2023: £246bn) netted
with non-structural hedging positions of £127bn (December 2023:
£118bn). The majority of these interest rate swaps are cleared with
Central Clearing Counterparties and margined daily with an average
duration of between 2.5 years and 3 years.
Gross structural hedge
contributions were £2,222m (H123: £1,639m). Gross structural hedge
contributions represent the absolute interest income earned on the
fixed legs of the swaps in the structural hedge as the floating leg
is offset by the base rate funding of the deposits.
Risk Management
Risk management and principal risks
The roles and responsibilities of
the business groups, Risk and Compliance in the management of risk
in the Group are defined in the Enterprise Risk Management
Framework (ERMF). The purpose of the ERMF is to identify the
principal risks of the Group, the process by which the Group sets
its appetite for these risks in its business activities, and the
consequent limits which it places on related risk
taking.
The ERMF identifies nine principal
risks: credit risk, market risk, treasury and capital risk, climate
risk, operational risk, model risk, compliance risk, reputation
risk and legal risk. Further detail on these principal risks and
material existing and emerging risks and how such risks are managed
is available in the Barclays PLC Annual Report 2023, which can be
accessed at
home.barclays/annualreport.
There have been no significant changes to these
principal risks or previously identified material existing and
emerging risks in the period and these risks are expected to be
relevant for the remaining six months of this year.
The following sections give an
overview of credit risk, market risk, and treasury and capital risk
for the period.
Credit Risk
Loans and advances at amortised cost by
geography
Total loans and advances at
amortised cost in the credit risk performance section includes
loans and advances at amortised cost to banks and loans and
advances at amortised cost to customers.
The table below presents a product
and geographical breakdown by stages of loans and advances at
amortised cost and the impairment allowance. Also included are
stage allocation of debt securities and off-balance sheet loan
commitments and financial guarantee contracts by gross exposure,
impairment allowance and coverage ratio.
Impairment allowance under IFRS 9
considers both the drawn and the undrawn counterparty exposure. For
retail portfolios, the total impairment allowance is allocated to
gross loans and advances to the extent allowance does not exceed
the drawn exposure and any excess is reported on the liabilities
side of the balance sheet as a provision. For corporate portfolios,
impairment allowance on undrawn exposure is reported on the
liability side of the balance sheet as a provision.
|
Gross exposure
|
|
Impairment allowance
|
|
|
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
|
|
As
at 30.06.24
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
|
Retail mortgages
|
142,023
|
20,811
|
1,691
|
164,525
|
|
39
|
80
|
101
|
220
|
|
|
Retail credit cards
|
8,673
|
2,021
|
194
|
10,888
|
|
109
|
459
|
95
|
663
|
|
|
Retail other
|
6,773
|
1,181
|
236
|
8,190
|
|
51
|
112
|
142
|
305
|
|
|
Corporate
loans1
|
50,913
|
8,266
|
1,525
|
60,704
|
|
159
|
184
|
327
|
670
|
|
|
Total UK
|
208,382
|
32,279
|
3,646
|
244,307
|
|
358
|
835
|
665
|
1,858
|
|
|
Retail mortgages
|
1,570
|
37
|
510
|
2,117
|
|
2
|
-
|
278
|
280
|
|
|
Retail credit cards
|
21,766
|
3,325
|
1,844
|
26,935
|
|
399
|
1,075
|
1,507
|
2,981
|
|
|
Retail other
|
1,618
|
131
|
162
|
1,911
|
|
2
|
1
|
26
|
29
|
|
|
Corporate loans
|
63,197
|
4,054
|
992
|
68,243
|
|
91
|
158
|
307
|
556
|
|
|
Total Rest of the World
|
88,151
|
7,547
|
3,508
|
99,206
|
|
494
|
1,234
|
2,118
|
3,846
|
|
|
Total loans and advances at amortised cost
|
296,533
|
39,826
|
7,154
|
343,513
|
|
852
|
2,069
|
2,783
|
5,704
|
|
|
Debt securities at amortised
cost
|
58,088
|
3,632
|
-
|
61,720
|
|
10
|
10
|
-
|
20
|
|
|
Total loans and advances at amortised cost including debt
securities
|
354,621
|
43,458
|
7,154
|
405,233
|
|
862
|
2,079
|
2,783
|
5,724
|
|
|
Off-balance sheet loan commitments
and financial guarantee contracts2
|
390,104
|
19,948
|
1,034
|
411,086
|
|
186
|
256
|
32
|
474
|
|
|
Total3,4
|
744,725
|
63,406
|
8,188
|
816,319
|
|
1,048
|
2,335
|
2,815
|
6,198
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net exposure
|
|
Coverage ratio
|
|
|
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
|
|
As
at 30.06.24
|
£m
|
£m
|
£m
|
£m
|
|
%
|
%
|
%
|
%
|
|
|
Retail mortgages
|
141,984
|
20,731
|
1,590
|
164,305
|
|
-
|
0.4
|
6.0
|
0.1
|
|
|
Retail credit cards
|
8,564
|
1,562
|
99
|
10,225
|
|
1.3
|
22.7
|
49.0
|
6.1
|
|
|
Retail other
|
6,722
|
1,069
|
94
|
7,885
|
|
0.8
|
9.5
|
60.2
|
3.7
|
|
|
Corporate
loans1
|
50,754
|
8,082
|
1,198
|
60,034
|
|
0.3
|
2.2
|
21.4
|
1.1
|
|
|
Total UK
|
208,024
|
31,444
|
2,981
|
242,449
|
|
0.2
|
2.6
|
18.2
|
0.8
|
|
|
Retail mortgages
|
1,568
|
37
|
232
|
1,837
|
|
0.1
|
-
|
54.5
|
13.2
|
|
|
Retail credit cards
|
21,367
|
2,250
|
337
|
23,954
|
|
1.8
|
32.3
|
81.7
|
11.1
|
|
|
Retail other
|
1,616
|
130
|
136
|
1,882
|
|
0.1
|
0.8
|
16.0
|
1.5
|
|
|
Corporate loans
|
63,106
|
3,896
|
685
|
67,687
|
|
0.1
|
3.9
|
30.9
|
0.8
|
|
|
Total Rest of the World
|
87,657
|
6,313
|
1,390
|
95,360
|
|
0.6
|
16.4
|
60.4
|
3.9
|
|
|
Total loans and advances at amortised cost
|
295,681
|
37,757
|
4,371
|
337,809
|
|
0.3
|
5.2
|
38.9
|
1.7
|
|
|
Debt securities at amortised
cost
|
58,078
|
3,622
|
-
|
61,700
|
|
-
|
0.3
|
-
|
-
|
|
|
Total loans and advances at amortised cost including debt
securities
|
353,759
|
41,379
|
4,371
|
399,509
|
|
0.2
|
4.8
|
38.9
|
1.4
|
|
|
Off-balance sheet loan commitments
and financial guarantee contracts2
|
389,918
|
19,692
|
1,002
|
410,612
|
|
-
|
1.3
|
3.1
|
0.1
|
|
|
Total3,4
|
743,677
|
61,071
|
5,373
|
810,121
|
|
0.1
|
3.7
|
34.4
|
0.8
|
|
|
1
|
Includes Business Banking, which has a gross exposure of
£14.1bn and an impairment allowance of £367m. This comprises £79m
impairment allowance on £9.6bn Stage 1 exposure, £53m on £3.3bn
Stage 2 exposure and £235m on £1.2bn Stage 3 exposure. Excluding
this, total coverage for corporate loans in UK is
0.7%.
|
2
|
Excludes loan commitments and financial guarantees of £19.3bn
carried at fair value and includes exposures relating to financial
assets classified as assets held for sale.
|
3
|
Other financial assets subject to impairment excluded in the
table above include cash collateral and settlement balances,
financial assets at fair value through other comprehensive income
and other assets. These have a total gross exposure of £228.4bn and
an impairment allowance of £154m. This comprises £18m impairment
allowance on £227.2bn Stage 1 exposure, £3m on £1.1bn Stage 2
exposure and £133m on £140m Stage 3 exposure.
|
4
|
The annualised loan loss rate is 45bps after applying the
total impairment charge of £897m.
|
|
Gross exposure
|
|
Impairment allowance
|
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
As
at 31.12.23
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
Retail mortgages
|
146,001
|
19,123
|
1,812
|
166,936
|
|
43
|
77
|
112
|
232
|
Retail credit cards
|
8,094
|
2,128
|
198
|
10,420
|
|
111
|
492
|
107
|
710
|
Retail other
|
6,832
|
1,252
|
264
|
8,348
|
|
56
|
117
|
144
|
317
|
Corporate
loans1
|
54,257
|
8,673
|
1,692
|
64,622
|
|
191
|
214
|
346
|
751
|
Total UK
|
215,184
|
31,176
|
3,966
|
250,326
|
|
401
|
900
|
709
|
2,010
|
Retail mortgages
|
4,201
|
346
|
612
|
5,159
|
|
7
|
28
|
316
|
351
|
Retail credit cards
|
22,315
|
3,450
|
1,522
|
27,287
|
|
412
|
1,138
|
1,226
|
2,776
|
Retail other
|
1,637
|
91
|
229
|
1,957
|
|
3
|
1
|
32
|
36
|
Corporate loans
|
58,248
|
4,629
|
862
|
63,739
|
|
96
|
200
|
252
|
548
|
Total Rest of the World
|
86,401
|
8,516
|
3,225
|
98,142
|
|
518
|
1,367
|
1,826
|
3,711
|
Total loans and advances at amortised cost
|
301,585
|
39,692
|
7,191
|
348,468
|
|
919
|
2,267
|
2,535
|
5,721
|
Debt securities
|
52,869
|
3,907
|
-
|
56,776
|
|
11
|
16
|
-
|
27
|
Total loans and advances at amortised cost including debt
securities
|
354,454
|
43,599
|
7,191
|
405,244
|
|
930
|
2,283
|
2,535
|
5,748
|
Off-balance sheet loan commitments
and financial guarantee contracts2
|
374,063
|
24,208
|
1,037
|
399,308
|
|
173
|
287
|
44
|
504
|
Total3,4
|
728,517
|
67,807
|
8,228
|
804,552
|
|
1,103
|
2,570
|
2,579
|
6,252
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
exposure
|
|
Coverage ratio
|
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
As
at 31.12.23
|
£m
|
£m
|
£m
|
£m
|
|
%
|
%
|
%
|
%
|
Retail mortgages
|
145,958
|
19,046
|
1,700
|
166,704
|
|
-
|
0.4
|
6.2
|
0.1
|
Retail credit cards
|
7,983
|
1,636
|
91
|
9,710
|
|
1.4
|
23.1
|
54.0
|
6.8
|
Retail other
|
6,776
|
1,135
|
120
|
8,031
|
|
0.8
|
9.3
|
54.5
|
3.8
|
Corporate
loans1
|
54,066
|
8,459
|
1,346
|
63,871
|
|
0.4
|
2.5
|
20.4
|
1.2
|
Total UK
|
214,783
|
30,276
|
3,257
|
248,316
|
|
0.2
|
2.9
|
17.9
|
0.8
|
Retail mortgages
|
4,194
|
318
|
296
|
4,808
|
|
0.2
|
8.1
|
51.6
|
6.8
|
Retail credit cards
|
21,903
|
2,312
|
296
|
24,511
|
|
1.8
|
33.0
|
80.6
|
10.2
|
Retail other
|
1,634
|
90
|
197
|
1,921
|
|
0.2
|
1.1
|
14.0
|
1.8
|
Corporate loans
|
58,152
|
4,429
|
610
|
63,191
|
|
0.2
|
4.3
|
29.2
|
0.9
|
Total Rest of the World
|
85,883
|
7,149
|
1,399
|
94,431
|
|
0.6
|
16.1
|
56.6
|
3.8
|
Total loans and advances at amortised cost
|
300,666
|
37,425
|
4,656
|
342,747
|
|
0.3
|
5.7
|
35.3
|
1.6
|
Debt securities
|
52,858
|
3,891
|
-
|
56,749
|
|
-
|
0.4
|
-
|
-
|
Total loans and advances at amortised cost including debt
securities
|
353,524
|
41,316
|
4,656
|
399,496
|
|
0.3
|
5.2
|
35.3
|
1.4
|
Off-balance sheet loan commitments
and financial guarantee contracts2
|
373,890
|
23,921
|
993
|
398,804
|
|
-
|
1.2
|
4.2
|
0.1
|
Total3,4
|
727,414
|
65,237
|
5,649
|
798,300
|
|
0.2
|
3.8
|
31.3
|
0.8
|
1
|
Includes Business Banking, which has a gross exposure of
£15.2bn and an impairment allowance of £431m. This comprises £99m
impairment allowance on £9.8bn Stage 1 exposure, £81m on £4.1bn
Stage 2 exposure and £251m on £1.3bn Stage 3 exposure. Excluding
this, total coverage for corporate loans in UK is
0.6%.
|
2
|
Excludes loan commitments and financial guarantees of £16.5bn
carried at fair value and includes exposures relating to financial
assets classified as assets held for sale.
|
3
|
Other financial assets subject to impairment not included in
the table above include cash collateral and settlement balances,
financial assets at fair value through other comprehensive income
and other assets. These have a total gross exposure of £183.6bn and
impairment allowance of £151m. This comprises £16m impairment
allowance on £182.8bn Stage 1 exposure, £2m on £0.6bn Stage 2
exposure and £133m on £140m Stage 3 exposure.
|
4
|
The annualised loan loss rate is 46bps after applying the
total impairment charge of £1,881m.
|
Assets held for sale
During 2023, gross loans and
advances and related impairment allowances for the German consumer
finance business portfolio were reclassified from loans and
advances to customers to assets held for sale in the balance
sheet.
Loans and advances to customers classified as assets held for
sale
|
|
Stage 1
|
|
Stage 2
|
|
Stage 3
|
|
Total
|
|
Gross
|
ECL
|
Coverage
|
|
Gross
|
ECL
|
Coverage
|
|
Gross
|
ECL
|
Coverage
|
|
Gross
|
ECL
|
Coverage
|
As at 30.06.24
|
£m
|
£m
|
%
|
|
£m
|
£m
|
%
|
|
£m
|
£m
|
%
|
|
£m
|
£m
|
%
|
Retail credit cards
|
1,660
|
17
|
1.0
|
|
453
|
41
|
9.1
|
|
93
|
68
|
73.1
|
|
2,206
|
126
|
5.7
|
Retail other
|
1,361
|
18
|
1.3
|
|
259
|
35
|
13.5
|
|
79
|
55
|
69.6
|
|
1,699
|
108
|
6.4
|
Total Rest of the World
|
3,021
|
35
|
1.2
|
|
712
|
76
|
10.7
|
|
172
|
123
|
71.5
|
|
3,905
|
234
|
6.0
|
As at 31.12.23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retail credit cards
|
1,621
|
15
|
0.9
|
|
445
|
41
|
9.2
|
|
92
|
68
|
73.9
|
|
2,158
|
124
|
5.7
|
Retail other
|
1,561
|
20
|
1.3
|
|
288
|
32
|
11.1
|
|
84
|
60
|
71.4
|
|
1,933
|
112
|
5.8
|
Total Rest of the World
|
3,182
|
35
|
1.1
|
|
733
|
73
|
10.0
|
|
176
|
128
|
72.7
|
|
4,091
|
236
|
5.8
|
Loans and advances at amortised cost by
product
The table below presents a product
breakdown by stages of loans and advances at amortised cost. Also
included is a breakdown of Stage 2 past due balances.
|
|
Stage 2
|
|
|
As
at 30.06.24
|
Stage 1
|
Not past due
|
<=30 days past due
|
>30 days past due
|
Total
|
Stage 3
|
Total
|
Gross exposure
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Retail mortgages
|
143,593
|
17,979
|
2,054
|
815
|
20,848
|
2,201
|
166,642
|
Retail credit cards
|
30,439
|
4,685
|
367
|
294
|
5,346
|
2,038
|
37,823
|
Retail other
|
8,391
|
1,065
|
106
|
141
|
1,312
|
398
|
10,101
|
Corporate loans
|
114,110
|
12,017
|
57
|
246
|
12,320
|
2,517
|
128,947
|
Total
|
296,533
|
35,746
|
2,584
|
1,496
|
39,826
|
7,154
|
343,513
|
|
|
|
|
|
|
|
|
Impairment allowance
|
|
|
|
|
|
|
|
Retail mortgages
|
41
|
44
|
16
|
20
|
80
|
379
|
500
|
Retail credit cards
|
508
|
1,191
|
160
|
183
|
1,534
|
1,602
|
3,644
|
Retail other
|
53
|
78
|
17
|
18
|
113
|
168
|
334
|
Corporate loans
|
250
|
327
|
7
|
8
|
342
|
634
|
1,226
|
Total
|
852
|
1,640
|
200
|
229
|
2,069
|
2,783
|
5,704
|
|
|
|
|
|
|
|
|
Net
exposure
|
|
|
|
|
|
|
|
Retail mortgages
|
143,552
|
17,935
|
2,038
|
795
|
20,768
|
1,822
|
166,142
|
Retail credit cards
|
29,931
|
3,494
|
207
|
111
|
3,812
|
436
|
34,179
|
Retail other
|
8,338
|
987
|
89
|
123
|
1,199
|
230
|
9,767
|
Corporate loans
|
113,860
|
11,690
|
50
|
238
|
11,978
|
1,883
|
127,721
|
Total
|
295,681
|
34,106
|
2,384
|
1,267
|
37,757
|
4,371
|
337,809
|
|
|
|
|
|
|
|
|
Coverage ratio
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
Retail mortgages
|
-
|
0.2
|
0.8
|
2.5
|
0.4
|
17.2
|
0.3
|
Retail credit cards
|
1.7
|
25.4
|
43.6
|
62.2
|
28.7
|
78.6
|
9.6
|
Retail other
|
0.6
|
7.3
|
16.0
|
12.8
|
8.6
|
42.2
|
3.3
|
Corporate loans
|
0.2
|
2.7
|
12.3
|
3.3
|
2.8
|
25.2
|
1.0
|
Total
|
0.3
|
4.6
|
7.7
|
15.3
|
5.2
|
38.9
|
1.7
|
As
at 31.12.23
|
|
|
|
|
|
|
|
Gross exposure
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Retail mortgages
|
150,202
|
16,834
|
1,971
|
664
|
19,469
|
2,424
|
172,095
|
Retail credit cards
|
30,409
|
4,858
|
392
|
328
|
5,578
|
1,720
|
37,707
|
Retail other
|
8,469
|
1,094
|
126
|
123
|
1,343
|
493
|
10,305
|
Corporate loans
|
112,505
|
12,960
|
179
|
163
|
13,302
|
2,554
|
128,361
|
Total
|
301,585
|
35,746
|
2,668
|
1,278
|
39,692
|
7,191
|
348,468
|
|
|
|
|
|
|
|
|
Impairment allowance
|
|
|
|
|
|
|
|
Retail mortgages
|
50
|
73
|
20
|
12
|
105
|
428
|
583
|
Retail credit cards
|
523
|
1,257
|
166
|
207
|
1,630
|
1,333
|
3,486
|
Retail other
|
59
|
82
|
18
|
18
|
118
|
176
|
353
|
Corporate loans
|
287
|
399
|
8
|
7
|
414
|
598
|
1,299
|
Total
|
919
|
1,811
|
212
|
244
|
2,267
|
2,535
|
5,721
|
|
|
|
|
|
|
|
|
Net
exposure
|
|
|
|
|
|
|
|
Retail mortgages
|
150,152
|
16,761
|
1,951
|
652
|
19,364
|
1,996
|
171,512
|
Retail credit cards
|
29,886
|
3,601
|
226
|
121
|
3,948
|
387
|
34,221
|
Retail other
|
8,410
|
1,012
|
108
|
105
|
1,225
|
317
|
9,952
|
Corporate loans
|
112,218
|
12,561
|
171
|
156
|
12,888
|
1,956
|
127,062
|
Total
|
300,666
|
33,935
|
2,456
|
1,034
|
37,425
|
4,656
|
342,747
|
|
|
|
|
|
|
|
|
Coverage ratio
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
Retail mortgages
|
-
|
0.4
|
1.0
|
1.8
|
0.5
|
17.7
|
0.3
|
Retail credit cards
|
1.7
|
25.9
|
42.3
|
63.1
|
29.2
|
77.5
|
9.2
|
Retail other
|
0.7
|
7.5
|
14.3
|
14.6
|
8.8
|
35.7
|
3.4
|
Corporate loans
|
0.3
|
3.1
|
4.5
|
4.3
|
3.1
|
23.4
|
1.0
|
Total
|
0.3
|
5.1
|
7.9
|
19.1
|
5.7
|
35.3
|
1.6
|
Movement in gross exposures and impairment allowance
including provisions for loan commitments and financial
guarantees
The following tables present a
reconciliation of the opening to the closing balance of the
exposure and impairment allowance.
Transfers between stages in the
tables have been reflected as if they had taken place at the
beginning of the period. 'Net drawdowns, repayments, net
re-measurement and movements due to exposure and risk parameter
changes' includes additional drawdowns and partial repayments from
existing facilities. Additionally, the below tables do not include
other financial assets subject to impairment such as debt
securities at amortised cost, cash collateral and settlement
balances, financial assets at fair value through other
comprehensive income and other assets.
The movements are measured over a
six-month period.
Loans and advances at amortised cost
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
|
Gross exposure
|
ECL
|
Gross exposure
|
ECL
|
Gross exposure
|
ECL
|
Gross exposure
|
ECL
|
Retail mortgages
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
As at 1 January 2024
|
150,202
|
50
|
19,469
|
105
|
2,424
|
428
|
172,095
|
583
|
Transfers from Stage 1 to Stage
2
|
(7,828)
|
(4)
|
7,828
|
4
|
-
|
-
|
-
|
-
|
Transfers from Stage 2 to Stage
1
|
4,688
|
20
|
(4,688)
|
(20)
|
-
|
-
|
-
|
-
|
Transfers to Stage 3
|
(76)
|
(1)
|
(158)
|
(5)
|
234
|
6
|
-
|
-
|
Transfers from Stage 3
|
30
|
3
|
76
|
1
|
(106)
|
(4)
|
-
|
-
|
Business activity in the
period
|
9,077
|
3
|
224
|
1
|
-
|
-
|
9,301
|
4
|
Refinements to models used for
calculation
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net drawdowns, repayments, net
re-measurement and movement due to exposure and risk parameter
changes
|
(3,874)
|
(22)
|
(554)
|
29
|
(8)
|
3
|
(4,436)
|
10
|
Final repayments
|
(6,149)
|
(3)
|
(1,033)
|
(6)
|
(204)
|
(12)
|
(7,386)
|
(21)
|
Disposals1
|
(2,477)
|
(5)
|
(316)
|
(29)
|
(129)
|
(32)
|
(2,922)
|
(66)
|
Write-offs
|
-
|
-
|
-
|
-
|
(10)
|
(10)
|
(10)
|
(10)
|
As at 30 June 2024
|
143,593
|
41
|
20,848
|
80
|
2,201
|
379
|
166,642
|
500
|
|
|
|
|
|
|
|
|
|
Retail credit cards
|
|
|
|
|
|
|
|
|
As at 1 January 2024
|
30,409
|
523
|
5,578
|
1,630
|
1,720
|
1,333
|
37,707
|
3,486
|
Transfers from Stage 1 to Stage
2
|
(1,898)
|
(63)
|
1,898
|
63
|
-
|
-
|
-
|
-
|
Transfers from Stage 2 to Stage
1
|
1,595
|
389
|
(1,595)
|
(389)
|
-
|
-
|
-
|
-
|
Transfers to Stage 3
|
(250)
|
(10)
|
(728)
|
(348)
|
978
|
358
|
-
|
-
|
Transfers from Stage 3
|
12
|
6
|
13
|
5
|
(25)
|
(11)
|
-
|
-
|
Business activity in the
period
|
1,547
|
31
|
72
|
23
|
1
|
1
|
1,620
|
55
|
Refinements to models used for
calculation2
|
-
|
27
|
-
|
(25)
|
-
|
11
|
-
|
13
|
Net drawdowns, repayments, net
re-measurement and movement due to exposure and risk parameter
changes
|
(202)
|
(371)
|
306
|
654
|
8
|
526
|
112
|
809
|
Final repayments
|
(75)
|
(4)
|
(22)
|
(9)
|
(2)
|
(2)
|
(99)
|
(15)
|
Disposals1
|
(699)
|
(20)
|
(176)
|
(70)
|
(79)
|
(51)
|
(954)
|
(141)
|
Write-offs
|
-
|
-
|
-
|
-
|
(563)
|
(563)
|
(563)
|
(563)
|
As at 30 June 2024
|
30,439
|
508
|
5,346
|
1,534
|
2,038
|
1,602
|
37,823
|
3,644
|
1
|
The £2.9bn of gross disposals reported within Retail
mortgages relate to sale of the performing Italian mortgage
portfolio. The £954m of gross disposals reported within Retail
credit cards include £876m sale of the outstanding US Cards
receivables to Blackstone and £78m of other debt sales undertaken
during the period.
|
2
|
Refinements to models used for calculation reported within
Retail credit cards include a £43m movement in the US Cards and a
£(30)m movement in the UK Cards portfolio. These reflect model
enhancements made during the period. Barclays continually reviews
the output of models to determine accuracy of the ECL calculation
including review of model monitoring, external benchmarking and
experience of model operation over an extended period of time. This
helps to ensure that the models used continue to reflect the risks
inherent across the businesses.
|
Loans and advances at amortised cost
|
|
|
|
|
|
|
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
|
Gross exposure
|
ECL
|
Gross exposure
|
ECL
|
Gross exposure
|
ECL
|
Gross exposure
|
ECL
|
Retail other
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
As at 1 January 2024
|
8,469
|
59
|
1,343
|
118
|
493
|
176
|
10,305
|
353
|
Transfers from Stage 1 to Stage
2
|
(516)
|
(7)
|
516
|
7
|
-
|
-
|
-
|
-
|
Transfers from Stage 2 to Stage
1
|
371
|
23
|
(371)
|
(23)
|
-
|
-
|
-
|
-
|
Transfers to Stage 3
|
(99)
|
(1)
|
(117)
|
(23)
|
216
|
24
|
-
|
-
|
Transfers from Stage 3
|
26
|
1
|
47
|
1
|
(73)
|
(2)
|
-
|
-
|
Business activity in the
period
|
2,092
|
13
|
117
|
9
|
6
|
4
|
2,215
|
26
|
Refinements to models used for
calculation
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net drawdowns, repayments, net
re-measurement and movement due to exposure and risk parameter
changes
|
(254)
|
(28)
|
(107)
|
28
|
(7)
|
55
|
(368)
|
55
|
Final repayments
|
(1,698)
|
(7)
|
(116)
|
(4)
|
(160)
|
(18)
|
(1,974)
|
(29)
|
Disposals1
|
-
|
-
|
-
|
-
|
(24)
|
(18)
|
(24)
|
(18)
|
Write-offs
|
-
|
-
|
-
|
-
|
(53)
|
(53)
|
(53)
|
(53)
|
As at 30 June 2024
|
8,391
|
53
|
1,312
|
113
|
398
|
168
|
10,101
|
334
|
|
|
|
|
|
|
|
|
|
Corporate loans
|
|
|
|
|
|
|
|
|
As at 1 January 2024
|
112,505
|
287
|
13,302
|
414
|
2,554
|
598
|
128,361
|
1,299
|
Transfers from Stage 1 to Stage
2
|
(2,905)
|
(21)
|
2,905
|
21
|
-
|
-
|
-
|
-
|
Transfers from Stage 2 to Stage
1
|
2,769
|
77
|
(2,769)
|
(77)
|
-
|
-
|
-
|
-
|
Transfers to Stage 3
|
(244)
|
(2)
|
(586)
|
(28)
|
830
|
30
|
-
|
-
|
Transfers from Stage 3
|
165
|
8
|
136
|
12
|
(301)
|
(20)
|
-
|
-
|
Business activity in the
period
|
15,755
|
27
|
637
|
16
|
136
|
6
|
16,528
|
49
|
Refinements to models used for
calculation2
|
-
|
(21)
|
-
|
9
|
-
|
-
|
-
|
(12)
|
Net drawdowns, repayments, net
re-measurement and movement due to exposure and risk parameter
changes3
|
4,398
|
(81)
|
(136)
|
26
|
(344)
|
167
|
3,918
|
112
|
Final repayments
|
(18,303)
|
(23)
|
(1,164)
|
(50)
|
(224)
|
(13)
|
(19,691)
|
(86)
|
Disposals1
|
(30)
|
(1)
|
(5)
|
(1)
|
-
|
-
|
(35)
|
(2)
|
Write-offs
|
-
|
-
|
-
|
-
|
(134)
|
(134)
|
(134)
|
(134)
|
As at 30 June 2024
|
114,110
|
250
|
12,320
|
342
|
2,517
|
634
|
128,947
|
1,226
|
1
|
The £24m of gross disposals reported within Retail other
relate to debt sales undertaken during the period. The £35m of
gross disposals reported within Corporate loans relate to debt
sales undertaken during the period.
|
2
|
Refinements to models used for calculation reported within
Corporate loans include a £(33)m movement in the ESHLA and a £21m
movement in the IB portfolio. These reflect model enhancements made
during the period. Barclays continually reviews the output of
models to determine accuracy of the ECL calculation including
review of model monitoring, external benchmarking and experience of
model operation over an extended period of time. This helps to
ensure that the models used continue to reflect the risks inherent
across the businesses.
|
3
|
'Net drawdowns, repayments, net re-measurement and movements
due to exposure and risk parameter changes' reported within
Corporate loans includes assets of £0.3bn de-recognised due to
payment received on defaulted loans from government guarantees
issued under the government's Bounce Back Loan
Scheme.
|
Reconciliation of ECL movement to impairment charge/(release)
for the period
|
|
|
|
|
|
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
|
|
|
|
|
£m
|
£m
|
£m
|
£m
|
Retail mortgages
|
(4)
|
4
|
(7)
|
(7)
|
Retail credit cards
|
5
|
(26)
|
883
|
862
|
Retail other
|
(6)
|
(5)
|
63
|
52
|
Corporate loans
|
(36)
|
(71)
|
170
|
63
|
ECL movements excluding disposals and
write-offs1
|
(41)
|
(98)
|
1,109
|
970
|
ECL movement on loan commitments
and other financial guarantees
|
13
|
(31)
|
(12)
|
(30)
|
ECL movement on other financial
assets
|
2
|
1
|
-
|
3
|
ECL movement on debt securities at
amortised cost
|
(1)
|
(6)
|
-
|
(7)
|
Recoveries and
reimbursements2
|
(31)
|
25
|
(50)
|
(56)
|
ECL charge on assets held for
sale
|
|
|
|
44
|
Total exchange and other
adjustments
|
|
|
|
(27)
|
Total income statement charge for the
period
|
|
|
|
897
|
1
|
In H124, gross write-offs amounted to £760m (H123: £583m) and
post write-off recoveries amounted to £38m (H123: £21m). Net
write-offs represent gross write-offs less post write-off
recoveries and amounted to £722m (H123: £562m).
|
2
|
Recoveries and reimbursements include £18m (H123 loss: £3m)
for reimbursements expected to be received under the arrangement
where Group has entered into financial guarantee contracts which
provide credit protection over certain assets with third parties
and cash recoveries of previously written off amounts of £38m
(H123: £21m).
|
Loan commitments and financial guarantees
|
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
|
Gross
exposure
|
ECL
|
Gross
exposure
|
ECL
|
Gross
exposure
|
ECL
|
Gross
exposure
|
ECL
|
Retail mortgages
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
As at 1 January 2024
|
7,776
|
-
|
448
|
-
|
4
|
-
|
8,228
|
-
|
Net transfers between
stages
|
(25)
|
-
|
25
|
-
|
-
|
-
|
-
|
-
|
Business activity in the
period
|
6,279
|
-
|
-
|
-
|
-
|
-
|
6,279
|
-
|
Net drawdowns, repayments, net
re-measurement and movement due to exposure and risk parameter
changes
|
(4,289)
|
-
|
(61)
|
-
|
(1)
|
-
|
(4,351)
|
-
|
Limit management and final
repayments
|
(165)
|
-
|
(20)
|
-
|
-
|
-
|
(185)
|
-
|
As at 30 June 2024
|
9,576
|
-
|
392
|
-
|
3
|
-
|
9,971
|
-
|
|
|
|
|
|
|
|
|
|
Retail credit cards1
|
|
|
|
|
|
|
|
|
As at 1 January 2024
|
144,791
|
59
|
2,807
|
54
|
142
|
-
|
147,740
|
113
|
Net transfers between
stages
|
(1,060)
|
27
|
1,026
|
(27)
|
34
|
-
|
-
|
-
|
Business activity in the
period
|
8,925
|
13
|
66
|
3
|
1
|
-
|
8,992
|
16
|
Net drawdowns, repayments, net
re-measurement and movement due to exposure and risk parameter
changes
|
3,106
|
(24)
|
(942)
|
18
|
(30)
|
-
|
2,134
|
(6)
|
Limit management and final
repayments
|
(5,851)
|
(6)
|
(252)
|
(12)
|
(8)
|
-
|
(6,111)
|
(18)
|
As at 30 June 2024
|
149,911
|
69
|
2,705
|
36
|
139
|
-
|
152,755
|
105
|
|
|
|
|
|
|
|
|
|
Retail other1
|
|
|
|
|
|
|
|
|
As at 1 January 2024
|
8,607
|
6
|
535
|
2
|
44
|
-
|
9,186
|
8
|
Net transfers between
stages
|
(8)
|
-
|
1
|
-
|
7
|
-
|
-
|
-
|
Business activity in the
period
|
497
|
1
|
84
|
-
|
-
|
-
|
581
|
1
|
Net drawdowns, repayments, net
re-measurement and movement due to exposure and risk parameter
changes
|
11
|
(1)
|
(46)
|
(2)
|
(1)
|
-
|
(36)
|
(3)
|
Limit management and final
repayments
|
(638)
|
-
|
(7)
|
-
|
(16)
|
-
|
(661)
|
-
|
As at 30 June 2024
|
8,469
|
6
|
567
|
-
|
34
|
-
|
9,070
|
6
|
|
|
|
|
|
|
|
|
|
Corporate loans
|
|
|
|
|
|
|
|
|
As at 1 January 2024
|
212,889
|
108
|
20,418
|
231
|
847
|
44
|
234,154
|
383
|
Net transfers between
stages
|
2,361
|
36
|
(2,503)
|
(38)
|
142
|
2
|
-
|
-
|
Business activity in the
period
|
48,341
|
19
|
2,365
|
20
|
72
|
-
|
50,778
|
39
|
Net drawdowns, repayments, net
re-measurement and movement due to exposure and risk parameter
changes
|
4,879
|
(40)
|
541
|
43
|
(99)
|
(9)
|
5,321
|
(6)
|
Limit management and final
repayments
|
(46,322)
|
(12)
|
(4,537)
|
(36)
|
(104)
|
(5)
|
(50,963)
|
(53)
|
As at 30 June 2024
|
222,148
|
111
|
16,284
|
220
|
858
|
32
|
239,290
|
363
|
1
|
Loan commitments reported within Retail credit cards and
Retail other also include financial assets classified as held for
sale.
|
Management adjustments to models for
impairment
Management adjustments to
impairment models are applied in order to factor in certain
conditions or changes in policy that are not fully incorporated
into the impairment models, or to reflect additional facts and
circumstances at the period end. Management adjustments are
reviewed and incorporated into future model development where
applicable.
Management adjustments are
captured through "Economic uncertainty" and "Other" adjustments,
and are presented by product and geography below:
Management adjustments to models for impairment
allowance presented by product and
geography1
|
Impairment allowance pre management
adjustments2
|
Economic uncertainty adjustments
|
Other adjustments3
|
Management adjustments
|
Total impairment allowance4
|
Proportion of Management adjustments to total impairment
allowance
|
|
|
(a)
|
(b)
|
(a+b)
|
|
|
As at 30.06.24
|
£m
|
£m
|
£m
|
£m
|
£m
|
%
|
Retail mortgages
|
50
|
42
|
128
|
170
|
220
|
77.3
|
Retail credit cards
|
643
|
45
|
(4)
|
41
|
684
|
6.0
|
Retail other
|
231
|
9
|
70
|
79
|
310
|
25.5
|
Corporate loans
|
683
|
55
|
23
|
78
|
761
|
10.2
|
Total UK
|
1,607
|
151
|
217
|
368
|
1,975
|
18.6
|
Retail mortgages
|
282
|
-
|
(2)
|
(2)
|
280
|
(0.7)
|
Retail credit cards
|
3,065
|
-
|
-
|
-
|
3,065
|
-
|
Retail other
|
28
|
-
|
2
|
2
|
30
|
6.7
|
Corporate loans
|
792
|
-
|
36
|
36
|
828
|
4.3
|
Total Rest of the World
|
4,167
|
-
|
36
|
36
|
4,203
|
0.9
|
Total
|
5,774
|
151
|
253
|
404
|
6,178
|
6.5
|
Debt securities at amortised
cost
|
29
|
-
|
(9)
|
(9)
|
20
|
(45.0)
|
Total including debt securities at amortised
cost
|
5,803
|
151
|
244
|
395
|
6,198
|
6.4
|
|
|
|
|
|
|
|
As at 31.12.23
|
£m
|
£m
|
£m
|
£m
|
£m
|
%
|
Retail mortgages
|
54
|
57
|
121
|
178
|
232
|
76.7
|
Retail credit cards
|
700
|
45
|
(9)
|
36
|
736
|
4.9
|
Retail other
|
251
|
9
|
62
|
71
|
322
|
22.0
|
Corporate loans
|
761
|
71
|
10
|
81
|
842
|
9.6
|
Total UK
|
1,766
|
182
|
184
|
366
|
2,132
|
17.2
|
Retail mortgages
|
354
|
-
|
(3)
|
(3)
|
351
|
(0.9)
|
Retail credit cards
|
2,855
|
-
|
8
|
8
|
2,863
|
0.3
|
Retail other
|
45
|
-
|
(6)
|
(6)
|
39
|
(15.4)
|
Corporate loans
|
828
|
16
|
(4)
|
12
|
840
|
1.4
|
Total Rest of the World
|
4,082
|
16
|
(5)
|
11
|
4,093
|
0.3
|
Total
|
5,848
|
198
|
179
|
377
|
6,225
|
6.1
|
Debt securities at amortised
cost
|
27
|
-
|
-
|
-
|
27
|
-
|
Total including debt securities at amortised
cost
|
5,875
|
198
|
179
|
377
|
6,252
|
6.0
|
Economic uncertainty adjustments presented by
stage
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
As at 30.06.24
|
£m
|
£m
|
£m
|
£m
|
Retail mortgages
|
8
|
25
|
9
|
42
|
Retail credit cards
|
8
|
37
|
-
|
45
|
Retail other
|
3
|
6
|
-
|
9
|
Corporate loans
|
35
|
8
|
12
|
55
|
Total UK
|
54
|
76
|
21
|
151
|
Retail mortgages
|
-
|
-
|
-
|
-
|
Retail credit cards
|
-
|
-
|
-
|
-
|
Retail other
|
-
|
-
|
-
|
-
|
Corporate loans
|
-
|
-
|
-
|
-
|
Total Rest of the World
|
-
|
-
|
-
|
-
|
Total
|
54
|
76
|
21
|
151
|
As at 31.12.23
|
£m
|
£m
|
£m
|
£m
|
Retail mortgages
|
12
|
32
|
13
|
57
|
Retail credit cards
|
8
|
37
|
-
|
45
|
Retail other
|
3
|
6
|
-
|
9
|
Corporate loans
|
48
|
12
|
11
|
71
|
Total UK
|
71
|
87
|
24
|
182
|
Retail mortgages
|
-
|
-
|
-
|
-
|
Retail credit cards
|
-
|
-
|
-
|
-
|
Retail other
|
-
|
-
|
-
|
-
|
Corporate loans
|
4
|
12
|
-
|
16
|
Total Rest of the World
|
4
|
12
|
-
|
16
|
Total
|
75
|
99
|
24
|
198
|
1
|
Positive values reflect an increase in impairment allowance
and negative values reflect a reduction in the impairment
allowance.
|
2
|
Includes £5.1bn (December 2023: £5.2bn) of modelled ECL,
£0.5bn (December 2023: £0.4bn) of individually assessed impairments
and £0.2bn (December 2023: £0.3bn) of ECL from non-modelled
exposures and debt securities.
|
3
|
Management adjustments related to other financial assets
subject to impairment not included in the table above include cash
collateral and settlement balances £(2)m and financial assets
at fair value through other comprehensive income
£(2)m within the IB
portfolio.
|
4
|
Total impairment allowance consists of ECL stock on drawn and
undrawn exposure.
|
Economic uncertainty adjustments
Models have been developed with
data from non-inflationary periods establishing a relationship
between input variables and customer delinquency based on past
behaviour. As such there is a risk that the modelled output fails
to capture the appropriate response to changes in macroeconomic
variables including high interest rates with modelled impairment
provisions impacted by uncertainty.
This uncertainty continues to be
captured in two ways. Firstly, customer uncertainty: the
identification of customers and clients who may be more vulnerable
to economic instability; and secondly, model uncertainty: to
capture the impact from model limitations and sensitivities to
specific macroeconomic parameters which are applied at a portfolio
level.
Economic uncertainty adjustments
have reduced during the period reflecting the updated macroeconomic
outlook.
The balance as at 30 June 2024 is £151m (December 2023:
£198m) and includes:
Customer and client uncertainty provisions of £129m (December
2023: £166m):
• Retail mortgages (UK) £20m
(December 2023: £25m): This
adjustment reflects the risk of borrowers refinancing onto higher
rates in the medium term and remains broadly stable compared to
year-end.
• Retail credit cards (UK)
£45m (December 2023: £45m) and Retail other (UK) £9m (December
2023: £9m): These reflect
adjustments applied to customers considered most vulnerable to
affordability pressures in light of uncertainty linked to higher
for longer interest rates and are unchanged from
year-end.
• Corporate
loans:
-
UK £55m
(December 2023: £71m): This
adjustment reflects the possible cross default risk on Barclays'
lending in respect of clients who have taken bounce back loans and
is partially reduced on account of the latest credit
performance.
-
ROW £nil
(December 2023: £16m): The
previously held adjustment to provide for expected downside
uncertainties on European Corporates has been retired following a
resilient credit performance and updated macroeconomic
outlook.
Model uncertainty provisions of £22m (December 2023:
£32m):
• Retail mortgages
(UK) £22m (December 2023: £32m): This
adjustment remediates the higher recovery expectations impacted by
model oversensitivity to certain macroeconomic variables and has
reduced following the updated macroeconomic outlook.
Other adjustments
Other adjustments are operational
in nature and are expected to remain in place until they can be
reflected in the underlying models. These adjustments result from
data limitations and model performance related issues identified
through model monitoring and other established governance
processes.
Other adjustments of £244m (December 2023: £179m)
includes:
Adjustments for definition of
default (DOD) under the Capital Requirements Regulation and model
monitoring in Retail mortgages, Retail other and Corporate
loans.
• Retail mortgages
(UK) £128m (December 2023: £121m): The
increase reflects re-sizing of the DOD adjustment informed by
credit performance.
• Retail other (UK) £70m
(December 2023: £62m): The increase
reflects re-sizing of model monitoring and operational adjustments
in the UK and PBWM portfolio.
• Corporate
loans:
-
UK £23m
(December 2023: £10m): The movement
reflects the reduction of an adjustment to remediate conservative
modelled recovery expectations in the ESHLA portfolio. This
reduction has been partially offset by the re-sizing of DOD and
model monitoring adjustments in SME lending.
-
ROW £36m
(December 2023: £(4)m): The
movement is driven by an adjustment introduced to align the credit
conversion factor on revolving credit facilities within the IB
portfolio to Basel 3.1.
• Debt securities
£(9)m: This reflects an adjustment
applied to Exposure at Default (EAD) within the IB portfolio to
remediate an overly conservative modelled amortisation
expectation.
Measurement uncertainty
Scenarios used to calculate the
Group's expected credit losses charge were refreshed in Q224 with
the Baseline scenario reflecting the latest consensus macroeconomic
forecasts available at the time of the scenario refresh. In the
Baseline scenario, the UK economy is gradually recovering and is
further stimulated as restrictive monetary policy starts loosening.
US GDP growth falls to 1.7% in 2025 but then stabilises at 2.0%.
Labour markets remain resilient. The average UK and US unemployment
rates peak at 4.4% and 4.1% respectively in 2025 and remain at
these levels for the rest of the 5-year projection period. With the
significant decline in inflationary pressures, major central banks
begin to cut rates in 2024. UK house prices keep falling in 2024
before stabilising and resuming the upward trend from 2025. The
housing market in the US remains more resilient, with house prices
continuing to grow.
In the Downside 2 scenario,
inflationary pressures are assumed to intensify again, mainly
driven by strong wage growth. Central banks raise rates further,
with the UK bank rate and the US federal funds rate each reaching
8.5% in Q125. Major economies experience a rapid tightening of
financial conditions alongside a significant increase in market
volatility resulting in a sharp repricing of assets and higher
credit losses. Central banks are forced to cut interest rates
aggressively. Falling demand reduces UK and US GDP and headline
inflation drops significantly. In the Upside 2 scenario, a rise in
labour force participation and higher productivity contribute to
accelerated economic growth without creating new inflationary
pressures. With inflation continuing to fall, central banks lower
interest rates, further stimulating aggregate demand, leading to
reduced unemployment and healthy GDP growth.
The methodology for estimating
scenario probability weights involves simulating a range of future
paths for UK and US GDP using historical data with the five
scenarios mapped against the distribution of these future paths.
The median is centred around the Baseline with scenarios further
from the Baseline attracting a lower weighting before the five
weights are normalised to total 100%. The increases in the Upside
scenario weightings were driven by the improvement in GDP in the
Baseline scenario, bringing the Baseline scenario closer to the
Upside scenarios. For further details see page 39.
The following tables show the key
macroeconomic variables used in the five scenarios (5-year annual
paths) and the probability weights applied to each
scenario.
Macroeconomic variables used in the calculation of
ECL
|
As at 30.06.24
|
2024
|
2025
|
2026
|
2027
|
2028
|
Baseline
|
%
|
%
|
%
|
%
|
%
|
UK GDP1
|
0.7
|
1.2
|
1.6
|
1.7
|
1.6
|
UK
unemployment2
|
4.3
|
4.4
|
4.4
|
4.4
|
4.4
|
UK HPI3
|
(1.2)
|
1.6
|
3.0
|
4.4
|
3.2
|
UK bank
rate6
|
5.0
|
4.3
|
3.8
|
3.6
|
3.5
|
US GDP1
|
2.3
|
1.7
|
2.0
|
2.0
|
2.0
|
US
unemployment4
|
4.0
|
4.1
|
4.1
|
4.1
|
4.1
|
US HPI5
|
3.3
|
3.0
|
3.3
|
3.3
|
3.3
|
US federal funds
rate6
|
5.3
|
4.4
|
4.0
|
3.8
|
3.8
|
|
|
|
|
|
|
Downside 2
|
|
|
|
|
|
UK GDP1
|
0.2
|
(3.2)
|
0.5
|
2.1
|
1.3
|
UK
unemployment2
|
4.4
|
6.4
|
6.9
|
5.3
|
4.7
|
UK HPI3
|
(3.6)
|
(23.3)
|
2.8
|
15.6
|
7.7
|
UK bank
rate6
|
5.9
|
4.0
|
1.0
|
1.0
|
1.0
|
US GDP1
|
1.8
|
(2.9)
|
1.2
|
2.8
|
1.6
|
US
unemployment4
|
4.2
|
6.3
|
6.4
|
5.3
|
4.9
|
US HPI5
|
0.9
|
(10.7)
|
2.0
|
8.0
|
5.3
|
US federal funds
rate6
|
5.9
|
4.1
|
1.5
|
1.5
|
1.5
|
|
|
|
|
|
|
Downside 1
|
|
|
|
|
|
UK GDP1
|
0.4
|
(1.0)
|
1.0
|
1.9
|
1.5
|
UK
unemployment2
|
4.3
|
5.4
|
5.6
|
4.9
|
4.6
|
UK HPI3
|
(2.4)
|
(11.5)
|
2.9
|
9.9
|
5.5
|
UK bank
rate6
|
5.5
|
4.1
|
2.4
|
2.3
|
2.3
|
US GDP1
|
2.0
|
(0.6)
|
1.6
|
2.4
|
1.8
|
US
unemployment4
|
4.1
|
5.2
|
5.3
|
4.7
|
4.5
|
US HPI5
|
2.1
|
(4.0)
|
2.7
|
5.6
|
4.3
|
US federal funds
rate6
|
5.6
|
4.3
|
2.8
|
2.6
|
2.6
|
|
|
|
|
|
|
Upside 2
|
|
|
|
|
|
UK GDP1
|
1.1
|
3.9
|
3.2
|
2.6
|
2.3
|
UK
unemployment2
|
4.1
|
3.4
|
3.4
|
3.3
|
3.2
|
UK HPI3
|
4.9
|
14.2
|
6.8
|
2.7
|
3.8
|
UK bank
rate6
|
4.9
|
3.4
|
2.6
|
2.6
|
2.5
|
US GDP1
|
2.6
|
3.2
|
2.9
|
2.8
|
2.8
|
US
unemployment4
|
3.7
|
3.5
|
3.4
|
3.4
|
3.4
|
US HPI5
|
5.3
|
3.9
|
5.0
|
4.6
|
4.6
|
US federal funds
rate6
|
5.2
|
3.7
|
3.1
|
2.8
|
2.8
|
|
|
|
|
|
|
Upside 1
|
|
|
|
|
|
UK GDP1
|
0.9
|
2.5
|
2.4
|
2.2
|
2.0
|
UK
unemployment2
|
4.2
|
3.9
|
3.9
|
3.9
|
3.8
|
UK HPI3
|
1.8
|
7.8
|
4.9
|
3.6
|
3.5
|
UK bank
rate6
|
5.0
|
3.8
|
3.2
|
3.1
|
3.0
|
US GDP1
|
2.4
|
2.5
|
2.4
|
2.4
|
2.4
|
US
unemployment4
|
3.8
|
3.8
|
3.8
|
3.8
|
3.8
|
US HPI5
|
4.3
|
3.5
|
4.2
|
3.9
|
3.9
|
US federal funds
rate6
|
5.3
|
4.1
|
3.5
|
3.3
|
3.3
|
1
|
Average Real GDP seasonally adjusted change in
year.
|
2
|
Average UK unemployment rate 16-year+.
|
3
|
Change in year end UK HPI = Halifax All Houses, All Buyers
index, relative to prior year end.
|
4
|
Average US civilian unemployment rate
16-year+.
|
5
|
Change in year end US HPI = FHFA House Price Index, relative
to prior year end.
|
6
|
Average rate.
|
As at 31.12.23
|
2023
|
2024
|
2025
|
2026
|
2027
|
Baseline
|
%
|
%
|
%
|
%
|
%
|
UK GDP1
|
0.5
|
0.3
|
1.2
|
1.6
|
1.6
|
UK
unemployment2
|
4.2
|
4.7
|
4.7
|
4.8
|
5.0
|
UK HPI3
|
(3.3)
|
(5.1)
|
0.7
|
3.1
|
5.3
|
UK bank
rate6
|
4.7
|
4.9
|
4.1
|
3.8
|
3.5
|
US GDP1
|
2.4
|
1.3
|
1.7
|
1.9
|
1.9
|
US
unemployment4
|
3.7
|
4.3
|
4.3
|
4.3
|
4.3
|
US HPI5
|
5.4
|
3.4
|
3.0
|
3.3
|
3.3
|
US federal funds
rate6
|
5.1
|
5.0
|
3.9
|
3.8
|
3.8
|
|
|
|
|
|
|
Downside 2
|
|
|
|
|
|
UK GDP1
|
0.5
|
(1.5)
|
(2.6)
|
2.4
|
1.6
|
UK
unemployment2
|
4.2
|
5.2
|
7.9
|
6.3
|
5.5
|
UK HPI3
|
(3.3)
|
(19.3)
|
(16.8)
|
14.5
|
12.4
|
UK bank
rate6
|
4.7
|
6.6
|
1.3
|
1.0
|
1.0
|
US GDP1
|
2.4
|
(0.6)
|
(2.0)
|
3.1
|
2.0
|
US
unemployment4
|
3.7
|
5.2
|
7.2
|
5.9
|
5.2
|
US HPI5
|
5.4
|
(6.5)
|
(5.7)
|
7.2
|
6.4
|
US federal funds
rate6
|
5.1
|
6.3
|
1.8
|
1.5
|
1.5
|
|
|
|
|
|
|
Downside 1
|
|
|
|
|
|
UK GDP1
|
0.5
|
(0.6)
|
(0.7)
|
2.0
|
1.6
|
UK
unemployment2
|
4.2
|
4.9
|
6.3
|
5.6
|
5.2
|
UK HPI3
|
(3.3)
|
(12.4)
|
(8.3)
|
8.7
|
8.8
|
UK bank
rate6
|
4.7
|
5.8
|
2.7
|
2.5
|
2.3
|
US GDP1
|
2.4
|
0.3
|
(0.2)
|
2.5
|
1.9
|
US
unemployment4
|
3.7
|
4.7
|
5.8
|
5.1
|
4.8
|
US HPI5
|
5.4
|
(1.7)
|
(1.4)
|
5.2
|
4.8
|
US federal funds
rate6
|
5.1
|
5.7
|
2.9
|
2.8
|
2.8
|
|
|
|
|
|
|
Upside 2
|
|
|
|
|
|
UK GDP1
|
0.5
|
2.4
|
3.7
|
2.9
|
2.4
|
UK
unemployment2
|
4.2
|
3.9
|
3.5
|
3.6
|
3.6
|
UK HPI3
|
(3.3)
|
7.8
|
7.6
|
4.5
|
5.6
|
UK bank
rate6
|
4.7
|
4.3
|
2.7
|
2.5
|
2.5
|
US GDP1
|
2.4
|
2.8
|
3.1
|
2.8
|
2.8
|
US
unemployment4
|
3.7
|
3.5
|
3.6
|
3.6
|
3.6
|
US HPI5
|
5.4
|
6.1
|
4.3
|
4.5
|
4.6
|
US federal funds
rate6
|
5.1
|
4.3
|
2.9
|
2.8
|
2.8
|
|
|
|
|
|
|
Upside 1
|
|
|
|
|
|
UK GDP1
|
0.5
|
1.4
|
2.5
|
2.3
|
2.0
|
UK
unemployment2
|
4.2
|
4.3
|
4.1
|
4.2
|
4.3
|
UK HPI3
|
(3.3)
|
1.2
|
4.1
|
3.8
|
5.4
|
UK bank
rate6
|
4.7
|
4.6
|
3.4
|
3.3
|
3.0
|
US GDP1
|
2.4
|
2.0
|
2.4
|
2.4
|
2.4
|
US
unemployment4
|
3.7
|
3.9
|
3.9
|
4.0
|
4.0
|
US HPI5
|
5.4
|
4.7
|
3.7
|
3.9
|
3.9
|
US federal funds
rate6
|
5.1
|
4.7
|
3.5
|
3.3
|
3.3
|
1
|
Average Real GDP seasonally adjusted change in
year.
|
2
|
Average UK unemployment rate 16-year+.
|
3
|
Change in year end UK HPI = Halifax All Houses, All Buyers
index, relative to prior year end.
|
4
|
Average US civilian unemployment rate
16-year+.
|
5
|
Change in year end US HPI = FHFA House Price Index, relative
to prior year end.
|
6
|
Average rate.
|
Scenario probability weighting
|
Upside 2
|
Upside 1
|
Baseline
|
Downside 1
|
Downside 2
|
|
%
|
%
|
%
|
%
|
%
|
As at 30.06.24
|
|
|
|
|
|
Scenario probability
weighting
|
16.5
|
26.1
|
32.6
|
16.2
|
8.6
|
As at 31.12.23
|
|
|
|
|
|
Scenario probability
weighting
|
13.8
|
24.7
|
32.4
|
18.3
|
10.8
|
Specific bases show the most
extreme position of each variable in the context of the
downside/upside scenarios, for example, the highest unemployment
for downside scenarios, average unemployment for baseline scenarios
and lowest unemployment for upside scenarios. GDP and HPI downside
and upside scenario data represents the lowest and highest
cumulative position relative to the start point in the 20 quarter
period.
Macroeconomic variables (specific
bases)1
|
|
Upside 2
|
Upside 1
|
Baseline
|
Downside 1
|
Downside 2
|
As at 30.06.24
|
%
|
%
|
%
|
%
|
%
|
UK GDP2
|
15.1
|
11.5
|
1.4
|
(0.7)
|
(3.7)
|
UK
unemployment3
|
3.1
|
3.8
|
4.4
|
6.2
|
8.0
|
UK HPI4
|
36.5
|
23.4
|
2.2
|
(14.6)
|
(28.2)
|
UK bank
rate3
|
2.5
|
3.0
|
4.0
|
6.5
|
8.5
|
US GDP2
|
14.8
|
12.3
|
2.0
|
(0.2)
|
(3.3)
|
US
unemployment3
|
3.4
|
3.8
|
4.1
|
5.7
|
7.3
|
US HPI4
|
25.7
|
21.5
|
3.2
|
(2.0)
|
(10.6)
|
US federal funds
rate3
|
2.8
|
3.3
|
4.3
|
6.6
|
8.5
|
As at 31.12.23
|
%
|
%
|
%
|
%
|
%
|
UK GDP2
|
13.4
|
9.6
|
1.1
|
(1.3)
|
(4.1)
|
UK
unemployment3
|
3.5
|
3.9
|
4.7
|
6.5
|
8.3
|
UK HPI4
|
23.8
|
11.5
|
0.1
|
(22.5)
|
(35.0)
|
UK bank
rate3
|
2.5
|
3.0
|
4.2
|
6.8
|
8.5
|
US GDP2
|
15.1
|
12.3
|
1.8
|
0.6
|
(1.7)
|
US
unemployment3
|
3.4
|
3.5
|
4.2
|
5.9
|
7.5
|
US HPI4
|
27.4
|
23.5
|
3.7
|
0.4
|
(7.6)
|
US federal funds
rate3
|
2.8
|
3.3
|
4.3
|
6.8
|
8.5
|
1
|
UK GDP = Real GDP growth seasonally adjusted; UK unemployment
= UK unemployment rate 16-year+; UK HI = Halifax All Houses, All
Buyers Index; US GDP = Real GDP growth seasonally adjusted; US
unemployment = US civilian unemployment rate 16-year+; US HPI =
FHFA House Price Index. 20 quarter period starts from Q124 (2023:
Q123).
|
2
|
Maximum growth relative to Q423 (2023: Q422), based on 20
quarter period in Upside scenarios; 5-year yearly average CAGR in
Baseline; minimum growth relative to Q423 (2023: Q422), based on 20
quarter period in Downside scenarios.
|
4
|
Lowest quarter in 20 quarter period in Upside scenarios;
5-year average in Baseline; highest quarter 20 quarter period in
Downside scenarios.
|
5
|
Maximum growth relative to Q423 (2023: Q422), based on 20
quarter period in Upside scenarios; 5-year quarter end CAGR in
Baseline; minimum growth relative to Q423 (2023: Q422), based on 20
quarter period in Downside scenarios.
|
Average basis represents the
average quarterly value of variables in the 20 quarter period with
GDP and HPI based on yearly average and quarterly CAGRs
respectively.
Macroeconomic variables (5-year
averages)1
|
|
Upside 2
|
Upside 1
|
Baseline
|
Downside 1
|
Downside 2
|
As at 30.06.24
|
%
|
%
|
%
|
%
|
%
|
UK GDP2
|
2.6
|
2.0
|
1.4
|
0.8
|
0.2
|
UK
unemployment3
|
3.5
|
3.9
|
4.4
|
5.0
|
5.5
|
UK HPI4
|
6.4
|
4.3
|
2.2
|
0.6
|
(1.1)
|
UK bank
rate3
|
3.2
|
3.6
|
4.0
|
3.3
|
2.6
|
US GDP2
|
2.9
|
2.4
|
2.0
|
1.5
|
0.9
|
US
unemployment3
|
3.5
|
3.8
|
4.1
|
4.7
|
5.4
|
US HPI4
|
4.7
|
4.0
|
3.2
|
2.1
|
0.9
|
US federal funds
rate3
|
3.5
|
3.9
|
4.3
|
3.6
|
2.9
|
As at 31.12.23
|
%
|
%
|
%
|
%
|
%
|
UK GDP2
|
2.4
|
1.7
|
1.1
|
0.6
|
0.1
|
UK
unemployment3
|
3.7
|
4.2
|
4.7
|
5.2
|
5.8
|
UK HPI4
|
4.4
|
2.2
|
0.1
|
(1.7)
|
(3.5)
|
UK bank
rate3
|
3.3
|
3.8
|
4.2
|
3.6
|
2.9
|
US GDP2
|
2.8
|
2.3
|
1.8
|
1.4
|
0.9
|
US
unemployment3
|
3.6
|
3.9
|
4.2
|
4.8
|
5.4
|
US HPI4
|
5.0
|
4.3
|
3.7
|
2.4
|
1.2
|
US federal funds
rate3
|
3.6
|
4.0
|
4.3
|
3.9
|
3.2
|
1
|
UK GDP = Real GDP growth seasonally adjusted; UK unemployment
= UK unemployment rate 16-year+; UK HPI = Halifax All Houses, All
Buyers Index; US GDP = Real GDP growth seasonally adjusted; US
unemployment = US civilian unemployment rate 16-year+; US HPI =
FHFA House Price Index.
|
2
|
5-year yearly average CAGR, starting 2023 (2023:
2022).
|
3
|
5-year average. Period based on 20 quarters from Q124 (2023:
Q123).
|
4
|
5-year quarter end CAGR, starting Q423 (2023:
Q422).
|
ECL under 100% weighted scenarios for modelled
portfolios
The table below shows the modelled
ECL assuming each of the five modelled scenarios are 100% weighted
with the dispersion of results around the Baseline, highlighting
the impact on exposure and ECL across the scenarios. Model exposure
uses exposure at default (EAD) values and is not directly
comparable to gross exposure used in prior disclosures.
|
Scenarios
|
As at 30.06.24
|
Weighted1
|
Upside 2
|
Upside 1
|
Baseline
|
Downside 1
|
Downside 2
|
Stage 1 Model Exposure (£m)
|
|
|
|
|
|
|
Retail mortgages
|
137,577
|
140,036
|
139,029
|
137,590
|
134,420
|
132,510
|
Retail credit
cards2
|
65,142
|
65,077
|
65,108
|
65,137
|
65,221
|
65,228
|
Retail
other2
|
8,050
|
8,183
|
8,122
|
8,056
|
7,918
|
7,749
|
Corporate loans
|
204,588
|
207,006
|
205,881
|
204,883
|
202,114
|
197,234
|
Stage 1 Model ECL (£m)
|
|
|
|
|
|
|
Retail mortgages
|
3
|
-
|
1
|
2
|
5
|
12
|
Retail credit
cards2
|
561
|
534
|
548
|
563
|
584
|
602
|
Retail
other2
|
32
|
31
|
32
|
32
|
33
|
31
|
Corporate loans
|
278
|
244
|
257
|
272
|
308
|
343
|
Stage 1 Coverage (%)
|
|
|
|
|
|
|
Retail mortgages
|
-
|
-
|
-
|
-
|
-
|
-
|
Retail credit cards
|
0.9
|
0.8
|
0.8
|
0.9
|
0.9
|
0.9
|
Retail other
|
0.4
|
0.4
|
0.4
|
0.4
|
0.4
|
0.4
|
Corporate loans
|
0.1
|
0.1
|
0.1
|
0.1
|
0.2
|
0.2
|
Stage 2 Model Exposure (£m)
|
|
|
|
|
|
|
Retail mortgages
|
21,804
|
18,809
|
19,974
|
21,598
|
25,532
|
28,707
|
Retail credit
cards2
|
6,493
|
6,351
|
6,420
|
6,490
|
6,605
|
6,799
|
Retail
other2
|
1,307
|
1,174
|
1,235
|
1,301
|
1,439
|
1,608
|
Corporate loans
|
22,261
|
19,695
|
20,872
|
21,984
|
24,870
|
29,877
|
Stage 2 Model ECL (£m)
|
|
|
|
|
|
|
Retail mortgages
|
8
|
1
|
3
|
5
|
16
|
40
|
Retail credit
cards2
|
1,544
|
1,449
|
1,492
|
1,537
|
1,633
|
1,759
|
Retail
other2
|
82
|
70
|
75
|
80
|
96
|
107
|
Corporate loans
|
537
|
426
|
467
|
513
|
670
|
923
|
Stage 2 Coverage (%)
|
|
|
|
|
|
|
Retail mortgages
|
-
|
-
|
-
|
-
|
0.1
|
0.1
|
Retail credit cards
|
23.8
|
22.8
|
23.2
|
23.7
|
24.7
|
25.9
|
Retail other
|
6.3
|
6.0
|
6.1
|
6.1
|
6.7
|
6.7
|
Corporate loans
|
2.4
|
2.2
|
2.2
|
2.3
|
2.7
|
3.1
|
Stage 3 Model Exposure (£m)3
|
|
|
|
|
|
|
Retail mortgages
|
1,546
|
1,546
|
1,546
|
1,546
|
1,546
|
1,546
|
Retail credit
cards2
|
2,151
|
2,151
|
2,151
|
2,151
|
2,151
|
2,151
|
Retail
other2
|
162
|
162
|
162
|
162
|
162
|
162
|
Corporate loans
|
3,561
|
3,561
|
3,561
|
3,561
|
3,561
|
3,561
|
Stage 3 Model ECL (£m)
|
|
|
|
|
|
|
Retail mortgages
|
285
|
268
|
273
|
281
|
304
|
333
|
Retail credit
cards2
|
1,602
|
1,567
|
1,585
|
1,602
|
1,635
|
1,663
|
Retail
other2
|
94
|
92
|
93
|
94
|
95
|
97
|
Corporate
loans4
|
67
|
62
|
63
|
66
|
74
|
81
|
Stage 3 Coverage (%)
|
|
|
|
|
|
|
Retail mortgages
|
18.4
|
17.3
|
17.7
|
18.2
|
19.7
|
21.5
|
Retail credit cards
|
74.5
|
72.8
|
73.7
|
74.5
|
76.0
|
77.3
|
Retail other
|
58.0
|
56.8
|
57.4
|
58.0
|
58.6
|
59.9
|
Corporate
loans4
|
1.9
|
1.7
|
1.8
|
1.9
|
2.1
|
2.3
|
Total Model ECL (£m)
|
|
|
|
|
|
|
Retail mortgages
|
296
|
269
|
277
|
288
|
325
|
385
|
Retail credit
cards2
|
3,707
|
3,550
|
3,625
|
3,702
|
3,852
|
4,024
|
Retail
other2
|
208
|
193
|
200
|
206
|
224
|
235
|
Corporate
loans4
|
882
|
732
|
787
|
851
|
1,052
|
1,347
|
Total Model ECL
|
5,093
|
4,744
|
4,889
|
5,047
|
5,453
|
5,991
|
Reconciliation to total ECL
|
£m
|
Total weighted model
ECL
|
5,093
|
ECL from individually assessed
exposures4
|
457
|
ECL from non-modelled exposures
and others
|
224
|
ECL from debt securities at
amortised cost
|
20
|
ECL from post model management
adjustments
|
404
|
Of which: ECL from economic uncertainty
adjustments
|
151
|
Total ECL
|
6,198
|
1
|
Model exposures are allocated to a stage based on an
individual scenario rather than a probability-weighted approach as
required for Barclays reported impairment allowances. As a result,
it is not possible to back solve the final reported weighted ECL
from individual scenarios given balances may be assigned to a
different stage dependent on the scenario.
|
2
|
Model exposures and ECL reported within Retail credit cards
and Retail other exclude the German consumer finance business
portfolio classified as assets held for sale.
|
3
|
Model exposures allocated to Stage 3 does not change in any
of the scenarios as the transition criteria relies only on an
observable evidence of default as at 30 June 2024 and not on
macroeconomic scenario.
|
4
|
Material corporate loan defaults are individually assessed
across different recovery strategies. As a result, ECL of £457m is
reported as an individually assessed impairment in the
reconciliation table.
|
The use of five scenarios with
associated weightings results in a total weighted ECL uplift from
the Baseline ECL of 0.9%.
Retail mortgages: Total
weighted ECL of £296m represents a 2.8% increase over the Baseline
ECL (£288m) with coverage ratios remaining steady across the Upside
scenarios, Baseline and Downside 1 scenario. Under the Downside 2
scenario, total ECL increases to £385m driven by a fall in UK
HPI.
Retail credit cards: Total
weighted ECL of £3,707m is broadly aligned to the Baseline ECL
(£3,702m). Total ECL increases to £4,024m under the Downside 2
scenario, driven by an increase in UK and US unemployment
rate.
Retail other: Total weighted
ECL of £208m is broadly aligned to the Baseline ECL (£206m). Total
ECL increases to £235m under the Downside 2 scenario, largely
driven by an increase in UK unemployment rate.
Corporate loans: Total
weighted ECL of £882m represents a 3.6% increase over the Baseline
ECL (£851m). Total ECL increases to £1,347m under the Downside 2
scenario, driven by a decrease in UK and US GDP.
|
Scenarios
|
As at 31.12.23
|
Weighted1
|
Upside 2
|
Upside 1
|
Baseline
|
Downside 1
|
Downside 2
|
Stage 1 Model Exposure (£m)
|
|
|
|
|
|
|
Retail mortgages
|
145,226
|
147,415
|
146,653
|
145,405
|
142,543
|
138,925
|
Retail credit
cards2
|
66,512
|
66,459
|
66,482
|
66,497
|
66,580
|
66,580
|
Retail
other2
|
8,749
|
8,915
|
8,841
|
8,758
|
8,631
|
8,479
|
Corporate loans
|
175,282
|
179,567
|
177,923
|
175,903
|
172,328
|
167,541
|
Stage 1 Model ECL (£m)
|
|
|
|
|
|
|
Retail mortgages
|
9
|
4
|
5
|
7
|
11
|
22
|
Retail credit
cards2
|
562
|
529
|
545
|
561
|
584
|
605
|
Retail
other2
|
32
|
31
|
32
|
32
|
32
|
31
|
Corporate loans
|
275
|
243
|
257
|
270
|
298
|
318
|
Stage 1 Coverage (%)
|
|
|
|
|
|
|
Retail mortgages
|
-
|
-
|
-
|
-
|
-
|
-
|
Retail credit cards
|
0.8
|
0.8
|
0.8
|
0.8
|
0.9
|
0.9
|
Retail other
|
0.4
|
0.3
|
0.4
|
0.4
|
0.4
|
0.4
|
Corporate loans
|
0.2
|
0.1
|
0.1
|
0.2
|
0.2
|
0.2
|
Stage 2 Model Exposure (£m)
|
|
|
|
|
|
|
Retail mortgages
|
20,615
|
17,769
|
18,702
|
20,149
|
23,836
|
28,822
|
Retail credit
cards2
|
7,076
|
6,897
|
6,976
|
7,064
|
7,183
|
7,387
|
Retail
other2
|
1,382
|
1,216
|
1,290
|
1,373
|
1,500
|
1,653
|
Corporate loans
|
24,374
|
19,919
|
21,621
|
23,763
|
27,445
|
32,375
|
Stage 2 Model ECL (£m)
|
|
|
|
|
|
|
Retail mortgages
|
41
|
23
|
27
|
34
|
59
|
123
|
Retail credit
cards2
|
1,684
|
1,554
|
1,609
|
1,668
|
1,775
|
1,922
|
Retail
other2
|
85
|
72
|
78
|
84
|
95
|
105
|
Corporate loans
|
663
|
509
|
565
|
633
|
782
|
1,031
|
Stage 2 Coverage (%)
|
|
|
|
|
|
|
Retail mortgages
|
0.2
|
0.1
|
0.1
|
0.2
|
0.2
|
0.4
|
Retail credit cards
|
23.8
|
22.5
|
23.1
|
23.6
|
24.7
|
26.0
|
Retail other
|
6.2
|
5.9
|
6.0
|
6.1
|
6.3
|
6.4
|
Corporate loans
|
2.7
|
2.6
|
2.6
|
2.7
|
2.8
|
3.2
|
Stage 3 Model Exposure (£m)3
|
|
|
|
|
|
|
Retail mortgages
|
1,672
|
1,672
|
1,672
|
1,672
|
1,672
|
1,672
|
Retail credit
cards2
|
1,827
|
1,827
|
1,827
|
1,827
|
1,827
|
1,827
|
Retail
other2
|
164
|
164
|
164
|
164
|
164
|
164
|
Corporate loans
|
3,436
|
3,436
|
3,436
|
3,436
|
3,436
|
3,436
|
Stage 3 Model ECL (£m)
|
|
|
|
|
|
|
Retail mortgages
|
333
|
308
|
316
|
325
|
351
|
393
|
Retail credit
cards2
|
1,315
|
1,279
|
1,296
|
1,313
|
1,341
|
1,366
|
Retail
other2
|
95
|
94
|
94
|
95
|
96
|
97
|
Corporate
loans4
|
77
|
71
|
73
|
75
|
82
|
89
|
Stage 3 Coverage (%)
|
|
|
|
|
|
|
Retail mortgages
|
19.9
|
18.4
|
18.9
|
19.4
|
21.0
|
23.5
|
Retail credit cards
|
72.0
|
70.0
|
70.9
|
71.9
|
73.4
|
74.8
|
Retail other
|
57.9
|
57.3
|
57.3
|
57.9
|
58.5
|
59.1
|
Corporate
loans4
|
2.2
|
2.1
|
2.1
|
2.2
|
2.4
|
2.6
|
Total Model ECL (£m)
|
|
|
|
|
|
|
Retail mortgages
|
383
|
335
|
348
|
366
|
421
|
538
|
Retail credit
cards2
|
3,561
|
3,362
|
3,450
|
3,542
|
3,700
|
3,893
|
Retail
other2
|
212
|
197
|
204
|
211
|
223
|
233
|
Corporate
loans4
|
1,015
|
823
|
895
|
978
|
1,162
|
1,438
|
Total Model ECL
|
5,171
|
4,717
|
4,897
|
5,097
|
5,506
|
6,102
|
Reconciliation to total ECL
|
£m
|
Total weighted model
ECL
|
5,171
|
ECL from individually assessed
exposures4
|
401
|
ECL from non-modelled exposures
and others
|
276
|
ECL from debt securities at
amortised cost
|
27
|
ECL from post model management
adjustments
|
377
|
Of which: ECL from economic uncertainty
adjustments
|
198
|
Total ECL
|
6,252
|
1
|
Model exposures are allocated to a stage based on an
individual scenario rather than a probability-weighted approach as
required for Barclays reported impairment allowances. As a result,
it is not possible to back solve the final reported weighted ECL
from individual scenarios given balances may be assigned to a
different stage dependent on the scenario.
|
2
|
Model exposures and ECL reported within Retail credit cards
and Retail other exclude the German consumer finance business
portfolio classified as assets held for sale.
|
3
|
Model exposures allocated to Stage 3 does not change in any
of the scenarios as the transition criteria relies only on an
observable evidence of default as at 31 December 2023 and not on
macroeconomic scenario.
|
4
|
Material corporate loan defaults are individually assessed
across different recovery strategies. As a result, ECL of £401m is
reported as an individually assessed impairment in the
reconciliation table.
|
Analysis of specific portfolios and asset
types
Secured home loans
The UK home loan portfolio
primarily comprises first lien mortgages and accounts for 97%
(December 2023: 95%) of the Group's total home loans
balance.
|
Barclays UK
|
Home loans principal portfolios
|
As at 30.06.24
|
As at 31.12.23
|
Gross loans and advances
(£m)
|
161,298
|
163,639
|
90 day arrears rate, excluding
recovery book (%)
|
0.2
|
0.2
|
Annualised gross charge-off rates
- 180 days past due (%)
|
0.6
|
0.5
|
Recovery book proportion of
outstanding balances (%)
|
0.7
|
0.6
|
Recovery book impairment coverage
ratio (%)1
|
6.8
|
7.2
|
|
|
|
Average marked to market LTV
|
|
|
Balance weighted %
|
52.7
|
53.6
|
Valuation weighted %
|
39.4
|
40.0
|
|
|
|
New lending
|
Half year ended 30.06.24
|
Half year ended 30.06.23
|
New home loan bookings
(£m)
|
9,239
|
12,531
|
New home loan proportion > 90%
LTV (%)
|
0.8
|
0.7
|
Average LTV on new home loans:
balance weighted (%)
|
63.4
|
62.5
|
Average LTV on new home loans:
valuation weighted (%)
|
54.1
|
53.7
|
1
|
Recovery Book Impairment Coverage Ratio excludes
KMC.
|
Home loans principal portfolios - distribution of balances by
LTV1
|
Distribution of balances
|
Distribution of impairment allowance
|
Coverage ratio
|
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
Barclays UK
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
As at 30.06.24
|
|
|
|
|
|
|
|
|
|
|
|
|
<=75%
|
74.3
|
11.6
|
0.9
|
86.8
|
7.8
|
16.4
|
24.5
|
48.7
|
-
|
0.2
|
3.5
|
0.1
|
>75% and <=90%
|
11.0
|
1.2
|
0.1
|
12.3
|
7.5
|
20.2
|
11.7
|
39.4
|
0.1
|
2.1
|
25.1
|
0.4
|
>90% and <=100%
|
0.8
|
0.1
|
-
|
0.9
|
1.0
|
2.2
|
4.0
|
7.2
|
0.1
|
4.0
|
63.8
|
1.0
|
>100%
|
-
|
-
|
-
|
-
|
0.3
|
0.3
|
4.1
|
4.7
|
2.5
|
25.7
|
95.3
|
25.7
|
As at 31.12.23
|
|
|
|
|
|
|
|
|
|
|
|
|
<=75%
|
73.5
|
10.4
|
0.9
|
84.8
|
8.5
|
16.2
|
26.7
|
51.4
|
-
|
0.2
|
3.8
|
0.1
|
>75% and <=90%
|
12.3
|
1.2
|
0.1
|
13.6
|
7.4
|
16.7
|
12.8
|
36.9
|
0.1
|
1.9
|
27.9
|
0.4
|
>90% and <=100%
|
1.5
|
0.1
|
-
|
1.6
|
1.2
|
2.5
|
3.6
|
7.3
|
0.1
|
2.6
|
63.3
|
0.6
|
>100%
|
-
|
-
|
-
|
-
|
0.3
|
0.7
|
3.4
|
4.4
|
1.0
|
12.1
|
100.0
|
12.4
|
1
|
Portfolio marked to market based on the most updated
valuation including recovery book balances. Updated valuations
reflect the application of the latest HPI available as at 30 June
2024.
|
New home loans bookings reduced 26% to £9.2bn (H123: £12.5bn) mainly driven by
economic conditions that resulted in general mortgage market
suppression, including higher mortgage payments due to higher
rates.
Head Office: Italian home loans loans and advances at amortised cost reduced to £0.4bn (2023:
£3.6bn) due to the disposal of the performing portfolio in Q224.The
remaining portfolio is secured on residential property with an
average balance weighted mark to market LTV of 73.9% (2023: 55.6%).
90-day arrears is 2.8% (2023: 2.4%) and gross charge-off rate
increased to 2.2% (2023: 0.7%).
Retail credit cards and Retail other
The principal portfolios listed
below accounted for 91% (December 2023: 91%) of the Group's total
retail credit cards and retail other.
Principal portfolios
|
Gross exposure
|
30 day arrears rate, excluding recovery
book
|
90 day arrears rate, excluding recovery
book
|
Annualised gross write-off rate
|
Annualised net write-off rate
|
As at 30.06.24
|
£m
|
%
|
%
|
%
|
%
|
Barclays UK
|
|
|
|
|
|
UK cards
|
10,889
|
0.8
|
0.2
|
1.7
|
1.4
|
UK personal loans
|
3,822
|
1.4
|
0.6
|
1.3
|
1.1
|
Barclays Partner
Finance
|
1,846
|
0.6
|
0.3
|
1.0
|
1.0
|
US Consumer Bank
|
|
|
|
|
|
US cards
|
26,935
|
2.9
|
1.6
|
3.5
|
3.5
|
|
|
|
|
|
|
As at 31.12.23
|
|
|
|
|
|
Barclays UK
|
|
|
|
|
|
UK cards
|
10,420
|
0.9
|
0.2
|
1.4
|
1.3
|
UK personal loans
|
3,641
|
1.5
|
0.6
|
1.3
|
1.0
|
Barclays Partner
Finance
|
2,344
|
0.6
|
0.3
|
0.7
|
0.7
|
US Consumer Bank
|
|
|
|
|
|
US cards
|
27,286
|
2.9
|
1.5
|
2.3
|
2.3
|
Retail Credit Cards and Retail Other held for
sale
|
Gross exposure
|
30 day arrears rate, excluding recovery
book
|
90 day arrears rate, excluding recovery
book
|
Annualised gross write-off rate
|
Annualised net write-off rate
|
As at 30.06.24
|
£m
|
%
|
%
|
%
|
%
|
Head Office
|
|
|
|
|
|
Germany consumer finance
business
|
3,905
|
1.8
|
0.8
|
1.2
|
1.1
|
|
|
|
|
|
|
As at 31.12.23
|
|
|
|
|
|
Head Office
|
|
|
|
|
|
Germany consumer finance
business
|
4,094
|
1.7
|
0.8
|
1.0
|
1.0
|
UK cards: 30 day and 90 day
arrears rates have remained broadly stable at 0.8% (Q423: 0.9%) and
0.2% (Q423: 0.2%) respectively. Total exposure increased from
£10.4bn to £10.9bn due to growth in spend and new lending
promotional balances. Both gross and net write-offs increased to
1.7% (Q423: 1.4%) and 1.4% (Q423: 1.3%) respectively, reflecting
further impact from the alignment of point of charge-off and
write-off and a marginal increase in
monthly flow.
UK personal loans: 30
and 90 day arrears rates have remained broadly
stable at 1.4% (Q423: 1.5%) and 0.6% (Q423: 0.6%) respectively.
Total exposure increased from £3.6bn to £3.8bn due to increased new
lending. Both the gross and net write-off rates have remained
broadly stable at 1.3% (Q423: 1.3%) and 1.1% (Q423: 1.0%)
respectively.
Barclays Partner Finance: 30 and 90 day arrears rates have
remained flat at 0.6% and 0.3% respectively. Total exposure fell to
£1.8bn (Q423: £2.3bn) due to a strategic decision to reduce the
number of active partner businesses. Both annualised gross and net
write off rates increased by 0.3% to 1.0% respectively as a result
of the reduction in total exposure.
US cards: 30 day arrears
rates were flat (2.9%) as delinquency reduced in Q224 following an
increase in Q124. 90 day arrears rates increased to 1.6% (2023:
1.5%) reflecting the increased flow into and through delinquency
observed in Q124. The increase in both gross and net write-off
rates reflected the overall delinquency trends through to
charge-off lagged by the charge off to write off period of 12
months.
German consumer finance business: Gross exposure decreased by 4.6% as a result of phasing out
Open Market loan originations from Q423. 30 day arrears rate
increased marginally to 1.8% (Q423: 1.7%) driven by the decrease in
gross exposure over the period. Lower debt sale prices in addition
to the decrease in gross exposure led to higher write-off
rates.
Market Risk
Analysis of management value at risk (VaR)
The table below shows the total
management VaR on a diversified basis by asset class. Total
management VaR includes all trading positions in Barclays Bank
Group and it is calculated with a one-day holding period. VaR
limits are applied to total management VaR and by asset class.
Additionally, the market risk management function applies VaR
sub-limits to material businesses and trading desks.
Management VaR (95%) by asset class
|
Half year ended 30.06.24
|
|
Half year ended 31.12.23
|
|
Half year ended 30.06.23
|
|
Average
|
High
|
Low
|
|
Average
|
High
|
Low
|
|
Average
|
High
|
Low
|
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
Credit risk
|
22
|
27
|
19
|
|
32
|
40
|
22
|
|
48
|
57
|
38
|
Interest rate risk
|
16
|
25
|
9
|
|
15
|
24
|
10
|
|
16
|
25
|
9
|
Equity risk
|
6
|
9
|
4
|
|
5
|
9
|
3
|
|
6
|
10
|
3
|
Basis risk
|
6
|
8
|
4
|
|
10
|
13
|
8
|
|
16
|
25
|
11
|
Spread risk
|
5
|
7
|
4
|
|
7
|
10
|
5
|
|
10
|
14
|
7
|
Foreign exchange risk
|
4
|
9
|
2
|
|
4
|
9
|
2
|
|
3
|
6
|
1
|
Commodity risk
|
-
|
1
|
-
|
|
-
|
1
|
-
|
|
-
|
1
|
-
|
Inflation risk
|
4
|
5
|
2
|
|
4
|
6
|
2
|
|
9
|
11
|
6
|
Diversification
effect1
|
(34)
|
n/a
|
n/a
|
|
(38)
|
n/a
|
n/a
|
|
(63)
|
n/a
|
n/a
|
Total management VaR
|
29
|
36
|
20
|
|
39
|
55
|
24
|
|
45
|
60
|
34
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
Diversification effects recognise that forecast losses from
different assets or businesses are unlikely to occur concurrently,
hence the expected aggregate loss is lower than the sum of the
expected losses from each area. Historical correlations between
losses are taken into account in making these assessments. The high
and low VaR figures reported for each category did not necessarily
occur on the same day as the high and low total management VaR.
Consequently, a diversification effect balance for the high and low
VaR figures would not be meaningful and is therefore omitted from
the above table.
|
Average Management VaR decreased
26% to £29m (H223: £39m). The decrease was mainly driven by lower
market volatility and credit spread levels in H124, as geopolitical
tensions eased (relative to H223), inflation continued to decline
and central banks started to cut rates.
Treasury and Capital Risk
The Group has established a
comprehensive set of policies, standards and controls for managing
its liquidity risk; together these set out the requirements for
Barclays' liquidity risk framework. The liquidity risk framework
meets the PRA standards and enables Barclays to maintain liquidity
resources that are sufficient in amount and quality, and a funding
profile that is appropriate to meet the Group's Liquidity Risk
Appetite. The liquidity risk framework is delivered via a
combination of policy formation, review and challenge, governance,
analysis, stress testing, limit setting and monitoring.
Liquidity risk stress testing
The Internal Liquidity Stress
Tests (ILST) measure the potential contractual and contingent
stress outflows under a range of scenarios, which are then used to
determine the size of the liquidity pool that is immediately
available to meet anticipated outflows if a stress occurs. The
short-term scenarios include a 30 day Barclays-specific stress
event, a 90 day market-wide stress event and a 30 day combined
scenario consisting of both a Barclays specific and market-wide
stress event. The Group also runs a liquidity stress test which
measures the anticipated outflows over a 12 month market-wide
scenario.
The LCR requirement takes into
account the relative stability of different sources of funding and
potential incremental funding requirements in a stress. The LCR is
designed to promote short-term resilience of a bank's liquidity
risk profile by holding sufficient high quality liquid assets to
survive an acute stress scenario lasting for 30 days.
As at 30 June 2024 the average LCR
was 167.0% (December 2023: 161.4%). The Group held eligible liquid
assets in excess of 100% of net stress outflows as measured
according to both its internal ILST and external regulatory
requirements.
Liquidity coverage ratio1
|
As at 30.06.24
|
As at 31.12.23
|
|
£bn
|
£bn
|
LCR Eligible High Quality Liquid
Assets (HQLA)
|
307.0
|
310.3
|
Net stress outflows
|
(184.2)
|
(192.6)
|
Surplus
|
122.8
|
117.7
|
|
|
|
Liquidity coverage ratio
|
167.0%
|
161.4%
|
1
|
Represents the average of the last 12 spot month end
ratios.
|
Net Stable Funding Ratio
The external NSFR metric requires
banks to maintain a stable funding profile taking into account both
on and certain off balance sheet exposures over a medium to long
term period. The ratio is defined as the Available Stable Funding
(capital and certain liabilities which are treated as stable
sources of funding) relative to the Required Stable Funding (a
measure of assets on the balance sheet and certain off balance
sheet exposures which may require longer term funding). The NSFR
(average of last four quarter ends) as at 30 June 2024 was 136.4%,
which was a surplus above requirements of
£165.9bn.
Net Stable Funding Ratio1
|
As at 30.06.24
|
As at 31.12.23
|
|
£bn
|
£bn
|
Total Available Stable
Funding
|
622.1
|
606.8
|
Total Required Stable
Funding
|
456.2
|
439.7
|
Surplus
|
165.9
|
167.1
|
|
|
|
Net Stable Funding Ratio
|
136.4%
|
138.0%
|
1
|
Represents the average of the last four spot quarter end
ratios.
|
As part of the liquidity risk
appetite, Barclays establishes minimum LCR, NSFR and internal
liquidity stress test limits. The Group plans to maintain its
surplus to the internal and regulatory requirements at an efficient
level. Risks to market funding conditions, the Group's liquidity
position and funding profile are assessed continuously, and actions
are taken to manage the size of the liquidity pool and the funding
profile as appropriate.
Composition of the Group liquidity pool
|
|
|
|
|
|
|
|
|
LCR eligible1 High Quality Liquid Assets
(HQLA)
|
|
Liquidity pool
|
|
Cash
|
Level 1
|
Level 2A
|
Level 2B
|
Total
|
|
2024
|
2023
|
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Cash and deposits with central
banks2
|
232
|
-
|
-
|
-
|
232
|
|
251
|
232
|
|
|
|
|
|
|
|
|
|
Government bonds3
|
|
|
|
|
|
|
|
|
AAA to AA-
|
-
|
58
|
-
|
-
|
58
|
|
55
|
48
|
A+ to A-
|
-
|
1
|
1
|
-
|
2
|
|
2
|
1
|
BBB+ to BBB-
|
-
|
1
|
-
|
-
|
1
|
|
1
|
1
|
Total government bonds
|
-
|
60
|
1
|
-
|
61
|
|
58
|
50
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
|
|
|
|
|
Government Guaranteed Issuers,
PSEs and GSEs
|
-
|
3
|
-
|
-
|
3
|
|
6
|
5
|
International Organisations and
MDBs
|
-
|
4
|
-
|
-
|
4
|
|
4
|
3
|
Covered bonds
|
-
|
2
|
5
|
-
|
7
|
|
8
|
7
|
Other
|
-
|
-
|
-
|
2
|
2
|
|
2
|
1
|
Total other
|
-
|
9
|
5
|
2
|
16
|
|
20
|
16
|
|
|
|
|
|
|
|
|
|
Total as at 30 June 2024
|
232
|
69
|
6
|
2
|
309
|
|
329
|
|
Total as at 31 December 2023
|
211
|
52
|
9
|
2
|
274
|
|
|
298
|
1
|
The LCR eligible HQLA is adjusted under the Liquidity
Coverage Ratio (CRR) part of the PRA rulebook for operational
restrictions upon consolidation, such as trapped liquidity within
Barclays subsidiaries. It also reflects differences in eligibility
of assets between the LCR and Barclays' Liquidity
Pool.
|
2
|
Includes cash held at central banks and surplus cash at
central banks related to payment schemes. Over 99% (December 2023:
over 99%) was placed with the Bank of England, US Federal Reserve,
European Central Bank, Bank of Japan and Swiss National
Bank.
|
3
|
Of which over 81% (December 2023: over 80%) comprised UK, US,
French, German, Japanese, Swiss and Dutch
securities.
|
The Group liquidity pool increased to £329bn as at June 2024 (December
2023: £298bn) primarily driven by an increase in deposits,
particularly in Corporate Bank and Private Bank
deposits.
In June
2024, the month-end liquidity pool ranged from £315bn to £341bn
(2023: £298bn to £342bn), and the month-end average balance was
£326bn (2023: £328bn). The liquidity pool is held unencumbered and
represents readily accessible funds to meet potential cash outflows
during stress periods.
As at 30 June 2024, 62% (December
2023: 59%) of the liquidity pool was located in Barclays Bank PLC,
21% (December 2023: 22%) in Barclays Bank UK PLC and 8% (December
2023: 11%) in Barclays Bank Ireland PLC. The residual portion of
the liquidity pool is held outside of these entities, predominantly
in US subsidiaries, to meet entity-specific stress outflows and
local regulatory requirements. To the extent the use of this
residual portion of the liquidity pool is restricted due to local
regulatory requirements, it is assumed to be unavailable to the
rest of the Group in calculating the LCR.
The composition of the pool is
subject to limits set by the Board and the independent liquidity
risk, credit risk and market risk functions. In addition, the
investment of the liquidity pool is monitored for concentration by
issuer, currency and asset type. Given returns generated by these
highly liquid assets, the risk and reward profile is continuously
managed.
Deposit funding
|
As at 30.06.24
|
|
As at 31.12.23
|
|
Loans and advances, debt securities at amortised
cost
|
Deposits at amortised cost
|
Loan: deposit ratio1
|
|
Loan: deposit ratio1
|
Funding of loans and advances
|
£bn
|
£bn
|
%
|
|
%
|
Barclays UK
|
215.7
|
236.8
|
91
|
|
92
|
Barclays UK Corporate
Bank
|
25.8
|
84.9
|
30
|
|
31
|
Barclays Private Bank and Wealth
Management
|
14.0
|
64.6
|
22
|
|
23
|
Barclays Investment
Bank
|
114.9
|
151.3
|
76
|
|
82
|
Barclays US consumer
Bank
|
25.4
|
20.0
|
125
|
|
125
|
Head Office
|
3.7
|
|
|
|
|
Barclays Group
|
399.5
|
557.5
|
72
|
|
74
|
1
|
The loan: deposit ratio is calculated as loans and advances
at amortised cost and debt securities at amortised cost divided by
deposits at amortised cost.
|
Funding structure and funding relationships
The basis for liquidity risk
management is a funding structure that reduces the probability of a
liquidity stress leading to an inability to meet funding
obligations as they fall due. The Group's overall funding strategy
is to develop a diversified funding base (geographically, by type
and by counterparty) and maintain access to a variety of
alternative funding sources, to provide protection against
unexpected fluctuations, while minimising the cost of
funding.
Within this, the Group aims to
align the sources and uses of funding. As such, retail and
corporate loans and advances are largely funded by deposits in the
relevant entities, with the surplus primarily funding the liquidity
pool. The majority of reverse repurchase agreements are matched by
repurchase agreements. Derivative liabilities and assets are
largely matched. A substantial proportion of balance sheet
derivative positions qualify for counterparty netting and the
remaining portions are largely offset when netted against cash
collateral received and paid. Wholesale debt and equity is used to
fund residual assets.
These funding relationships as at
30 June 2024 are summarised below:
|
As at 30.06.24
|
As at 31.12.23
|
|
|
As at 30.06.24
|
As at 31.12.23
|
Assets
|
£bn
|
£bn
|
|
Liabilities and equity
|
£bn
|
£bn
|
Loans and advances at amortised
cost1
|
382
|
386
|
|
Deposits at amortised
cost
|
557
|
539
|
Group liquidity pool
|
329
|
298
|
|
<1 Year wholesale
funding
|
59
|
59
|
|
|
|
|
>1 Year wholesale
funding
|
123
|
118
|
Reverse repurchase agreements,
trading portfolio assets, cash collateral and settlement
balances
|
505
|
435
|
|
Repurchase agreements, trading
portfolio liabilities, cash collateral and settlement
balances
|
461
|
380
|
Derivative financial
instruments
|
254
|
257
|
|
Derivative financial
instruments
|
242
|
250
|
Other
assets2
|
107
|
101
|
|
Other liabilities
|
63
|
59
|
|
|
|
|
Equity
|
72
|
72
|
Total assets
|
1,577
|
1,477
|
|
Total liabilities and equity
|
1,577
|
1,477
|
1
|
Adjusted for liquidity pool debt securities reported at
amortised cost of £18bn (December 2023: £18bn).
|
2
|
Other assets include fair value assets that are not part of
reverse repurchase agreements or trading portfolio assets, and
other asset categories.
|
Composition of wholesale funding
Wholesale funding outstanding
(excluding repurchase agreements) was £182.2bn (December 2023:
£176.8bn). In H124, the Group issued £9.7bn of MREL eligible
instruments from Barclays PLC (the Parent company) in a range of
tenors and currencies.
Our operating companies also
access wholesale funding markets to maintain their stable and
diversified funding bases. Barclays Bank PLC continued to issue in
the shorter-term and medium-term notes markets. In addition,
Barclays Bank UK PLC continued to issue in the shorter-term markets
and maintains active secured funding programmes.
Wholesale funding of £58.9bn
(December 2023: £58.6bn) matures in less than one year,
representing 32% (December 2023: 33%) of total wholesale funding
outstanding. This includes £20.8bn (December 2023: £18.7bn) related
to term funding1.
Maturity profile of wholesale
funding1,2
|
<1
|
1-3
|
3-6
|
6-12
|
<1
|
1-2
|
2-3
|
3-4
|
4-5
|
>5
|
|
|
month
|
months
|
months
|
months
|
year
|
years
|
years
|
years
|
years
|
years
|
Total
|
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
Barclays PLC (the Parent company)
|
|
|
|
|
|
|
|
|
|
|
|
Senior unsecured (public
benchmark)
|
-
|
-
|
-
|
1.6
|
1.6
|
6.9
|
5.8
|
7.0
|
4.0
|
23.0
|
48.3
|
Senior unsecured (privately
placed)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1.0
|
1.0
|
Subordinated
liabilities
|
-
|
0.4
|
-
|
-
|
0.4
|
1.5
|
-
|
1.6
|
-
|
7.0
|
10.5
|
Barclays Bank PLC (including subsidiaries)
|
|
|
|
|
|
|
|
|
|
|
|
Certificates of deposit and
commercial paper
|
2.2
|
5.7
|
4.0
|
9.5
|
21.4
|
0.8
|
0.1
|
-
|
-
|
-
|
22.3
|
Asset backed commercial
paper
|
3.7
|
7.3
|
2.2
|
-
|
13.2
|
-
|
-
|
-
|
-
|
-
|
13.2
|
Senior unsecured (privately
placed)3
|
1.5
|
3.4
|
4.2
|
7.2
|
16.3
|
9.4
|
10.1
|
7.7
|
9.1
|
20.6
|
73.2
|
Asset backed securities
|
-
|
-
|
1.0
|
1.1
|
2.1
|
1.0
|
0.1
|
0.2
|
0.5
|
3.0
|
6.9
|
Subordinated
liabilities
|
-
|
0.1
|
0.2
|
0.1
|
0.4
|
-
|
0.4
|
0.2
|
-
|
0.3
|
1.3
|
Barclays Bank UK PLC (including
subsidiaries)
|
|
|
|
|
|
|
|
|
|
|
|
Certificates of deposit and
commercial paper
|
3.5
|
-
|
-
|
-
|
3.5
|
-
|
-
|
-
|
-
|
-
|
3.5
|
Senior unsecured (privately
placed)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.1
|
0.1
|
Covered bonds
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.5
|
0.7
|
0.7
|
1.9
|
Total as at 30 June 2024
|
10.9
|
16.9
|
11.6
|
19.5
|
58.9
|
19.6
|
16.5
|
17.2
|
14.3
|
55.7
|
182.2
|
Of which secured
|
3.7
|
7.3
|
3.2
|
1.1
|
15.3
|
1.0
|
0.1
|
0.7
|
1.2
|
3.7
|
22.0
|
Of which unsecured
|
7.2
|
9.6
|
8.4
|
18.4
|
43.6
|
18.6
|
16.4
|
16.5
|
13.1
|
52.0
|
160.2
|
|
|
|
|
|
|
|
|
|
|
|
|
Total as at 31 December 2023
|
7.5
|
19.6
|
13.9
|
17.6
|
58.6
|
20.3
|
20.4
|
11.7
|
13.5
|
52.3
|
176.8
|
Of which secured
|
2.4
|
8.2
|
1.1
|
1.0
|
12.7
|
1.2
|
0.5
|
0.5
|
0.3
|
3.8
|
19.0
|
Of which unsecured
|
5.1
|
11.4
|
12.8
|
16.6
|
45.9
|
19.1
|
19.9
|
11.2
|
13.2
|
48.5
|
157.8
|
1
|
The composition of wholesale funds comprises the balance
sheet reported financial liabilities at fair value, debt securities
in issue and subordinated liabilities. It does not include
participation in the central bank facilities reported within
repurchase agreements and other similar secured
borrowing.
|
2
|
Term funding comprises public benchmark and privately placed
senior unsecured notes, covered bonds, asset-backed securities and
subordinated debt where the original maturity of the instrument is
more than 1 year.
|
3
|
Includes structured notes of £58.7bn, of which £13.7bn
matures within one year.
|
Credit ratings
In addition to monitoring and
managing key metrics related to the financial strength of the
Group, Barclays solicits independent credit ratings from agencies
such as Standard & Poor's Global (S&P), Moody's and Fitch.
These ratings assess the creditworthiness of the Group, its
subsidiaries and its branches, and are based on reviews of a broad
range of business and financial attributes including capital
strength, profitability, funding, liquidity, asset quality,
strategy and governance.
Barclays Bank PLC
|
Standard & Poor's
|
Moody's
|
Fitch
|
Long-term
|
A+ / Stable
|
A1 / Stable
|
A+ / Stable
|
Short-term
|
A-1
|
P-1
|
F1
|
|
|
|
|
Barclays Bank UK PLC
|
|
|
|
Long-term
|
A+ / Stable
|
A1 / Stable
|
A+ / Stable
|
Short-term
|
A-1
|
P-1
|
F1
|
|
|
|
|
Barclays PLC
|
|
|
|
Long-term
|
BBB+ / Stable
|
Baa1 / Stable
|
A / Stable
|
Short-term
|
A-2
|
P-2
|
F1
|
In H124, S&P and Fitch
affirmed all ratings for Barclays PLC, Barclays Bank PLC and
Barclays Bank UK PLC.
A credit rating downgrade could
result in outflows to meet collateral requirements on existing
contracts. Outflows related to credit rating downgrades are
included in the ILST scenarios and a portion of the liquidity pool
is held against this risk. Credit ratings downgrades could also
result in reduced funding capacity and increased funding
costs.
The contractual collateral
requirement following one- and two-notch long-term and associated
short-term downgrades across all credit rating agencies, would
result in outflows of £1bn and £3bn respectively on derivative
contracts and other off balance sheet products, and are provided
for in determining an appropriate liquidity pool size given the
Group's liquidity risk appetite. These numbers do not assume any
management or restructuring actions that could be taken to reduce
posting requirements.
Regulatory minimum requirements
Capital
The Group's Overall Capital
Requirement for CET1 remained 12.0% comprising a 4.5% Pillar 1
minimum, a 2.5% Capital Conservation Buffer (CCB), a 1.5% Global
Systemically Important Institution (G-SII) buffer, a 2.6% Pillar 2A
requirement and a 0.9% Countercyclical Capital Buffer
(CCyB).
The Group's CCyB is based on the
buffer rate applicable for each jurisdiction in which the Group has
exposures. The buffer rates set by other national authorities for
non-UK exposures are not currently material.
The Group's Pillar 2A requirement
as per the PRA's Individual Capital Requirement is 4.6% of which at
least 56.25% needs to be met with CET1 capital, equating to 2.6% of
RWAs. The Pillar 2A requirement, based on a point in time
assessment, has been set as a proportion of RWAs and is subject to
at least annual review.
The Group's CET1 target ratio of
13-14% takes into account headroom above requirements which
includes a confidential institution-specific PRA buffer. The Group
remains above its minimum capital regulatory requirements including
the PRA buffer.
Leverage
The Group is subject to a UK
leverage ratio requirement of 4.1%. This comprises the 3.25%
minimum requirement, a G-SII additional leverage ratio buffer
(G-SII ALRB) of 0.53% and a countercyclical leverage ratio buffer
(CCLB) of 0.3%. The Group is also required to disclose an average
UK leverage ratio which is based on capital on the last day of each
month in the quarter and an exposure measure for each day in the
quarter.
MREL
The Group is required to meet the
higher of: (i) two times the sum of 8% Pillar 1 and 4.6% Pillar 2A
equating to 25.2% of RWAs; and (ii) 6.75% of leverage exposures. In
addition, the higher of regulatory capital and leverage buffers
apply. CET1 capital cannot be counted towards both MREL and the
buffers, meaning that the buffers, including the above mentioned
confidential institution-specific PRA buffer, will effectively be
applied above MREL requirements.
Capital ratios1,2
|
As at 30.06.24
|
As at 31.03.24
|
As at 31.12.23
|
CET1
|
13.6%
|
13.5%
|
13.8%
|
T1
|
17.3%
|
17.3%
|
17.7%
|
Total regulatory
capital
|
19.9%
|
19.6%
|
20.1%
|
MREL ratio as a percentage of
total RWAs
|
33.5%
|
33.4%
|
33.6%
|
|
|
|
|
Own funds and eligible liabilities
|
£m
|
£m
|
£m
|
Total equity excluding non-controlling interests per the
balance sheet
|
71,173
|
71,680
|
71,204
|
Less: other equity instruments
(recognised as AT1 capital)
|
(12,959)
|
(13,241)
|
(13,259)
|
Adjustment to retained earnings
for foreseeable ordinary share dividends
|
(645)
|
(1,123)
|
(795)
|
Adjustment to retained earnings
for foreseeable repurchase of shares
|
(222)
|
(796)
|
-
|
Adjustment to retained earnings
for foreseeable other equity coupons
|
(41)
|
(46)
|
(43)
|
|
|
|
|
Other regulatory adjustments and deductions
|
|
|
|
Additional value adjustments
(PVA)
|
(1,887)
|
(1,834)
|
(1,901)
|
Goodwill and intangible
assets
|
(7,835)
|
(7,807)
|
(7,790)
|
Deferred tax assets that rely on
future profitability excluding temporary differences
|
(1,630)
|
(1,558)
|
(1,630)
|
Fair value reserves related to
gains or losses on cash flow hedges
|
3,799
|
4,049
|
3,707
|
Excess of expected losses over
impairment
|
(324)
|
(299)
|
(296)
|
Gains or losses on liabilities at
fair value resulting from own credit
|
622
|
378
|
136
|
Defined benefit pension fund
assets
|
(2,564)
|
(2,509)
|
(2,654)
|
Direct and indirect holdings by an
institution of own CET1 instruments
|
(5)
|
(3)
|
(20)
|
Adjustment under IFRS 9
transitional arrangements
|
123
|
137
|
288
|
Other regulatory
adjustments
|
90
|
116
|
357
|
CET1 capital
|
47,695
|
47,144
|
47,304
|
|
|
|
|
AT1 capital
|
|
|
|
Capital instruments and related
share premium accounts
|
13,000
|
13,263
|
13,263
|
Other regulatory adjustments and
deductions
|
(41)
|
(22)
|
(60)
|
AT1 capital
|
12,959
|
13,241
|
13,203
|
|
|
|
|
T1 capital
|
60,654
|
60,385
|
60,507
|
|
|
|
|
T2 capital
|
|
|
|
Capital instruments and related
share premium accounts
|
8,836
|
7,704
|
7,966
|
Qualifying T2 capital (including
minority interests) issued by subsidiaries
|
385
|
401
|
569
|
Credit risk adjustments (excess of
impairment over expected losses)
|
39
|
-
|
-
|
Other regulatory adjustments and
deductions
|
(43)
|
(35)
|
(160)
|
Total regulatory capital
|
69,871
|
68,455
|
68,882
|
|
|
|
|
Less : Ineligible T2 capital
(including minority interests) issued by subsidiaries
|
(385)
|
(401)
|
(569)
|
Eligible liabilities
|
48,299
|
48,770
|
46,995
|
|
|
|
|
Total own funds and eligible
liabilities3
|
117,785
|
116,824
|
115,308
|
|
|
|
|
Total RWAs
|
351,433
|
349,635
|
342,717
|
1
|
CET1, T1 and T2 capital, and RWAs are calculated applying the
transitional arrangements in accordance with UK CRR. This includes
IFRS 9 transitional arrangements and the grandfathering of certain
capital instruments until 28 June 2025.
|
2
|
The fully loaded CET1 ratio, as is relevant for assessing
against the conversion trigger in Barclays PLC AT1 securities, was
13.5%, with £47.6bn of CET1 capital and £351.4bn of RWAs calculated
without applying the transitional arrangements in accordance with
UK CRR.
|
3
|
As at 30 June 2024, the Group's MREL requirement, excluding
the PRA buffer, was to hold £105.8bn of own funds and eligible
liabilities equating to 30.1% of RWAs. The Group remains above its
MREL regulatory requirement including the PRA
buffer.
|
Movement in CET1 capital
|
Three months ended 30.06.24
|
Six months ended 30.06.24
|
|
£m
|
£m
|
Opening CET1 capital
|
47,144
|
47,304
|
|
|
|
Profit for the period attributable
to equity holders
|
1,488
|
3,297
|
Own credit relating to derivative
liabilities
|
5
|
24
|
Ordinary share dividends paid and
foreseen
|
(317)
|
(645)
|
Purchased and foreseeable share
repurchase
|
-
|
(1,000)
|
Other equity coupons paid and
foreseen
|
(246)
|
(508)
|
Increase in retained regulatory capital generated from
earnings
|
930
|
1,168
|
|
|
|
Net impact of share
schemes
|
171
|
(70)
|
Fair value through other
comprehensive income reserve
|
(100)
|
(269)
|
Currency translation
reserve
|
(121)
|
(84)
|
Other reserves
|
(105)
|
(103)
|
Decrease in other qualifying reserves
|
(155)
|
(526)
|
|
|
|
Pension remeasurements within
reserves
|
56
|
(97)
|
Defined benefit pension fund asset
deduction
|
(55)
|
90
|
Net impact of pensions
|
1
|
(7)
|
|
|
|
Additional value adjustments
(PVA)
|
(53)
|
14
|
Goodwill and intangible
assets
|
(28)
|
(45)
|
Deferred tax assets that rely on
future profitability excluding those arising from temporary
differences
|
(72)
|
-
|
Excess of expected loss over
impairment
|
(25)
|
(28)
|
Direct and indirect holdings by an
institution of own CET1 instruments
|
(2)
|
15
|
Adjustment under IFRS 9
transitional arrangements
|
(14)
|
(165)
|
Other regulatory
adjustments
|
(31)
|
(35)
|
Decrease in regulatory capital due to adjustments and
deductions
|
(225)
|
(244)
|
|
|
|
Closing CET1 capital
|
47,695
|
47,695
|
CET1 capital increased £0.4bn to
£47.7bn (December 2023: £47.3bn), primarily due to:
• £3.3bn of capital generated from profit partially offset by
distributions of £2.1bn comprising:
-
£1.0bn of share buybacks announced with FY23
results
-
£0.6bn accrual towards the FY24
dividend
-
£0.5bn of equity coupons paid and
foreseen
• £0.5bn decrease in other qualifying reserves including a
reduction in the fair value through other comprehensive income
reserve
RWAs by risk type and business
|
|
Credit risk
|
|
Counterparty credit risk
|
|
Market Risk
|
|
Operational risk
|
Total RWAs
|
|
STD
|
IRB
|
|
STD
|
IRB
|
Settlement Risk
|
CVA
|
|
STD
|
IMA
|
|
|
|
As at 30.06.24
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
|
£m
|
£m
|
Barclays UK
|
9,349
|
55,055
|
|
101
|
12
|
-
|
72
|
|
169
|
-
|
|
11,715
|
76,473
|
Barclays UK Corporate
Bank
|
4,033
|
13,881
|
|
91
|
327
|
-
|
12
|
|
3
|
487
|
|
3,024
|
21,858
|
Barclays Private Bank & Wealth
Management
|
4,612
|
467
|
|
85
|
33
|
-
|
13
|
|
-
|
293
|
|
1,546
|
7,049
|
Barclays Investment
Bank
|
41,151
|
50,854
|
|
20,426
|
23,636
|
159
|
2,897
|
|
14,173
|
25,811
|
|
24,179
|
203,286
|
Barclays US Consumer
Bank
|
19,462
|
917
|
|
-
|
-
|
-
|
-
|
|
-
|
-
|
|
4,051
|
24,430
|
Head Office
|
6,470
|
10,609
|
|
1
|
21
|
-
|
4
|
|
1
|
188
|
|
1,043
|
18,337
|
Barclays Group
|
85,077
|
131,783
|
|
20,704
|
24,029
|
159
|
2,998
|
|
14,346
|
26,779
|
|
45,558
|
351,433
|
As at 31.03.24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Barclays UK
|
10,220
|
54,103
|
|
184
|
-
|
-
|
109
|
|
190
|
-
|
|
11,715
|
76,521
|
Barclays UK Corporate
Bank
|
3,453
|
13,966
|
|
105
|
364
|
-
|
34
|
|
2
|
484
|
|
3,024
|
21,432
|
Barclays Private Bank & Wealth
Management
|
4,678
|
452
|
|
173
|
28
|
-
|
19
|
|
-
|
292
|
|
1,546
|
7,188
|
Barclays Investment
Bank
|
39,230
|
53,204
|
|
20,182
|
23,437
|
48
|
2,789
|
|
13,727
|
23,631
|
|
24,179
|
200,427
|
Barclays US Consumer
Bank
|
18,817
|
1,001
|
|
-
|
-
|
-
|
-
|
|
-
|
-
|
|
4,051
|
23,869
|
Head Office
|
6,409
|
12,535
|
|
1
|
18
|
-
|
4
|
|
1
|
187
|
|
1,043
|
20,198
|
Barclays Group
|
82,807
|
135,261
|
|
20,645
|
23,847
|
48
|
2,955
|
|
13,920
|
24,594
|
|
45,558
|
349,635
|
As at 31.12.23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Barclays UK
|
10,472
|
50,761
|
|
178
|
-
|
-
|
94
|
|
274
|
-
|
|
11,715
|
73,494
|
Barclays UK Corporate
Bank
|
3,458
|
13,415
|
|
262
|
167
|
-
|
14
|
|
2
|
541
|
|
3,024
|
20,883
|
Barclays Private Bank & Wealth
Management
|
4,611
|
455
|
|
182
|
27
|
-
|
30
|
|
1
|
322
|
|
1,546
|
7,174
|
Barclays Investment
Bank
|
37,749
|
52,190
|
|
18,512
|
21,873
|
159
|
3,248
|
|
14,623
|
24,749
|
|
24,179
|
197,282
|
Barclays US Consumer
Bank
|
19,824
|
966
|
|
-
|
-
|
-
|
-
|
|
-
|
-
|
|
4,051
|
24,841
|
Head Office
|
6,772
|
10,951
|
|
1
|
21
|
-
|
6
|
|
1
|
248
|
|
1,043
|
19,043
|
Barclays Group
|
82,886
|
128,738
|
|
19,135
|
22,088
|
159
|
3,392
|
|
14,901
|
25,860
|
|
45,558
|
342,717
|
Movement analysis of RWAs
|
Credit risk
|
Counterparty credit risk
|
Market risk
|
Operational risk
|
Total RWAs
|
|
£m
|
£m
|
£m
|
£m
|
£m
|
Opening RWAs (as at 31.12.23)
|
211,624
|
44,774
|
40,761
|
45,558
|
342,717
|
Book size
|
2,469
|
2,998
|
434
|
-
|
5,901
|
Acquisitions and
disposals
|
(856)
|
-
|
-
|
-
|
(856)
|
Book quality
|
(1,380)
|
(21)
|
-
|
-
|
(1,401)
|
Model updates
|
-
|
-
|
-
|
-
|
-
|
Methodology and policy
|
4,974
|
525
|
-
|
-
|
5,499
|
Foreign exchange
movements1
|
29
|
(386)
|
(70)
|
-
|
(427)
|
Total RWA movements
|
5,236
|
3,116
|
364
|
-
|
8,716
|
Closing RWAs (as at 30.06.24)
|
216,860
|
47,890
|
41,125
|
45,558
|
351,433
|
1
|
Foreign exchange movements does not include the impact of
foreign exchange for modelled market risk or operational
risk.
|
Overall RWAs increased £8.7bn to
£351.4bn (December 2023: £342.7bn).
Credit risk RWAs increased
£5.2bn:
• A £2.5bn increase in book size due to business activity in IB
and higher client lending limits within UKCB
• A £0.9bn decrease in acquisitions and disposals due to the
sale of the performing Italian mortgage portfolio
• A £1.4bn decrease in book quality RWAs mainly driven by
changes in risk parameters primarily within Barclays UK
• A £5.0bn increase in methodology and policy primarily driven
by regulatory model changes in Barclays UK
Counterparty Credit risk RWAs
increased £3.1bn:
• A £3.0bn increase in book size primarily due to seasonal
increases in the Investment Bank, relative to FY23
Leverage ratios1,2
|
As at 30.06.24
|
As at 31.12.23
|
£m
|
£m
|
UK leverage
ratio3
|
5.0%
|
5.2%
|
T1 capital
|
60,654
|
60,507
|
UK leverage exposure
|
1,222,722
|
1,168,275
|
Average UK leverage
ratio
|
4.7%
|
4.8%
|
Average T1 capital
|
60,617
|
60,343
|
Average UK leverage
exposure
|
1,300,424
|
1,266,880
|
1
|
Capital and leverage measures are calculated applying the
transitional arrangements in accordance with UK
CRR.
|
2
|
Fully loaded UK leverage ratio was 5.0%, with £60.5bn of T1
capital and £1,222.6bn of leverage exposure. Fully loaded average
UK leverage ratio was 4.7% with £60.5bn of T1 capital and
£1,300.3bn of leverage exposure. Fully loaded UK leverage ratios
are calculated without applying the transitional arrangements in
accordance with UK CRR. fully loaded CET1 ratio, as is
relevant for assessing against the conversion trigger in Barclays
PLC AT1 securities, was 13.5%, with £47.6bn of CET1 capital and
£351.4bn of RWAs calculated without applying the transitional
arrangements in accordance with UK CRR.
|
3
|
Although the leverage ratio is expressed in terms of T1
capital, the leverage ratio buffers and 75% of the minimum
requirement must be covered solely with CET1 capital. The CET1
capital held against the 0.53% G-SII ALRB was £6.4bn and against
the 0.3% CCLB was £3.7bn.
|
The UK leverage ratio decreased to
5.0% (December 2023: 5.2%) primarily due to a £54.4bn increase in
leverage exposure to £1,222.7bn, largely driven by an increase in
trading securities and secured lending in IB.
Statement of Directors' Responsibilities
The Directors (the names of whom
are set out below) are required to prepare the financial statements
on a going concern basis unless it is not appropriate to do so. In
making this assessment, the directors have considered information
relating to present and future conditions. Each of the Directors
confirm that to the best of their knowledge, the condensed
consolidated interim financial statements set out on pages 61 to 66
have been prepared in accordance with International Accounting
Standard 34, 'Interim Financial Reporting', as adopted by the UK,
and that the interim management report herein includes a fair
review of the information required by Disclosure Guidance and
Transparency Rules 4.2.7R and 4.2.8R namely:
• an
indication of important events that have occurred during the six
months ended 30 June 2024 and their impact on the condensed
consolidated interim financial statements, and a description of the
principal risks and uncertainties for the remaining six months of
the financial year
• any
related party transactions in the six months ended 30 June 2024
that have materially affected the financial position or performance
of Barclays during that period and any changes in the related party
transactions described in the last Annual Report that could have a
material effect on the financial position or performance of
Barclays in the six months ended 30 June 2024
Signed on 31 July 2024 on behalf
of the Board by
C.S. Venkatakrishnan
|
Anna Cross
|
Group Chief Executive
|
Group Finance Director
|
|
|
Barclays PLC Board of
Directors
Chairman
|
Executive Directors
|
Non-Executive Directors
|
Nigel Higgins
|
C.S. Venkatakrishnan
|
Robert Berry
|
|
Anna Cross
|
Tim Breedon CBE
|
|
|
Mohamed A. El-Erian
|
|
|
Dawn Fitzpatrick
|
|
|
Mary Francis CBE
|
|
|
Brian Gilvary
|
|
|
Sir John Kingman
|
|
|
Marc Moses
|
|
|
Diane Schueneman
|
|
|
Brian Shea
|
|
|
Julia Wilson
|
Independent Review Report to Barclays PLC
Conclusion
We have been engaged by Barclays
PLC ("the Company" or "the Group") to review the condensed set of
financial statements in the Interim Results Announcement for the
six months ended 30 June 2024 which comprises:
• the condensed consolidated income statement and condensed
consolidated statement of comprehensive income for the period then
ended;
• the condensed consolidated balance sheet as at 30 June
2024;
• the condensed consolidated statement of changes in equity for
the period then ended;
• the condensed consolidated cash flow statement for the period
then ended; and
• the related explanatory notes.
Based on our review, nothing has
come to our attention that causes us to believe that the condensed
set of financial statements in the Interim Results Announcement for
the six months ended 30 June 2024 is not prepared, in all material
respects, in accordance with IAS 34 Interim Financial Reporting as
adopted for use in the UK and the Disclosure Guidance and
Transparency Rules ("the DTR") of the UK's Financial Conduct
Authority ("the UK FCA").
Basis for conclusion
We conducted our review in
accordance with International Standard on Review Engagements (UK)
2410 Review of Interim Financial Information Performed by the
Independent Auditor of the Entity ("ISRE (UK) 2410") issued for use
in the UK. A review of interim financial information consists
of making enquiries, primarily of persons responsible for financial
and accounting matters, and applying analytical and other review
procedures. We read the other information contained in the
Interim Results Announcement and consider whether it contains any
apparent misstatements or material inconsistencies with the
information in the condensed set of financial
statements.
A review is substantially less in
scope than an audit conducted in accordance with International
Standards on Auditing (UK) and consequently does not enable us to
obtain assurance that we would become aware of all significant
matters that might be identified in an audit. Accordingly, we
do not express an audit opinion.
Conclusions relating to going concern
Based on our review procedures,
which are less extensive than those performed in an audit as
described in the Basis for conclusion section of this report,
nothing has come to our attention that causes us to believe that
the directors have inappropriately adopted the going concern basis
of accounting, or that the directors have identified material
uncertainties relating to going concern that have not been
appropriately disclosed.
This conclusion is based on the
review procedures performed in accordance with ISRE (UK) 2410.
However, future events or conditions may cause the Group to cease
to continue as a going concern, and the above conclusions are not a
guarantee that the Group will continue in operation.
Directors' responsibilities
The Interim Results Announcement
is the responsibility of, and has been approved by, the
directors. The directors are responsible for preparing the
Interim Results Announcement in accordance with the DTR of the UK
FCA.
As disclosed in note 1, the annual
financial statements of the Barclays PLC Group are prepared in
accordance with UK-adopted international accounting
standards.
The directors are responsible for
preparing the condensed set of financial statements included in the
Interim Results Announcement in accordance with IAS 34 as adopted
for use in the UK.
In preparing the condensed set of
financial statements, the directors are responsible for assessing
the Group's ability to continue as a going concern, disclosing, as
applicable, matters related to going concern and using the going
concern basis of accounting unless the directors either intend to
liquidate the Group or to cease operations, or have no realistic
alternative but to do so.
Our responsibility
Our responsibility is to express
to the Company a conclusion on the condensed set of financial
statements in the Interim Results Announcement based on our
review. Our conclusion, including our conclusions relating to
going concern, are based on procedures that are less extensive than
audit procedures, as described in the Basis for conclusion section
of this report.
The purpose of our review work and to whom we owe our
responsibilities
This report is made solely to the
Company in accordance with the terms of our engagement to assist
the Company in meeting the requirements of the DTR of the UK
FCA. Our review has been undertaken so that we might state to
the Company those matters we are required to state to it in this
report and for no other purpose. To the fullest extent
permitted by law, we do not accept or assume responsibility to
anyone other than the Company for our review work, for this report,
or for the conclusions we have reached.
Stuart Crisp
for and on behalf of KPMG LLP
Chartered Accountants
15 Canada Square
London, E14 5GL
31 July 2024
Condensed Consolidated Financial Statements
Condensed consolidated income statement
(unaudited)
|
|
|
Half year ended 30.06.24
|
Half year ended 30.06.23
|
|
Notes1
|
£m
|
£m
|
Interest and similar
income
|
|
18,642
|
15,632
|
Interest and similar
expense
|
|
(12,514)
|
(9,309)
|
Net interest income
|
|
6,128
|
6,323
|
Fee and commission
income
|
3
|
5,429
|
5,257
|
Fee and commission
expense
|
3
|
(1,691)
|
(1,898)
|
Net fee and commission income
|
3
|
3,738
|
3,359
|
Net trading income
|
|
3,228
|
3,786
|
Net investment income
|
|
160
|
10
|
Other income
|
|
23
|
44
|
Total income
|
|
13,277
|
13,522
|
|
|
|
|
Staff costs
|
4
|
(4,964)
|
(4,985)
|
Infrastructure, administration and
general expenses
|
5
|
(3,033)
|
(3,045)
|
UK regulatory
levies2
|
|
(120)
|
-
|
Litigation and conduct
|
|
(64)
|
(32)
|
Operating expenses
|
|
(8,181)
|
(8,062)
|
|
|
|
|
Share of post-tax results of
associates and joint ventures
|
|
16
|
(2)
|
Profit before impairment
|
|
5,112
|
5,458
|
Credit impairment
charges
|
|
(897)
|
(896)
|
Profit before tax
|
|
4,215
|
4,562
|
Tax charge
|
|
(892)
|
(914)
|
Profit after tax
|
|
3,323
|
3,648
|
|
|
|
|
Attributable to:
|
|
|
|
Shareholders of the
parent
|
|
2,787
|
3,111
|
Other equity holders
|
|
510
|
507
|
Equity holders of the parent
|
|
3,297
|
3,618
|
Non-controlling
interests
|
|
26
|
30
|
Profit after tax
|
|
3,323
|
3,648
|
|
|
|
|
Earnings per share
|
|
|
|
Basic earnings per ordinary
share
|
6
|
18.6p
|
19.9p
|
Diluted earnings per ordinary
share
|
6
|
18.1p
|
19.3p
|
|
|
|
|
1
|
For Notes to the Financial Statements see pages 67 to
88.
|
2
|
Comprises the impact of the BoE levy scheme. Please refer to
Financial Review, Other matters for details.
|
Condensed consolidated statement of comprehensive income
(unaudited)
|
|
|
Half year ended 30.06.24
|
Half year ended 30.06.23
|
|
Notes1
|
£m
|
£m
|
Profit after tax
|
|
3,323
|
3,648
|
|
|
|
|
Other comprehensive (loss)/ income that may be recycled to
profit or loss:2
|
|
|
Currency translation
reserve
|
14
|
(84)
|
(1,173)
|
Fair value through other
comprehensive income reserve
|
14
|
(269)
|
77
|
Cash flow hedging
reserve
|
14
|
(90)
|
(755)
|
Other comprehensive loss that may be recycled to
profit
|
|
(443)
|
(1,851)
|
|
|
|
|
Other comprehensive loss not recycled to profit or
loss:2
|
|
|
Retirement benefit
remeasurements
|
13
|
(97)
|
(476)
|
Fair value through other
comprehensive income reserve
|
14
|
-
|
(2)
|
Own credit
|
14
|
(462)
|
(494)
|
Other comprehensive loss not recycled to
profit
|
|
(559)
|
(972)
|
|
|
|
|
Other comprehensive loss for the period
|
|
(1,002)
|
(2,823)
|
|
|
|
|
Total comprehensive income for the period
|
|
2,321
|
825
|
|
|
|
|
Attributable to:
|
|
|
|
Equity holders of the
parent
|
|
2,295
|
795
|
Non-controlling
interests
|
|
26
|
30
|
Total comprehensive income for the period
|
|
2,321
|
825
|
|
|
|
|
1
|
For Notes to the Financial Statements see pages 67 to
88.
|
2
|
Reported net of tax.
|
Condensed consolidated balance sheet
(unaudited)
|
|
|
As at 30.06.24
|
As at 31.12.23
|
Assets
|
Notes1
|
£m
|
£m
|
Cash and balances at central
banks
|
|
243,459
|
224,634
|
Cash collateral and settlement
balances
|
|
146,754
|
108,889
|
Debt securities at amortised
cost
|
|
61,700
|
56,749
|
Loans and advances at amortised
cost to banks
|
|
8,014
|
9,459
|
Loans and advances at amortised
cost to customers
|
|
329,795
|
333,288
|
Reverse repurchase agreements and
other similar secured lending at amortised cost
|
|
4,724
|
2,594
|
Trading portfolio
assets
|
|
197,306
|
174,605
|
Financial assets at fair value
through the income statement
|
|
215,206
|
206,651
|
Derivative financial
instruments
|
8
|
253,614
|
256,836
|
Financial assets at fair value
through other comprehensive income
|
|
82,747
|
71,836
|
Investments in associates and
joint ventures
|
|
876
|
879
|
Goodwill and intangible
assets
|
10
|
7,839
|
7,794
|
Property, plant and
equipment
|
|
3,650
|
3,417
|
Current tax assets
|
|
176
|
121
|
Deferred tax assets
|
|
6,274
|
5,960
|
Retirement benefit
assets
|
13
|
3,541
|
3,667
|
Assets included in a disposal
group classified as held for sale
|
|
3,725
|
3,916
|
Other assets
|
|
7,234
|
6,192
|
Total assets
|
|
1,576,634
|
1,477,487
|
|
|
|
|
Liabilities
|
|
|
|
Deposits at amortised cost from
banks
|
|
19,371
|
14,472
|
Deposits at amortised cost from
customers
|
|
538,081
|
524,317
|
Cash collateral and settlement
balances
|
|
144,582
|
94,084
|
Repurchase agreements and other
similar secured borrowings at amortised cost
|
|
52,352
|
41,601
|
Debt securities in
issue
|
|
96,772
|
96,825
|
Subordinated
liabilities
|
11
|
11,795
|
10,494
|
Trading portfolio
liabilities
|
|
59,315
|
58,669
|
Financial liabilities designated
at fair value
|
|
320,957
|
297,539
|
Derivative financial
instruments
|
8
|
242,136
|
250,044
|
Current tax liabilities
|
|
686
|
529
|
Deferred tax
liabilities
|
|
22
|
22
|
Retirement benefit
liabilities
|
13
|
277
|
266
|
Provisions
|
12
|
1,292
|
1,584
|
Liabilities included in a disposal
group classified as held for sale
|
|
3,984
|
3,164
|
Other liabilities
|
|
13,179
|
12,013
|
Total liabilities
|
|
1,504,801
|
1,405,623
|
|
|
|
|
Equity
|
|
|
|
Called up share capital and share
premium
|
|
4,256
|
4,288
|
Other reserves
|
14
|
(882)
|
(77)
|
Retained earnings
|
|
54,840
|
53,734
|
Shareholders' equity attributable to ordinary shareholders of
the parent
|
|
58,214
|
57,945
|
Other equity
instruments
|
|
12,959
|
13,259
|
Total equity excluding non-controlling
interests
|
|
71,173
|
71,204
|
Non-controlling
interests
|
|
660
|
660
|
Total equity
|
|
71,833
|
71,864
|
|
|
|
|
Total liabilities and equity
|
|
1,576,634
|
1,477,487
|
1
|
For Notes to the Financial Statements see pages 67 to
88.
|
Condensed consolidated statement of changes in equity
(unaudited)
|
|
Called up share capital and share premium1,
2
|
Other equity instruments3
|
Other reserves4
|
Retained earnings
|
Total
|
Non-controlling interests
|
Total equity
|
Half year ended 30.06.2024
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Balance as at 1 January 2024
|
4,288
|
13,259
|
(77)
|
53,734
|
71,204
|
660
|
71,864
|
Profit after tax
|
-
|
510
|
-
|
2,787
|
3,297
|
26
|
3,323
|
Currency translation
movements
|
-
|
-
|
(84)
|
-
|
(84)
|
-
|
(84)
|
Fair value through other
comprehensive income reserve
|
-
|
-
|
(269)
|
-
|
(269)
|
-
|
(269)
|
Cash flow hedges
|
-
|
-
|
(90)
|
-
|
(90)
|
-
|
(90)
|
Retirement benefit
remeasurements
|
|
-
|
-
|
(97)
|
(97)
|
-
|
(97)
|
Own credit
|
-
|
-
|
(462)
|
-
|
(462)
|
-
|
(462)
|
Total comprehensive income for the period
|
-
|
510
|
(905)
|
2,690
|
2,295
|
26
|
2,321
|
Employee share schemes and hedging
thereof
|
65
|
-
|
-
|
582
|
647
|
-
|
647
|
Issue and redemption of other
equity instruments
|
-
|
(263)
|
-
|
(92)
|
(355)
|
-
|
(355)
|
Other equity instruments coupon
paid
|
-
|
(510)
|
-
|
-
|
(510)
|
-
|
(510)
|
Vesting of employee share
schemes
|
-
|
-
|
3
|
(488)
|
(485)
|
-
|
(485)
|
Dividends paid
|
-
|
-
|
-
|
(796)
|
(796)
|
(26)
|
(822)
|
Repurchase of shares
|
(97)
|
-
|
97
|
(782)
|
(782)
|
-
|
(782)
|
Other movements
|
-
|
(37)
|
-
|
(8)
|
(45)
|
-
|
(45)
|
Balance as at 30 June 2024
|
4,256
|
12,959
|
(882)
|
54,840
|
71,173
|
660
|
71,833
|
Condensed consolidated statement of changes in equity
(unaudited)
|
|
Called up share capital and share premium1,
2
|
Other equity instruments3
|
Other reserves
|
Retained earnings
|
Total
|
Non-controlling interests
|
Total equity
|
Half year ended 31.12.2023
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Balance as at 1 July 2023
|
4,325
|
13,759
|
(4,457)
|
54,042
|
67,669
|
876
|
68,545
|
Profit after tax
|
-
|
478
|
-
|
1,163
|
1,641
|
34
|
1,675
|
Currency translation
movements
|
-
|
-
|
72
|
-
|
72
|
-
|
72
|
Fair value through other
comprehensive income reserve
|
-
|
-
|
119
|
-
|
119
|
-
|
119
|
Cash flow hedges
|
-
|
-
|
4,283
|
-
|
4,283
|
-
|
4,283
|
Retirement benefit
remeasurements
|
-
|
-
|
-
|
(379)
|
(379)
|
-
|
(379)
|
Own credit
|
-
|
-
|
(216)
|
-
|
(216)
|
-
|
(216)
|
Total comprehensive income for the period
|
-
|
478
|
4,258
|
784
|
5,520
|
34
|
5,554
|
Employee share schemes and hedging
thereof
|
86
|
-
|
-
|
126
|
212
|
-
|
212
|
Issue and redemption of other
equity instruments
|
-
|
(530)
|
-
|
(30)
|
(560)
|
(219)
|
(779)
|
Other equity instruments coupon
paid
|
-
|
(478)
|
-
|
-
|
(478)
|
-
|
(478)
|
Vesting of employee share
schemes
|
-
|
-
|
(4)
|
(22)
|
(26)
|
-
|
(26)
|
Dividends paid
|
-
|
-
|
-
|
(417)
|
(417)
|
(34)
|
(451)
|
Repurchase of shares
|
(123)
|
-
|
123
|
(754)
|
(754)
|
-
|
(754)
|
Other movements
|
-
|
30
|
3
|
5
|
38
|
3
|
41
|
Balance as at 31 December 2023
|
4,288
|
13,259
|
(77)
|
53,734
|
71,204
|
660
|
71,864
|
Condensed consolidated statement of changes in equity
(unaudited)
|
|
Called up share capital and share premium1,
2
|
Other equity instruments3
|
Other reserves
|
Retained earnings
|
Total
|
Non-controlling interests
|
Total equity
|
Half year ended 30.06.2023
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Balance as at 1 January 2023
|
4,373
|
13,284
|
(2,192)
|
52,827
|
68,292
|
968
|
69,260
|
Profit after tax
|
-
|
507
|
-
|
3,111
|
3,618
|
30
|
3,648
|
Currency translation
movements
|
-
|
-
|
(1,173)
|
-
|
(1,173)
|
-
|
(1,173)
|
Fair value through other
comprehensive income reserve
|
-
|
-
|
75
|
-
|
75
|
-
|
75
|
Cash flow hedges
|
-
|
-
|
(755)
|
-
|
(755)
|
-
|
(755)
|
Retirement benefit
remeasurements
|
-
|
-
|
-
|
(476)
|
(476)
|
-
|
(476)
|
Own credit
|
-
|
-
|
(494)
|
-
|
(494)
|
-
|
(494)
|
Total comprehensive income for the period
|
-
|
507
|
(2,347)
|
2,635
|
795
|
30
|
825
|
Employee share schemes and hedging
thereof
|
38
|
-
|
-
|
371
|
409
|
-
|
409
|
Issue and redemption of other
equity instruments
|
-
|
500
|
-
|
(8)
|
492
|
(93)
|
399
|
Other equity instruments coupon
paid
|
-
|
(507)
|
-
|
-
|
(507)
|
-
|
(507)
|
Vesting of employee share
schemes
|
-
|
-
|
(4)
|
(484)
|
(488)
|
-
|
(488)
|
Dividends paid
|
-
|
-
|
-
|
(793)
|
(793)
|
(30)
|
(823)
|
Repurchase of shares
|
(86)
|
-
|
86
|
(503)
|
(503)
|
-
|
(503)
|
Other movements
|
-
|
(25)
|
-
|
(3)
|
(28)
|
1
|
(27)
|
Balance as at 30 June 2023
|
4,325
|
13,759
|
(4,457)
|
54,042
|
67,669
|
876
|
68,545
|
1
|
As at 30 June 2024, Called up share capital comprises 14,826m
(December 2023: 15,155m) ordinary shares of 25p
each
|
2
|
During the period ended 30 June 2024, Barclays PLC announced
and executed a share buy-back of up to £1,000m. 389m shares were
repurchased and cancelled. The nominal value of £97m has been
transferred from Share capital to Capital redemption reserve within
Other reserves. During the year ended 31 December 2023, two share
buybacks were executed, totalling £1,250m. Barclays PLC repurchased
and cancelled 837m shares. The nominal value of £209m was
transferred from Share capital to Capital redemption reserve within
Other reserves.
|
3
|
Other equity instruments of £12,959m (December 2023:
£13,259m) comprise AT1 securities issued by Barclays PLC. There was
one issuance in the form of Fixed Rate Resetting Perpetual
Subordinated Contingent Convertible Securities for £1,245m (net of
£5m issuance costs) and one redemption of £1,509m (net of £6m
issuance costs, transferred to retained earnings on redemption) for
the period ended 30th June 2024. During the period ended 31
December 2023, there were three issuances in the form of Fixed Rate
Resetting Perpetual Subordinated Contingent Convertible Securities,
for £3,140m, which includes issuance costs of £10m and two
redemptions totalling £3,170m.
|
4
|
See Note 14 Other reserves.
|
Condensed consolidated cash flow statement
(unaudited)
|
|
Half year ended 30.06.24
|
Half year ended 30.06.23
|
|
£m
|
£m
|
Profit before tax
|
4,215
|
4,562
|
Adjustment for non-cash
items
|
4,976
|
10,085
|
Net decrease in loans and advances
at amortised cost
|
1,839
|
7,734
|
Net increase in deposits at
amortised cost
|
18,663
|
8,919
|
Net decrease in debt securities in
issue
|
(1,686)
|
(9,596)
|
Changes in other operating assets
and liabilities
|
10,103
|
2,553
|
Corporate income tax
paid
|
(540)
|
(346)
|
Net cash from operating activities
|
37,570
|
23,911
|
Net cash from investing activities
|
(16,333)
|
(14,784)
|
Net cash from financing
activities1
|
166
|
(191)
|
Effect of exchange rates on cash
and cash equivalents
|
(1,624)
|
(6,069)
|
Net increase in cash and cash equivalents
|
19,779
|
2,867
|
Cash and cash equivalents at
beginning of the period
|
248,007
|
278,790
|
Cash and cash equivalents at end of the
period
|
267,786
|
281,657
|
1
|
Issuance and redemption of debt securities included in
financing activities relate to instruments that qualify as eligible
liabilities and satisfy regulatory requirements for MREL
instruments which came into effect during 2019.
|
Financial Statement Notes
1. Basis of
preparation
These condensed consolidated
interim financial statements ("the financial statements") for the
six months ended 30 June 2024 have been prepared in accordance with
the Disclosure Guidance and Transparency Rules (DTR) of the UK's
FCA, and IAS 34, Interim Financial Reporting, as published by the
International Accounting Standards Board (IASB) and adopted by the
UK.
The condensed consolidated interim
financial statements should be read in conjunction with the annual
financial statements for the year ended 31 December 2023. The
annual financial statements for the year ended 31 December 2023
were prepared in accordance with international accounting standards
in conformity with the requirements of the Companies Act 2006 and
in accordance with International Financial Reporting Standards
(IFRS) and interpretations (IFRICs) as issued by the IASB and
adopted by the UK.
The accounting policies and
methods of computation used in these condensed consolidated interim
financial statements are the same as those used in the Barclays PLC
Annual Report for the financial year ended 31 December
2023.
1. Going
concern
The financial statements are
prepared on a going concern basis, as the Directors are satisfied
that the Group and parent company have the resources to continue in
business for a period of at least 12 months from approval of the
interim financial statements. In making this assessment, the
Directors have considered a wide range of information relating to
present and future conditions and includes a review of a working
capital report (WCR). The WCR is used by the Directors to assess
the future performance of the business and that it has the
resources in place that are required to meet its ongoing regulatory
requirements. The WCR also includes an assessment of the impact of
internally generated stress testing scenarios on the liquidity and
capital requirement forecasts. The stress tests used were based
upon an assessment of reasonably possible downside economic
scenarios that the Group could experience.
The WCR indicated that the Group
had sufficient capital in place to support its future business
requirements and remained above its regulatory minimum requirements
in the internal stress scenarios.
2. Other
disclosures
The Credit risk disclosures on
pages 27 to 46 form part of these interim financial
statements.
2. Segmental
reporting
Analysis of results by business
|
|
|
|
|
|
|
|
Barclays UK
|
Barclays UK Corporate Bank
|
Barclays Private Bank and Wealth
Management
|
Barclays Investment Bank
|
Barclays US Consumer Bank
|
Head Office
|
Barclays Group
|
Half year ended 30.06.24
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Net interest income
|
3,146
|
573
|
362
|
465
|
1,334
|
248
|
6,128
|
Non-interest
income/(expense)
|
567
|
304
|
270
|
5,882
|
344
|
(218)
|
7,149
|
Total income
|
3,713
|
877
|
632
|
6,347
|
1,678
|
30
|
13,277
|
Operating costs
|
(2,048)
|
(456)
|
(434)
|
(3,858)
|
(796)
|
(406)
|
(7,997)
|
UK regulatory
levies1
|
(54)
|
(30)
|
(3)
|
(33)
|
-
|
-
|
(120)
|
Litigation and conduct
|
(6)
|
-
|
1
|
(11)
|
(4)
|
(43)
|
(64)
|
Total operating expenses
|
(2,108)
|
(486)
|
(436)
|
(3,902)
|
(800)
|
(449)
|
(8,181)
|
Other net
income2
|
-
|
-
|
-
|
-
|
-
|
16
|
16
|
Profit/(loss) before impairment
|
1,605
|
391
|
196
|
2,445
|
878
|
(403)
|
5,112
|
Credit impairment (charges)/
releases
|
(66)
|
(23)
|
3
|
(34)
|
(719)
|
(58)
|
(897)
|
Profit/(loss) before tax
|
1,539
|
368
|
199
|
2,411
|
159
|
(461)
|
4,215
|
|
|
|
|
|
|
|
|
As at 30.06.24
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
Total assets
|
293.0
|
64.0
|
35.8
|
1,113.8
|
32.1
|
37.9
|
1,576.6
|
Total liabilities
|
262.5
|
86.4
|
65.2
|
997.1
|
21.5
|
72.1
|
1,504.8
|
|
Barclays UK
|
Barclays UK Corporate Bank
|
Barclays Private Bank and Wealth
Management
|
Barclays Investment Bank
|
Barclays US Consumer Bank
|
Head Office
|
Barclays Group
|
Half year ended 30.06.23
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Net interest income
|
3,278
|
609
|
367
|
714
|
1,256
|
99
|
6,323
|
Non-interest income
|
644
|
326
|
191
|
5,598
|
337
|
103
|
7,199
|
Total income
|
3,922
|
935
|
558
|
6,312
|
1,593
|
202
|
13,522
|
Operating costs
|
(2,182)
|
(423)
|
(326)
|
(3,845)
|
(828)
|
(425)
|
(8,030)
|
UK regulatory
levies1
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Litigation and conduct
|
3
|
-
|
-
|
1
|
(4)
|
(33)
|
(32)
|
Total operating expenses
|
(2,179)
|
(423)
|
(326)
|
(3,844)
|
(832)
|
(458)
|
(8,062)
|
Other net
income/(expenses)2
|
-
|
2
|
-
|
(1)
|
-
|
(3)
|
(2)
|
Profit/(loss) before impairment
|
1,743
|
514
|
232
|
2,467
|
761
|
(259)
|
5,458
|
Credit impairment
(charges)/releases
|
(208)
|
60
|
(10)
|
(102)
|
(585)
|
(51)
|
(896)
|
Profit/(loss) before tax
|
1,535
|
574
|
222
|
2,365
|
176
|
(310)
|
4,562
|
|
|
|
|
|
|
|
|
As at 31.12.23
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
Total assets
|
293.1
|
61.5
|
32.0
|
1,019.1
|
33.6
|
38.2
|
1,477.5
|
Total liabilities
|
264.2
|
85.9
|
60.9
|
904.5
|
21.1
|
69.0
|
1,405.6
|
Prior period segmental comparators
shown in this document were re-presented in the 2023 Results
Resegmentation Document, which may be accessed via the Barclays
website at: home.barclays/investor-relations
1
|
Comprises the impact of the BoE levy scheme and the UK bank
levy.
|
2
|
Other net income/(expenses) represents the share of post-tax
results of associates and joint ventures, profit (or loss) on
disposal of subsidiaries, associates and joint ventures and gains
on acquisitions.
|
Split of income by geographic
region1
|
|
|
|
Half year ended 30.06.24
|
Half year ended 30.06.23
|
|
£m
|
£m
|
United Kingdom
|
6,829
|
7,312
|
Europe
|
1,180
|
1,265
|
Americas
|
4,574
|
4,187
|
Africa and Middle East
|
39
|
42
|
Asia
|
655
|
716
|
Total
|
13,277
|
13,522
|
1
|
The geographical analysis is based on the location of the
office where the transactions are recorded.
|
3. Net fee and commission
income
Fee and commission income is
disaggregated below and includes a total for fees in scope of IFRS
15, Revenue from Contracts with Customers:
|
Barclays UK
|
Barclays UK Corporate Bank
|
Barclays Private Bank and Wealth Management
|
Barclays Investment Bank
|
Barclays US consumer Bank
|
Head Office
|
Barclays Group
|
Half year ended 30.06.24
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Fee type
|
|
|
|
|
|
|
|
Transactional
|
551
|
232
|
16
|
171
|
1,320
|
171
|
2,461
|
Advisory
|
-
|
-
|
156
|
325
|
-
|
-
|
481
|
Brokerage and execution
|
107
|
-
|
62
|
776
|
-
|
-
|
945
|
Underwriting and
syndication
|
17
|
46
|
-
|
1,391
|
-
|
-
|
1,454
|
Other
|
13
|
-
|
-
|
-
|
-
|
6
|
19
|
Total revenue from contracts with customers
|
688
|
278
|
234
|
2,663
|
1,320
|
177
|
5,360
|
Other non-contract fee
income
|
-
|
11
|
-
|
58
|
-
|
-
|
69
|
Fee and commission income
|
688
|
289
|
234
|
2,721
|
1,320
|
177
|
5,429
|
Fee and commission
expense
|
(177)
|
(43)
|
(19)
|
(516)
|
(893)
|
(43)
|
(1,691)
|
Net fee and commission income
|
511
|
246
|
215
|
2,205
|
427
|
134
|
3,738
|
|
Barclays UK
|
Barclays UK Corporate Bank
|
Barclays Private Bank and Wealth Management
|
Barclays Investment Bank
|
Barclays US consumer Bank
|
Head Office
|
Barclays Group
|
Half year ended 30.06.23
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Fee type
|
|
|
|
|
|
|
|
Transactional
|
560
|
212
|
13
|
160
|
1,290
|
152
|
2,387
|
Advisory
|
57
|
-
|
94
|
363
|
-
|
-
|
514
|
Brokerage and execution
|
122
|
-
|
44
|
998
|
-
|
-
|
1,164
|
Underwriting and
syndication
|
-
|
39
|
-
|
997
|
-
|
-
|
1,036
|
Other
|
27
|
1
|
1
|
11
|
5
|
37
|
82
|
Total revenue from contracts with customers
|
766
|
252
|
152
|
2,529
|
1,295
|
189
|
5,183
|
Other non-contract fee
income
|
-
|
15
|
3
|
56
|
-
|
-
|
74
|
Fee and commission income
|
766
|
267
|
155
|
2,585
|
1,295
|
189
|
5,257
|
Fee and commission
expense
|
(188)
|
(47)
|
(14)
|
(740)
|
(870)
|
(39)
|
(1,898)
|
Net fee and commission income
|
578
|
220
|
141
|
1,845
|
425
|
150
|
3,359
|
Transactional fees are service
charges on deposit accounts, cash management services and
transactional processing fees. These include interchange and
merchant fee income generated from credit and bank card
usage.
Advisory fees are generated from
wealth management services and investment banking advisory services
related to mergers, acquisitions and financial
restructurings.
Brokerage and execution fees are
earned for executing client transactions with various exchanges and
over-the-counter markets and assisting clients in clearing
transactions and facilitating foreign exchange transactions for
spot/forward contracts.
Underwriting and syndication fees
are earned for the distribution of client equity or debt securities
and the arrangement and administration of a loan syndication. These
include commitment fees to provide loan financing.
4. Staff
costs
|
Half year ended 30.06.24
|
Half year ended 30.06.23
|
Compensation costs
|
£m
|
£m
|
Upfront bonus charge
|
675
|
665
|
Deferred bonus charge
|
269
|
263
|
Other incentives
|
35
|
42
|
Performance costs
|
979
|
970
|
Salaries
|
2,491
|
2,540
|
Social security costs
|
395
|
399
|
Post-retirement
benefits
|
296
|
268
|
Other compensation
costs
|
282
|
281
|
Total compensation costs
|
4,443
|
4,458
|
|
|
|
Other resourcing costs
|
|
|
Outsourcing
|
299
|
340
|
Redundancy and
restructuring
|
138
|
63
|
Temporary staff costs
|
31
|
53
|
Other
|
53
|
71
|
Total other resourcing costs
|
521
|
527
|
|
|
|
Total staff costs
|
4,964
|
4,985
|
|
|
|
Barclays Group compensation costs as a % of total
income
|
33.5%
|
33.0%
|
5. Infrastructure,
administration and general expenses
|
Half year ended 30.06.24
|
Half year ended 30.06.23
|
Infrastructure costs
|
£m
|
£m
|
Property and equipment
|
857
|
857
|
Depreciation and
amortisation
|
843
|
902
|
Impairment of property, equipment
and intangible assets
|
4
|
18
|
Total infrastructure costs
|
1,704
|
1,777
|
|
|
|
Administration and general expenses
|
|
|
Consultancy, legal and
professional fees
|
388
|
336
|
Marketing and
advertising
|
308
|
288
|
Other administration and general
expenses
|
633
|
644
|
Total administration and general expenses
|
1,329
|
1,268
|
|
|
|
Total infrastructure, administration and general
expenses
|
3,033
|
3,045
|
6. Earnings per
share
|
Half year ended 30.06.24
|
Half year ended 30.06.23
|
|
£m
|
£m
|
Profit attributable to ordinary
equity holders of the parent
|
2,787
|
3,111
|
|
|
|
|
m
|
m
|
Basic weighted average number of
shares in issue
|
14,972
|
15,645
|
Number of potential ordinary
shares
|
445
|
470
|
Diluted weighted average number of shares
|
15,417
|
16,115
|
|
|
|
|
p
|
p
|
Basic earnings per ordinary
share
|
18.6
|
19.9
|
Diluted earnings per ordinary
share
|
18.1
|
19.3
|
7. Dividends on ordinary
shares
|
Half year ended 30.06.24
|
Half year ended 30.06.23
|
|
Per share
|
Total
|
Per share
|
Total
|
Dividends paid during the period
|
p
|
£m
|
p
|
£m
|
Full year dividend paid during
period
|
5.30
|
796
|
5.00
|
793
|
It is Barclays' policy to declare
and pay dividends on a semi-annual basis. The 2023 full year
dividend of 5.3p per ordinary share was paid on 3 April 2024 to the
shareholders on the Share Register on 1 March 2024. A half year
dividend for 2024 of 2.9p (H123: 2.7p) per ordinary share
will be paid on 20 September 2024.
For qualifying American Depositary
Receipt (ADR) holders, the half year dividend of
2.9p per ordinary share
becomes 11.6p per American Depositary Share (ADS) (representing
four shares). The depositary bank will post the half year dividend
on 20 September 2024 to ADR holders on the record at close of
business on 16 August 2024.
The Directors have confirmed their
intention to initiate a share buyback of up to £750m after the
balance sheet date. The share buyback is expected to commence in
the third quarter of 2024. The financial statements for the six
months ended 30 June 2024 do not reflect the impact of the proposed
share buyback, which will be accounted for as and when shares are
repurchased by the Company.
8. Derivative financial
instruments
|
Contract notional amount
|
|
Fair value
|
|
|
Assets
|
Liabilities
|
As at 30.06.24
|
£m
|
|
£m
|
£m
|
Foreign exchange
derivatives
|
7,727,915
|
|
78,912
|
(72,582)
|
Interest rate
derivatives
|
73,107,979
|
|
102,047
|
(89,954)
|
Credit derivatives
|
1,533,970
|
|
6,449
|
(7,169)
|
Equity and stock index and
commodity derivatives
|
3,091,961
|
|
63,339
|
(71,790)
|
Derivative assets/(liabilities) held for
trading
|
85,461,825
|
|
250,747
|
(241,495)
|
|
|
|
|
|
Derivatives in hedge accounting
relationships
|
|
|
|
|
Derivatives designated as cash
flow hedges
|
145,884
|
|
2,738
|
(75)
|
Derivatives designated as fair
value hedges
|
156,031
|
|
122
|
(549)
|
Derivatives designated as hedges
of net investments
|
4,152
|
|
7
|
(17)
|
Derivative assets/(liabilities) designated in hedge
accounting relationships
|
306,067
|
|
2,867
|
(641)
|
|
|
|
|
|
Total recognised derivative
assets/(liabilities)
|
85,767,892
|
|
253,614
|
(242,136)
|
|
|
|
|
|
As at 31.12.23
|
|
|
|
|
Foreign exchange
derivatives
|
6,740,828
|
|
87,518
|
(83,225)
|
Interest rate
derivatives
|
54,134,591
|
|
109,431
|
(97,427)
|
Credit derivatives
|
1,448,350
|
|
7,662
|
(8,630)
|
Equity and stock index and
commodity derivatives
|
2,669,722
|
|
50,032
|
(60,176)
|
Derivative assets/(liabilities) held for
trading
|
64,993,491
|
|
254,643
|
(249,458)
|
|
|
|
|
|
Derivatives in hedge accounting
relationships
|
|
|
|
|
Derivatives designated as cash
flow hedges
|
157,817
|
|
1,904
|
(8)
|
Derivatives designated as fair
value hedges
|
138,015
|
|
178
|
(533)
|
Derivatives designated as hedges
of net investments
|
3,744
|
|
111
|
(45)
|
Derivative assets/(liabilities) designated in hedge
accounting relationships
|
299,576
|
|
2,193
|
(586)
|
|
|
|
|
|
Total recognised derivative
assets/(liabilities)
|
65,293,067
|
|
256,836
|
(250,044)
|
The IFRS netting posted against
derivative assets was £51bn including £9bn of cash collateral
netted (December 2023: £56bn including £8bn cash collateral netted)
and £51bn for liabilities including £10bn of cash collateral netted
(December 2023: £54bn including £9bn of cash collateral netted).
Derivative asset exposures would be £227bn (December 2023: £230bn)
lower than reported under IFRS if netting were permitted for assets
and liabilities with the same counterparty or for which the Group
holds cash collateral of £32bn (December 2023: £31bn). Similarly,
derivative liabilities would be £218bn (December 2023: £223bn)
lower reflecting counterparty netting and cash collateral placed of
£23bn (December 2023: £24bn). In addition, non-cash collateral of
£11bn (December 2023: £10bn) was held in respect of derivative
assets £4bn (December 2023: £4bn) was placed in respect of
derivative liabilities. Collateral amounts are limited to net on
balance sheet exposure so as to not include
over-collateralisation.
9. Fair value of financial
instruments
This section should be read in
conjunction with Note 17, Fair value of financial instruments of
the Barclays PLC Annual Report 2023 which provides more detail
about accounting policies adopted, valuation methodologies used in
calculating fair value and the valuation control framework which
governs oversight of valuations. There have been no changes in the
accounting policies adopted or the valuation methodologies
used.
Valuation
The following table shows the
Group's assets and liabilities that are held at fair value
disaggregated by valuation technique (fair value hierarchy) and
balance sheet classification:
|
Valuation technique using
|
|
|
Quoted market prices
|
Observable inputs
|
Significant unobservable inputs
|
|
|
(Level 1)
|
(Level 2)
|
(Level 3)
|
Total
|
As at 30.06.24
|
£m
|
£m
|
£m
|
£m
|
Trading portfolio
assets
|
98,992
|
89,588
|
8,726
|
197,306
|
Financial assets at fair value
through the income statement
|
7,502
|
198,187
|
9,517
|
215,206
|
Derivative financial
instruments
|
86
|
250,695
|
2,833
|
253,614
|
Financial assets at fair value
through other comprehensive income
|
32,151
|
48,142
|
2,454
|
82,747
|
Investment property
|
-
|
-
|
1
|
1
|
Total assets
|
138,731
|
586,612
|
23,531
|
748,874
|
|
|
|
|
|
Trading portfolio
liabilities
|
(33,309)
|
(25,621)
|
(385)
|
(59,315)
|
Financial liabilities designated
at fair value
|
(182)
|
(318,283)
|
(2,492)
|
(320,957)
|
Derivative financial
instruments
|
(66)
|
(237,735)
|
(4,335)
|
(242,136)
|
Total liabilities
|
(33,557)
|
(581,639)
|
(7,212)
|
(622,408)
|
|
|
|
|
|
As at 31.12.23
|
|
|
|
|
Trading portfolio
assets
|
94,658
|
73,438
|
6,509
|
174,605
|
Financial assets at fair value
through the income statement
|
5,831
|
192,571
|
8,249
|
206,651
|
Derivative financial
instruments
|
107
|
253,189
|
3,540
|
256,836
|
Financial assets at fair value
through other comprehensive income
|
30,247
|
40,511
|
1,078
|
71,836
|
Investment property
|
-
|
-
|
2
|
2
|
Total assets
|
130,843
|
559,709
|
19,378
|
709,930
|
|
|
|
|
|
Trading portfolio
liabilities
|
(29,274)
|
(29,027)
|
(368)
|
(58,669)
|
Financial liabilities designated
at fair value
|
(117)
|
(296,200)
|
(1,222)
|
(297,539)
|
Derivative financial
instruments
|
(81)
|
(245,310)
|
(4,653)
|
(250,044)
|
Total liabilities
|
(29,472)
|
(570,537)
|
(6,243)
|
(606,252)
|
The following table shows the
Group's Level 3 assets and liabilities that are held at fair value
disaggregated by product type:
|
As at 30.06.24
|
As at 31.12.23
|
|
Assets
|
Liabilities
|
Assets
|
Liabilities
|
|
£m
|
£m
|
£m
|
£m
|
Interest rate
derivatives
|
1,623
|
(1,538)
|
2,211
|
(1,701)
|
Foreign exchange
derivatives
|
175
|
(118)
|
111
|
(91)
|
Credit derivatives
|
216
|
(798)
|
241
|
(820)
|
Equity derivatives
|
819
|
(1,881)
|
977
|
(2,041)
|
Issued debt
|
-
|
(1,539)
|
-
|
(637)
|
Corporate debt
|
2,261
|
(353)
|
1,867
|
(352)
|
Reverse repurchase and repurchase
agreements
|
620
|
(934)
|
209
|
(517)
|
Loans
|
12,932
|
-
|
10,614
|
-
|
Asset backed securities
|
2,145
|
(2)
|
603
|
-
|
Private equity
investments
|
1,128
|
(18)
|
1,375
|
(10)
|
Other1
|
1,612
|
(31)
|
1,170
|
(74)
|
Total
|
23,531
|
(7,212)
|
19,378
|
(6,243)
|
1
|
Other includes funds and fund-linked products, Government and
Government sponsored debt, equity cash products and investment
property.
|
Assets and liabilities reclassified between Level 1 and Level
2
During the six-month period ended
30 June 2024, there were no material transfers between Level 1 and
Level 2 (year ended 31 December 2023: no material transfers between
Level 1 and Level 2).
Level 3 movement analysis
The following table summarises the
movements in the balances of Level 3 assets and liabilities during
the period. The table shows gains and losses and includes amounts
for all financial assets and liabilities that are held at fair
value transferred to and from Level 3 during the period. Transfers
have been reflected as if they had taken place at the beginning of
the period.
Asset and liability movements
between Level 2 and Level 3 are primarily due to i) an increase or
decrease in observable market activity related to an input or ii) a
change in the significance of the unobservable input, with assets
and liabilities classified as Level 3 if an unobservable input is
deemed significant.
Level 3 movement analysis
|
|
|
|
|
|
|
Total gains and (losses) in the period recognised in the
income statement
|
Total gains or (losses) recognised in OCI
|
Transfers
|
|
|
As
at 01.01.24
|
Purchases
|
Sales
|
Issues
|
Settle-ments
|
Trading income
|
Other income
|
In
|
Out
|
As
at 30.06.24
|
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Corporate debt
|
681
|
831
|
(225)
|
-
|
(49)
|
(56)
|
-
|
-
|
144
|
(21)
|
1,305
|
Loans
|
4,469
|
1,478
|
(247)
|
-
|
(661)
|
42
|
-
|
-
|
139
|
(10)
|
5,210
|
Asset backed securities
|
318
|
39
|
(196)
|
-
|
-
|
23
|
-
|
-
|
611
|
(65)
|
730
|
Other
|
1,041
|
765
|
(339)
|
-
|
(4)
|
(16)
|
-
|
-
|
152
|
(118)
|
1,481
|
Trading portfolio assets
|
6,509
|
3,113
|
(1,007)
|
-
|
(714)
|
(7)
|
-
|
-
|
1,046
|
(214)
|
8,726
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate debt
|
888
|
-
|
(2)
|
-
|
-
|
13
|
7
|
-
|
-
|
-
|
906
|
Loans
|
5,612
|
1,760
|
(999)
|
-
|
(344)
|
(36)
|
18
|
-
|
139
|
(70)
|
6,080
|
Private equity
investments
|
1,371
|
112
|
(482)
|
-
|
(17)
|
3
|
140
|
-
|
-
|
(3)
|
1,124
|
Reverse repurchase and repurchase
agreements
|
209
|
297
|
-
|
-
|
-
|
-
|
-
|
-
|
141
|
(27)
|
620
|
Asset backed securities
|
85
|
590
|
(1)
|
-
|
(12)
|
1
|
-
|
-
|
9
|
(14)
|
658
|
Other
|
84
|
45
|
-
|
-
|
(7)
|
-
|
9
|
-
|
2
|
(4)
|
129
|
Financial assets at fair value through the income
statement
|
8,249
|
2,804
|
(1,484)
|
-
|
(380)
|
(19)
|
174
|
-
|
291
|
(118)
|
9,517
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate debt
|
298
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(248)
|
50
|
Loans
|
533
|
1,097
|
-
|
-
|
-
|
1
|
11
|
-
|
-
|
-
|
1,642
|
Private equity
investments
|
4
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
4
|
Asset backed securities
|
200
|
757
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(200)
|
757
|
Other
|
43
|
-
|
(42)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
Assets at fair value through other comprehensive
income
|
1,078
|
1,854
|
(42)
|
-
|
-
|
1
|
11
|
-
|
-
|
(448)
|
2,454
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment property
|
2
|
-
|
(1)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading portfolio liabilities
|
(368)
|
(24)
|
17
|
-
|
-
|
18
|
-
|
-
|
(34)
|
6
|
(385)
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial liabilities designated at fair
value
|
(1,222)
|
(6)
|
28
|
(627)
|
16
|
(27)
|
(21)
|
-
|
(881)
|
248
|
(2,492)
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate
derivatives
|
510
|
10
|
-
|
-
|
(135)
|
(158)
|
-
|
-
|
31
|
(173)
|
85
|
Foreign exchange
derivatives
|
20
|
(1)
|
(1)
|
-
|
19
|
6
|
-
|
-
|
21
|
(7)
|
57
|
Credit derivatives
|
(579)
|
5
|
33
|
-
|
-
|
(22)
|
-
|
-
|
(22)
|
3
|
(582)
|
Equity derivatives
|
(1,064)
|
(196)
|
-
|
(19)
|
(53)
|
(7)
|
-
|
-
|
(9)
|
286
|
(1,062)
|
Net derivative financial
instruments1
|
(1,113)
|
(182)
|
32
|
(19)
|
(169)
|
(181)
|
-
|
-
|
21
|
109
|
(1,502)
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
13,135
|
7,559
|
(2,457)
|
(646)
|
(1,247)
|
(215)
|
164
|
-
|
443
|
(417)
|
16,319
|
1
|
Derivative financial instruments are presented on a net
basis. On a gross basis, derivative financial assets were £2,833m
and derivative financial liabilities were
£(4,335)m.
|
Level 3 movement analysis
|
|
As
at 01.01.23
|
Purchases
|
Sales
|
Issues
|
Settle-
ments
|
Total gains and (losses) in the period recognised in the
income statement
|
Total gains or (losses) recognised in OCI
|
Transfers
|
As
at 30.06.23
|
|
Trading income
|
Other income
|
In
|
Out
|
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Corporate debt
|
597
|
336
|
(118)
|
-
|
(53)
|
5
|
-
|
-
|
36
|
(29)
|
774
|
Loans
|
4,837
|
919
|
(1,152)
|
-
|
(311)
|
4
|
-
|
-
|
556
|
(334)
|
4,519
|
Asset backed securities
|
175
|
324
|
(278)
|
|
|
(11)
|
|
|
288
|
(60)
|
438
|
Other
|
871
|
706
|
(328)
|
-
|
(38)
|
(32)
|
-
|
-
|
142
|
(253)
|
1,068
|
Trading portfolio assets
|
6,480
|
2,285
|
(1,876)
|
-
|
(402)
|
(34)
|
-
|
-
|
1,022
|
(676)
|
6,799
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate debt
|
1,079
|
-
|
(120)
|
-
|
-
|
(20)
|
(3)
|
-
|
-
|
-
|
936
|
Loans
|
6,396
|
1,837
|
(823)
|
-
|
(771)
|
(57)
|
(42)
|
-
|
50
|
(114)
|
6,476
|
Private equity
investments
|
1,284
|
50
|
(22)
|
-
|
(3)
|
(50)
|
14
|
-
|
2
|
-
|
1,275
|
Reverse repurchase and repurchase
agreements
|
38
|
-
|
-
|
-
|
-
|
(11)
|
-
|
-
|
46
|
(29)
|
44
|
Asset backed securities
|
192
|
10
|
(4)
|
-
|
-
|
(13)
|
-
|
-
|
21
|
(16)
|
190
|
Other
|
136
|
-
|
(8)
|
-
|
(21)
|
(2)
|
(9)
|
-
|
1
|
-
|
97
|
Financial assets at fair value through the income
statement
|
9,125
|
1,897
|
(977)
|
-
|
(795)
|
(153)
|
(40)
|
-
|
120
|
(159)
|
9,018
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate debt
|
-
|
13
|
-
|
-
|
-
|
-
|
-
|
-
|
46
|
-
|
59
|
Loans
|
-
|
47
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
47
|
Private equity
investments
|
7
|
-
|
-
|
-
|
-
|
-
|
-
|
(2)
|
-
|
-
|
5
|
Asset backed securities
|
3
|
-
|
-
|
-
|
(1)
|
-
|
-
|
-
|
-
|
-
|
2
|
Other
|
1
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
Assets at fair value through other comprehensive
income
|
11
|
60
|
-
|
-
|
(1)
|
-
|
-
|
(2)
|
46
|
-
|
114
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment property
|
5
|
-
|
-
|
-
|
-
|
-
|
(3)
|
-
|
-
|
-
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading portfolio liabilities
|
(56)
|
(16)
|
4
|
-
|
-
|
15
|
-
|
-
|
(8)
|
9
|
(52)
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial liabilities designated at fair
value
|
(1,050)
|
-
|
-
|
(226)
|
-
|
4
|
(1)
|
-
|
(290)
|
463
|
(1,100)
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate
derivatives
|
(496)
|
2
|
-
|
-
|
19
|
(35)
|
-
|
-
|
544
|
446
|
480
|
Foreign exchange
derivatives
|
39
|
-
|
-
|
-
|
-
|
(31)
|
-
|
-
|
12
|
(15)
|
5
|
Credit derivatives
|
(313)
|
(191)
|
5
|
-
|
66
|
13
|
-
|
-
|
52
|
16
|
(352)
|
Equity derivatives
|
(419)
|
(90)
|
-
|
-
|
(132)
|
(135)
|
-
|
-
|
(104)
|
12
|
(868)
|
Net derivative financial
instruments1
|
(1,189)
|
(279)
|
5
|
-
|
(47)
|
(188)
|
-
|
-
|
504
|
459
|
(735)
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
13,326
|
3,947
|
(2,844)
|
(226)
|
(1,245)
|
(356)
|
(44)
|
(2)
|
1,394
|
96
|
14,046
|
1
|
Derivative financial instruments are presented on a net
basis. On a gross basis, derivative financial assets were £4,532m
and derivative financial liabilities were
£(5,269)m.
|
Unrealised gains and losses on Level 3 financial assets and
liabilities
The following table discloses the
unrealised gains and losses recognised in the period arising on
Level 3 financial assets and liabilities held at the period
end.
|
Half year ended 30.06.24
|
Half year ended 30.06.23
|
|
Income statement
|
Other compre hensive income
|
Total
|
Income statement
|
Other compre hensive income
|
Total
|
|
Trading income
|
Other income
|
Trading income
|
Other income
|
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Trading portfolio
assets
|
(2)
|
-
|
-
|
(2)
|
(35)
|
-
|
-
|
(35)
|
Financial assets at fair value
through the income statement
|
1
|
47
|
-
|
48
|
(144)
|
(40)
|
-
|
(184)
|
Financial assets at fair value
through other comprehensive income
|
1
|
11
|
-
|
12
|
-
|
-
|
(2)
|
(2)
|
Investment properties
|
-
|
-
|
-
|
-
|
-
|
(3)
|
-
|
(3)
|
Trading portfolio
liabilities
|
17
|
-
|
-
|
17
|
15
|
-
|
-
|
15
|
Financial liabilities designated
at fair value
|
(29)
|
(10)
|
-
|
(39)
|
2
|
(1)
|
-
|
1
|
Net derivative financial
instruments
|
(180)
|
-
|
-
|
(180)
|
(186)
|
-
|
-
|
(186)
|
Total
|
(192)
|
48
|
-
|
(144)
|
(348)
|
(44)
|
(2)
|
(394)
|
Valuation techniques and sensitivity
analysis
Sensitivity analysis is performed
on products with significant unobservable inputs (Level 3) to
generate a range of reasonably possible alternative valuations. The
sensitivity methodologies applied take account of the nature of
valuation techniques used, as well as the availability and
reliability of observable proxy and historical data and the impact
of using alternative models.
Sensitivities are dynamically
calculated on a monthly basis. The calculation is based on range or
spread data of a reliable reference source or a scenario based on
relevant market analysis alongside the impact of using alternative
models. Sensitivities are calculated without reflecting the impact
of any diversification in the portfolio.
Current period valuation and
sensitivity methodologies are consistent with those described
within Note 17, Fair value of financial instruments in the Barclays
PLC Annual Report 2023.
Sensitivity analysis of valuations using unobservable inputs
(Relates to Level 3 Portfolios)
|
|
|
|
|
|
|
|
|
|
|
As at 30.06.24
|
As at 31.12.23
|
|
Favourable changes
|
Unfavourable changes
|
Favourable changes
|
Unfavourable changes
|
|
Income statement
|
Equity
|
Income statement
|
Equity
|
Income statement
|
Equity
|
Income statement
|
Equity
|
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Interest rate
derivatives
|
99
|
-
|
(170)
|
-
|
78
|
-
|
(158)
|
-
|
Foreign exchange
derivatives
|
6
|
-
|
(10)
|
-
|
4
|
-
|
(9)
|
-
|
Credit derivatives
|
11
|
-
|
(15)
|
-
|
27
|
-
|
(32)
|
-
|
Equity derivatives
|
202
|
-
|
(289)
|
-
|
142
|
-
|
(226)
|
-
|
Corporate debt
|
55
|
-
|
(31)
|
-
|
34
|
-
|
(22)
|
-
|
Loans
|
687
|
32
|
(851)
|
(32)
|
612
|
2
|
(801)
|
(2)
|
Private equity
investments
|
215
|
-
|
(215)
|
-
|
263
|
1
|
(263)
|
(1)
|
Asset Backed Securities
|
39
|
4
|
(29)
|
(4)
|
36
|
1
|
(27)
|
(1)
|
Other1
|
95
|
-
|
(108)
|
-
|
90
|
-
|
(91)
|
-
|
Total
|
1,409
|
36
|
(1,718)
|
(36)
|
1,286
|
4
|
(1,629)
|
(4)
|
1
|
Other includes, Equity Cash Products, Fund and Fund Linked,
Government and Government Sponsored Debt, Issued
debt.
|
The effect of stressing
unobservable inputs to a range of reasonably possible alternatives,
alongside considering the impact of using alternative models, would
be to increase fair values by up to £1,445m (December 2023:
£1,290m) or to decrease fair values by up to £1,754m (December
2023: £1,633m) with substantially all the potential effect
impacting profit and loss rather than reserves.
Significant unobservable inputs
The valuation techniques and
significant unobservable inputs for assets and liabilities
recognised at fair value and classified as Level 3 are consistent
with Note 17, Fair value of financial instruments in the Barclays
PLC Annual Report 2023.
Fair value adjustments
Key balance sheet valuation
adjustments are quantified below:
|
As at 30.06.24
|
As at 31.12.23
|
|
£m
|
£m
|
Exit price adjustments derived
from market bid-offer spreads
|
(510)
|
(569)
|
Uncollateralised derivative
funding
|
5
|
(4)
|
Derivative credit valuation
adjustments
|
(190)
|
(209)
|
Derivative debit valuation
adjustments
|
111
|
144
|
• Exit price adjustments derived from market bid-offer spreads
decreased by £59m to £(510)m.
• Uncollateralised derivative funding moved marginally from
£(4)m to £5m.
• Derivative credit valuation adjustments decreased by £19m to
£(190)m as a result of reduced uncollateralised asset exposure
profile.
• Derivative debit valuation adjustments decreased by £33m to
£111m as a result of the tightening of input credit
spreads.
Portfolio exemption
The Group uses the portfolio
exemption in IFRS 13, Fair Value Measurement to measure the fair
value of groups of financial assets and liabilities. Financial
instruments are measured using the price that would be received to
sell a net long position (i.e., an asset) for a particular risk
exposure or to transfer a net short position (i.e., a liability)
for a particular risk exposure in an orderly transaction between
market participants at the balance sheet date under current market
conditions. Accordingly, the Group measures the fair value of the
group of financial assets and liabilities consistently with how
market participants would price the net risk exposure at the
measurement date.
Unrecognised gains as a result of the use of valuation models
using unobservable inputs
The amount that has yet to be
recognised in income that relates to the difference between the
transaction price (the fair value at initial recognition) and the
amount that would have arisen had valuation models using
unobservable inputs been used on initial recognition, less amounts
subsequently recognised, is £218m (December 2023: £205m) for
financial instruments measured at fair value and £187m (December
2023: £192m) for financial instruments carried at amortised cost.
There are additions and FX gains of £85m (December 2023: £136m FX
loss) and amortisation and releases of £72m (December 2023: £57m)
in amounts attributable to financial instruments measured at fair
value and additions of £nil (December 2023: £nil) and amortisation
and releases of £5m (December 2023: £24m) in amounts attributable
to financial instruments measured at amortised
cost.
Third party credit enhancements
Structured and brokered
certificates of deposit issued by the Group are insured up to
$250,000 per depositor by the Federal Deposit Insurance Corporation
(FDIC) in the United States. The FDIC is funded by premiums that
Barclays and other banks pay for deposit insurance coverage. The
carrying value of these issued certificates of deposit that are
designated under the IFRS 9 fair value option includes this
third-party credit enhancement. The on-balance sheet value of these
brokered certificates of deposit amounted to £3,829m
(December 2023: £5,162m).
Comparison of carrying amounts and fair values for assets and
liabilities not held at fair value
Valuation methodologies employed
in calculating the fair value of financial assets and liabilities
measured at amortised cost are consistent with those described
within Note 17, Fair value of financial instruments in the Barclays
PLC Annual Report 2023.
The following table summarises the
fair value of financial assets and liabilities measured at
amortised cost on the Group's balance sheet.
|
As at 30.06.24
|
As at 31.12.23
|
|
Carrying amount
|
Fair value
|
Carrying amount
|
Fair value
|
Financial assets
|
£m
|
£m
|
£m
|
£m
|
Debt securities at amortised
cost
|
61,700
|
60,738
|
56,749
|
55,437
|
Loans and advances at amortised
cost
|
337,809
|
333,405
|
342,747
|
334,706
|
Reverse repurchase agreements and
other similar secured lending
|
4,724
|
4,724
|
2,594
|
2,594
|
|
|
|
|
|
Financial liabilities
|
|
|
|
|
Deposits at amortised
cost
|
(557,452)
|
(557,528)
|
(538,789)
|
(538,502)
|
Repurchase agreements and other
similar secured borrowing
|
(52,352)
|
(52,352)
|
(41,601)
|
(41,601)
|
Debt securities in
issue
|
(96,772)
|
(98,656)
|
(96,825)
|
(98,123)
|
Subordinated
liabilities
|
(11,795)
|
(12,242)
|
(10,494)
|
(10,803)
|
10. Goodwill and intangible
assets
The Group performed an impairment
review to assess the recoverability of its goodwill and intangible
asset balances as at 31 December 2023. The outcome of this review
is disclosed on pages 464-467 of the Barclays PLC Annual Report
2023. No impairment was recognised as a result of the review as
value in use exceeded carrying amount. A review of the Group's
goodwill and intangible assets as at 30 June 2024 did not identify
any factors indicating impairment.
11. Subordinated
liabilities
|
Half year ended 30.06.24
|
Year ended 31.12.23
|
|
£m
|
£m
|
Opening balance as at 1
January
|
10,494
|
11,423
|
Issuances
|
1,355
|
1,523
|
Redemptions
|
-
|
(2,239)
|
Other
|
(54)
|
(213)
|
Closing balance
|
11,795
|
10,494
|
Issuances of £1,355m comprise
£1,276m EUR 4.973% Fixed Rate Resetting Tier 2 Subordinated
Callable Notes issued externally by Barclays PLC and £79m USD
Floating Rate Notes issued externally by a Barclays
subsidiary.
Other movements predominantly
comprise foreign exchange movements and fair value hedge
adjustments.
12. Provisions
|
As at 30.06.24
|
As at 31.12.23
|
|
£m
|
£m
|
Customer redress
|
204
|
295
|
Legal, competition and regulatory
matters
|
95
|
99
|
Redundancy and
restructuring
|
241
|
397
|
Undrawn contractually committed
facilities and guarantees
|
474
|
504
|
Sundry provisions
|
278
|
289
|
Total
|
1,292
|
1,584
|
13. Retirement
benefits
As at 30 June 2024, the Group's
IAS 19 net retirement benefit assets were £3.3bn (December 2023:
£3.4bn). The UK Retirement Fund (UKRF), which is the Group's main
scheme, had an IAS 19 net surplus of £3.5bn (December
2023: £3.6bn).
The UKRF annual funding update as
at 30 September 2023 showed a surplus of £2.02bn compared to
£1.97bn at the 30 September 2022 triennial actuarial
valuation.
14. Other
reserves
|
As at 30.06.24
|
As at 31.12.23
|
|
£m
|
£m
|
Currency translation
reserve
|
3,587
|
3,671
|
Fair value through other
comprehensive income reserve
|
(1,635)
|
(1,366)
|
Cash flow hedging
reserve
|
(3,797)
|
(3,707)
|
Own credit reserve
|
(702)
|
(240)
|
Other reserves and treasury
shares
|
1,665
|
1,565
|
Total
|
(882)
|
(77)
|
Currency translation reserve
The currency translation reserve
represents the cumulative gains and losses on the retranslation of
the Group's net investment in foreign operations, net of the
effects of hedging.
As at 30 June 2024, there was a
cumulative gain of £3,587m (December 2023: £3,671m gain) in the
currency translation reserve, a loss during the period of £84m
(2023: loss of £1,101m) inclusive of tax credit of £4m (2023: £9m).
This principally reflects the appreciation of GBP against EUR and
JPY offset by GBP depreciating against USD during H1 2024, in
contrast to the strengthening of GBP against USD and EUR during
2023.
Fair value through other comprehensive income
reserve
The fair value through other
comprehensive income reserve represents the total of unrealised
gains and losses on fair value through other comprehensive income
investments since initial recognition.
As at 30 June 2024 there was a
cumulative loss of £1,635m (December 2023: £1,366m loss) in the
reserve. The loss during the period of £269m (2023: £194m gain) was
principally driven by a £185m loss (2023: £299m gain) from the
movement in fair value of bonds due to change in bond yields and a
net gain of £186m transferred to the income statement (2023: £26m
gain) and tax credit of £101m (2023: tax charge of
£78m).
Cash flow hedging reserve
The cash flow hedging reserve
represents the cumulative gains and losses on effective cash flow
hedging instruments that will be recycled to the income statement
when the hedged transactions affect profit or loss.
As at 30 June 2024, there was a
cumulative loss of £3,797m (December 2023: £3,707m loss) in the
cash flow hedging reserve. The £90m loss in the period (2023:
£3,528m gain) is driven by a £1,057m loss (2023: £3,120m gain) from
fair value movements on interest rate swaps as major interest rate
forward curves increased (2023: decreased), this was offset by
£939m of accumulated losses transferred to the income statement
(2023: £1,750m losses) and a tax benefit of £28m (2023: tax charge
of £1,342m).
Own credit reserve
The own credit reserve reflects
the cumulative own credit gains and losses on financial liabilities
at fair value. Amounts in the own credit reserve are not recycled
to profit or loss in future periods.
As at 30 June 2024 there was a
cumulative loss of £702m (December 2023: £240m loss) in the own
credit reserve, the loss of £462m during the period (2023: loss of
£707m) principally reflects a £635m loss (2023: loss of £983m) from
the tightening of credit spreads partially offset by tax credit of
£173m (2023: tax credit of £273m).
Other reserves and treasury shares
Other reserves relate to redeemed
ordinary and preference shares issued by the Group. Treasury shares
relate to Barclays PLC shares held principally in relation to the
Group's various share schemes.
As at 30 June 2024, there was a
cumulative gain of £1,665m (December 2023: £1,565m gain). This
principally reflects an increase of £97m (December 2023: increase
of £209m) due to the repurchase of 389m shares (December 2023:
837m) as part of the share buybacks conducted in 2024 followed by
£3m gain (December 2023: £8m loss) on account of decrease in
treasury shares balance held in relation to employee share
schemes.
15. Contingent liabilities and
commitments
|
As at 30.06.24
|
As at 31.12.23
|
Contingent liabilities and financial
guarantees
|
£m
|
£m
|
Guarantees and letters of credit
pledged as collateral security
|
17,052
|
17,353
|
Performance guarantees,
acceptances and endorsements
|
8,434
|
7,987
|
Total
|
25,486
|
25,340
|
|
|
|
Commitments
|
|
|
Documentary credits and other
short-term trade related transactions
|
2,489
|
2,352
|
Standby facilities, credit lines
and other commitments
|
402,361
|
388,085
|
Total
|
404,850
|
390,437
|
Further details on contingent
liabilities, where it is not practicable to disclose an estimate of
the potential financial effect on Barclays relating to legal and
competition and regulatory matters can be found in Note
16.
16. Legal, competition and
regulatory matters
The Group faces legal, competition
and regulatory challenges, many of which are beyond our control.
The extent of the impact of these matters cannot always be
predicted but may materially impact our operations, financial
results, condition and prospects. Matters arising from a set of
similar circumstances can give rise to either a contingent
liability or a provision, or both, depending on the relevant facts
and circumstances.
The recognition of provisions in
relation to such matters involves critical accounting estimates and
judgments in accordance with the relevant accounting policies
applicable to Note 12, Provisions. We have not disclosed an
estimate of the potential financial impact or effect on the Group
of contingent liabilities where it is not currently practicable to
do so. Various matters detailed in this note seek damages of an
unspecified amount. While certain matters specify the damages
claimed, such claimed amounts do not necessarily reflect the
Group's potential financial exposure in respect of those
matters.
Matters are ordered under headings
corresponding to the financial statements in which they are
disclosed.
1. Barclays PLC and Barclays
Bank PLC
Investigations into certain advisory services agreements and
other proceedings
FCA proceedings
In 2008, Barclays Bank PLC and
Qatar Holdings LLC entered into two advisory service agreements
(the Agreements). The FCA conducted an investigation into whether
the Agreements may have related to Barclays PLC's capital raisings
in June and November 2008 (the Capital Raisings) and therefore
should have been disclosed in the announcements or public documents
relating to the Capital Raisings. In 2013, the FCA issued warning
notices (the Warning Notices) finding that Barclays PLC and
Barclays Bank PLC acted recklessly and in breach of certain
disclosure-related listing rules, and that Barclays PLC was also in
breach of Listing Principle 3. The financial penalty provided in
the Warning Notices was £50m. Barclays PLC and Barclays Bank PLC
contested the findings. In 2022, the FCA's Regulatory Decisions
Committee (RDC) issued Decision Notices finding that Barclays PLC
and Barclays Bank PLC breached certain disclosure-related listing
rules. The RDC also found that in relation to the disclosures made
in the Capital Raising of November 2008, Barclays PLC and Barclays
Bank PLC acted recklessly, and that Barclays PLC breached Listing
Principle 3. The RDC upheld the combined penalty of £50m on
Barclays PLC and Barclays Bank PLC, the same penalty as in the
Warning Notices. Barclays PLC and Barclays Bank PLC have referred
the RDC's findings to the Upper Tribunal for
reconsideration.
Other proceedings
In 2023, Barclays received
requests for arbitration from two Jersey special purpose vehicles
connected to PCP International Finance Limited asserting claims in
relation to the October 2008 capital raising. Barclays is defending
these claims.
Civil actions related to LIBOR and other
benchmarks
Various individuals and corporates
in a range of jurisdictions have threatened or brought civil
actions against the Group and other banks in relation to the
alleged manipulation of LIBOR and/or other benchmarks.
USD LIBOR civil actions
The majority of the USD LIBOR
cases, which have been filed in various US jurisdictions, have been
consolidated for pre-trial purposes in the US District Court in the
Southern District of New York (SDNY). The complaints are
substantially similar and allege, among other things, that Barclays
PLC, Barclays Bank PLC, Barclays Capital Inc. (BCI) and other
financial institutions individually and collectively violated
provisions of the US Sherman Antitrust Act (Antitrust Act), the US
Commodity Exchange Act (CEA), the US Racketeer Influenced and
Corrupt Organizations Act (RICO), the US Securities Exchange Act of
1934 and various state laws by manipulating USD LIBOR
rates.
The remaining claims are
individual actions seeking unspecified damages with the exception
of one lawsuit, in which the plaintiffs sought no less than $100m
in actual damages and additional punitive damages against all
defendants, including Barclays Bank PLC. The parties have reached a
settlement in principle in respect of such lawsuit. The financial
impact of this settlement is not expected to be material to the
Group's operating results, cash flows or financial position. Some
of the other lawsuits also seek trebling of damages under the
Antitrust Act and RICO.
Sterling LIBOR civil actions
In 2016, two putative class
actions filed in the SDNY against Barclays Bank PLC, BCI and other
Sterling LIBOR panel banks alleging, among other things, that the
defendants manipulated the Sterling LIBOR rate in violation of the
Antitrust Act, CEA and RICO, were consolidated. The defendants'
motion to dismiss the claims was granted in 2018. The plaintiffs
have appealed the dismissal.
ICE LIBOR civil action
In 2020, an action related to the
LIBOR benchmark administered by the Intercontinental Exchange Inc.
and certain of its affiliates (ICE) was filed by a group of
individual plaintiffs in the US District Court for the Northern
District of California on behalf of individual borrowers and
consumers of loans and credit cards with variable interest rates
linked to USD ICE LIBOR. The defendants' motion to dismiss the case
was granted in 2022. The plaintiffs filed an amended complaint,
which was dismissed in 2023. The plaintiffs are appealing the
dismissal.
Non-US benchmarks civil actions
There remains one claim, issued in
2017, against Barclays Bank PLC and other banks in the UK in
connection with alleged manipulation of LIBOR. Proceedings have
also been brought in a number of other jurisdictions in Europe,
Argentina and Israel relating to alleged manipulation of LIBOR and
EURIBOR. Additional proceedings in other jurisdictions may be
brought in the future.
Foreign Exchange civil actions
Various individuals and corporates
in a range of jurisdictions have threatened or brought civil
actions against the Group and other banks in relation to alleged
manipulation of Foreign Exchange markets.
US retail basis civil action
In 2015, a putative class action
was filed against several international banks, including Barclays
PLC and BCI, on behalf of a proposed class of individuals who
exchanged currencies on a retail basis at bank branches (Retail
Basis Claims). The SDNY has ruled that the Retail Basis Claims are
not covered by the settlement agreement in the Consolidated FX
Action. The Court subsequently dismissed all Retail Basis Claims
against the Group and all other defendants. The plaintiffs filed an
amended complaint. The defendants' motion for summary judgment was
granted in 2023, dismissing the plaintiffs' remaining claims. The
plaintiffs appealed the decision and the dismissal was upheld by
the appellate court in May 2024. The plaintiffs' motion for
reconsideration was denied.
Non-US FX civil actions
Legal proceedings have been
brought or are threatened against Barclays PLC, Barclays Bank PLC,
BCI and Barclays Execution Services Limited (BX) in connection with
alleged manipulation of Foreign Exchange in the UK, a number of
other jurisdictions in Europe, Israel, Brazil and Australia.
Additional proceedings may be brought in the future.
The above-mentioned proceedings
include two purported class actions filed against Barclays PLC,
Barclays Bank PLC, BX, BCI and other financial institutions in the
UK Competition Appeal Tribunal (CAT) in 2019. The CAT refused to
certify these claims in 2022 and in 2023, the Court of Appeal
overturned the CAT's decision and found that the claims should be
certified on an opt out basis. The Court of Appeal upheld the CAT's
determination as to which of the two purported class
representatives should be chosen to bring the claim. Barclays and
the other financial institutions involved have obtained permission
to appeal this decision to the UK Supreme Court.
Metals-related civil actions
A US civil complaint alleging
manipulation of the price of silver in violation of the CEA, the
Antitrust Act and state antitrust and consumer protection laws was
brought by a proposed class of plaintiffs against a number of
banks, including Barclays Bank PLC, BCI and BX, and transferred to
the SDNY. The complaint was dismissed against these Barclays
entities and certain other defendants in 2018, and against the
remaining defendants in 2023. The plaintiffs have appealed the
dismissal of the complaint against all defendants.
Civil actions have also been filed
in Canadian courts against Barclays PLC, Barclays Bank PLC,
Barclays Capital Canada Inc. and BCI on behalf of proposed classes
of plaintiffs alleging manipulation of gold and silver
prices.
US residential mortgage related civil
action
There remains one US Residential
Mortgage-Backed Securities (RMBS) related civil action arising from
unresolved repurchase requests submitted by Trustees for certain
RMBS, alleging breaches of various loan-level representations and
warranties (R&Ws) made by Barclays Bank PLC and/or a subsidiary
acquired in 2007. Barclays' motion to dismiss the action was denied
in 2023. The parties are appealing the decision.
Government and agency securities civil
actions
Treasury auction securities civil actions
Consolidated putative class action
complaints filed in US federal court against Barclays Bank PLC, BCI
and other financial institutions under the Antitrust Act and state
common law allege that the defendants (i) conspired to manipulate
the US Treasury securities market and/or (ii) conspired to prevent
the creation of certain platforms by boycotting or threatening to
boycott such trading platforms. The court dismissed the
consolidated action in 2021. The plaintiffs filed an amended
complaint. The defendants' motion to dismiss the amended complaint
was granted in 2022. The plaintiffs appealed this decision, and in
February 2024 the appellate court affirmed the dismissal. The
plaintiffs did not seek US Supreme Court review, thereby concluding
the matter.
In addition, certain plaintiffs
have filed a related, direct action against BCI and certain other
financial institutions, alleging that defendants conspired to fix
and manipulate the US Treasury securities market in violation of
the Antitrust Act, the CEA and state common law. This action
remains stayed.
Supranational, Sovereign and Agency bonds civil
actions
Civil antitrust actions have been
filed in the Federal Court of Canada in Toronto against Barclays
Bank PLC, BCI, BX, Barclays Capital Securities Limited and Barclays
Capital Canada, Inc. and other financial institutions alleging that
the defendants conspired to fix prices and restrain competition in
the market for US dollar-denominated Supranational, Sovereign and
Agency bonds.
The parties have reached a
settlement, which has received preliminary court approval and has
been paid. The financial impact of the settlement is not material
to the Group's operating results, cash flows or financial
position.
Variable Rate Demand Obligations civil
actions
Civil actions have been filed
against Barclays Bank PLC and BCI and other financial institutions
alleging the defendants conspired or colluded to artificially
inflate interest rates set for Variable Rate Demand Obligations
(VRDOs). VRDOs are municipal bonds with interest rates that reset
on a periodic basis, most commonly weekly. An action in state court
has been filed by private plaintiffs on behalf of the state of
California. Three putative class action complaints have been
consolidated in the SDNY. In the consolidated SDNY class action,
certain of the plaintiffs' claims were dismissed in 2020 and 2022
and the plaintiffs' motion for class certification was granted in
2023, which means the case may proceed as a class action. The
defendants are appealing this decision. In the California action,
the California appeals court reversed the dismissal of the
plaintiffs' claims in 2023.
Odd-lot corporate bonds antitrust class
action
In 2020, BCI, together with other
financial institutions, were named as defendants in a putative
class action in the US. The complaint alleges a conspiracy to
boycott developing electronic trading platforms for odd-lots and
price fixing. The plaintiffs demand unspecified money damages. The
defendants' motion to dismiss was granted in 2021, which the
plaintiffs appealed. In July 2024, the Second Circuit vacated the
judgment and remanded the case to the SDNY for further
proceedings.
Credit Default Swap civil action
A putative antitrust class action
is pending in New Mexico federal court against Barclays Bank PLC,
BCI and various other financial institutions. The plaintiffs, the
New Mexico State Investment Council and certain New Mexico pension
funds, allege that the defendants conspired to manipulate the
benchmark price used to value Credit Default Swap (CDS) contracts
at settlement (i.e., the CDS final auction price). The plaintiffs
allege violations of US antitrust laws and the CEA, and unjust
enrichment under state law. The defendants' motion to dismiss was
denied in 2023.
Interest rate swap and credit default swap US civil
actions
Barclays PLC, Barclays Bank PLC
and BCI, together with other financial institutions that act as
market makers for interest rate swaps (IRS), are named as
defendants in several antitrust actions, including one putative
class action and individual actions brought by certain swap
execution facilities, which are consolidated in the SDNY. The
complaints allege the defendants conspired to prevent the
development of exchanges for IRS and demand unspecified money
damages. The parties have reached a settlement of the matter, which
remains subject to final court approval. The financial impact of
the settlement is not expected to be material to the Group's
operating results, cash flows or financial position.
In 2017, Tera Group Inc. (Tera)
filed a separate civil antitrust action in the SDNY claiming that
certain conduct alleged in the IRS cases also caused Tera to suffer
harm with respect to the Credit Default Swaps market. In 2019, the
court dismissed Tera's claims for unjust enrichment and tortious
interference but denied motions to dismiss the antitrust claims.
Tera filed an amended complaint in 2020. Barclays' motion to
dismiss all claims was granted in 2023. Tera is appealing the
decision.
BDC Finance L.L.C.
In 2008, BDC Finance L.L.C. (BDC)
filed a complaint in the Supreme Court of the State of New York (NY
Supreme Court), demanding damages of $298m, alleging that Barclays
Bank PLC had breached a contract in connection with a portfolio of
total return swaps governed by an ISDA Master Agreement (the Master
Agreement). Following a trial, the court ruled in 2018 that
Barclays Bank PLC was not a defaulting party, which was affirmed on
appeal. In 2021, the trial court entered judgment in favour of
Barclays Bank PLC for $3.3m and as yet to be determined legal fees
and costs. BDC appealed. In 2022, the appellate court reversed the
trial court's summary judgment decision in favour of Barclays Bank
PLC and remanded the case to the lower court for further
proceedings. The parties filed cross-motions on the scope of trial.
In January 2024, the court ruled in Barclays' favour. BDC is
appealing, and the trial is adjourned until the appeal is
decided.
Civil actions in respect of the US Anti-Terrorism
Act
Eight civil actions, on behalf of
more than 4,000 plaintiffs, were filed in US federal courts in the
US District Court in the Eastern District of New York (EDNY) and
SDNY against Barclays Bank PLC and a number of other banks. The
complaints generally allege that Barclays Bank PLC and those banks
engaged in a conspiracy to facilitate US dollar-denominated
transactions for the Iranian Government and various Iranian banks,
which in turn funded acts of terrorism that injured or killed the
plaintiffs or the plaintiffs' family members. The plaintiffs seek
to recover damages for pain, suffering and mental anguish under the
provisions of the US Anti-Terrorism Act, which allow for the
trebling of any proven damages.
The court granted the defendants'
motions to dismiss three out of the six actions in the EDNY. The
plaintiffs appealed in one action and the dismissal was affirmed,
and judgment was entered, in 2023. The plaintiffs' motion to vacate
the judgment is fully briefed. The other two dismissed actions in
the EDNY were consolidated into one action. The plaintiffs in that
action, and in one other action in the EDNY, filed amended
complaints in 2023. The two other actions in the EDNY are currently
stayed. Out of the two actions in the SDNY, the court granted the
defendants' motion to dismiss the first action. That action is
stayed, and the second SDNY action is stayed pending any appeal on
the dismissal of the first.
Shareholder derivative action
In 2020, a purported Barclays
shareholder filed a putative derivative action in New York state
court against BCI and a number of current and former members of the
Board of Directors of Barclays PLC and senior executives or
employees of the Group. The shareholder filed the claim on behalf
of nominal defendant Barclays PLC, alleging that the individual
defendants harmed the company through breaches of their duties,
including under the Companies Act 2006. The plaintiff seeks damages
on behalf of Barclays PLC for the losses that Barclays PLC
allegedly suffered as a result of these alleged breaches. An
amended complaint was filed in 2021, which BCI and certain other
defendants moved to dismiss. The motion to dismiss was granted in
2022. The plaintiff appealed the decision, and the dismissal was
unanimously affirmed in 2023 by the First Judicial Department in
New York. The plaintiff is appealing the First Judicial
Department's decision to the New York Court of Appeals.
Derivative transactions civil action
In 2021, Vestia, a Dutch housing
association, brought a claim against Barclays Bank PLC in the UK in
the High Court in relation to a series of derivative transactions
entered into with Barclays Bank PLC between 2008 and 2011, seeking
damages of £329m. In May 2024, Barclays Bank PLC reached a
settlement whereby Barclays paid €43.5m with no acknowledgement of
liability. This matter is now closed.
Skilled person review in relation to historic timeshare loans
and associated matters
Clydesdale Financial Serviced
Limited (CFS), which trades as Barclays Partner Finance and houses
Barclays' point-of-sale finance business, was required by the FCA
to undertake a skilled person review in 2020 following concerns
about historic affordability assessments for certain loans to
customers in connection with timeshare purchases. The skilled
person review was concluded in 2021. CFS complied fully with the
skilled person review requirements, including carrying out certain
remediation measures. CFS was not required to conduct a full back
book review. Instead, CFS reviewed limited historic lending to
ascertain whether its practices caused customer harm and is
remediating any examples of harm. This work was substantially
completed during 2023, utilising provisions booked to account for
any remediations.
Motor finance commission arrangements
In January 2024, the FCA announced
that it was appointing a skilled person to undertake a review of
the historical use of discretionary commission arrangements and
sales in the motor finance market across several firms. This
follows two final decisions by the UK Financial Ombudsman Service
(FOS), including one upholding a complaint against CFS (a
subsidiary of Barclays PLC) in relation to commission arrangements
and disclosure in the sale of motor finance products and a number
of complaints and court claims, including some against CFS. We have
commenced a judicial review challenge against the FOS in the High
Court in relation to this decision. Barclays will co-operate fully
with the FCA's skilled person review, the outcome of which is
unknown, including any potential financial impact. The FCA
currently plans to set out next steps on this matter in May 2025.
Barclays ceased operating in the motor finance market in late 2019
whilst CFS was a subsidiary of Barclays Bank group.
Over-issuance of securities in the US
In 2022, executive management
became aware that Barclays Bank PLC had issued securities
materially in excess of the set amount under its US shelf
registration statements.
In 2022, a purported class action
claim was filed in the US District Court in Manhattan seeking to
hold Barclays PLC, Barclays Bank PLC and former and current
executives responsible for declines in the price of Barclays PLC's
American depositary receipts, which the plaintiffs claim occurred
as a result of alleged misstatements and omissions in its public
disclosures. The defendants' motion to dismiss the case was granted
in part and denied in part in February 2024. Barclays has filed a
motion for reconsideration or, alternatively, permission to appeal
the decision.
In addition, holders of a series
of ETNs have brought a purported class action in federal court in
New York against Barclays PLC, Barclays Bank PLC, and former and
current executives and board members in the US alleging, among
other things, that Barclays' failure to disclose that these ETNs
were unregistered securities misled investors and that, as a
result, Barclays is liable for the holders' alleged losses
following the suspension of further sales and issuances of such
series of ETNs. The plaintiffs were granted leave to amend and
filed a new complaint in March 2024. Barclays has filed a motion to
dismiss.
In March 2024, a putative class
action was filed in federal court in New York against Barclays PLC,
Barclays Bank PLC and former and current executives. The plaintiff
purports to bring claims on behalf of a class of short sellers,
alleging that their short positions suffered substantial losses
when Barclays suspended new issuances and sales of VXX ETNs as a
result of the over-issuance of securities.
2. Barclays PLC, Barclays Bank
PLC and Barclays Bank UK PLC
HM Revenue & Customs (HMRC) assessments concerning UK
Value Added Tax
In 2018, HMRC issued notices that
have the effect of either removing certain Barclays overseas
subsidiaries that have operations in the UK from Barclays' UK VAT
group or preventing them from joining it. Supplies between members
of a UK VAT group are generally free from VAT. The notices had both
retrospective and prospective effect. Barclays has appealed HMRC's
decisions to the First Tier Tribunal (Tax Chamber) in relation to
both the retrospective VAT assessments and the on-going VAT
payments made since 2018. £181m of VAT (inclusive of interest) was
assessed retrospectively by HMRC covering the periods 2014 to 2018,
of which approximately £128m is expected to be attributed to
Barclays Bank UK PLC and £53m to Barclays Bank PLC. This
retrospectively assessed VAT was paid in 2018 and an asset,
adjusted to reflect expected eventual recovery, is recognised.
Since 2018 Barclays has paid, and recognised as an expense, VAT on
intra-group supplies from the relevant subsidiaries to the members
of the VAT group. Trial was completed in Q2 2024 in respect of the
ongoing VAT payments. Judgment is awaited.
3. Barclays
PLC
Civil action in respect of Barclays' statements regarding the
relationship between its former CEO and Jeffrey
Epstein
In 2023, a purported class action
was filed in federal court in California against Barclays PLC and a
number of current and former members of the Board of Directors of
Barclays PLC. The complaint seeks to hold the defendants
responsible for declines in the price of Barclays PLC's American
depositary receipts, which the plaintiffs claim occurred as a
result of alleged misstatements and omissions in Barclays' public
disclosures relating to its former CEO's relationship with Jeffrey
Epstein.
Alternative trading systems
In 2020, a claim was brought
against Barclays PLC in the UK in the High Court by various
shareholders regarding Barclays PLC's share price based on the
allegations contained within a complaint by the New York State
Attorney General (NYAG) in 2014, which alleged, among other things,
that Barclays PLC and BCI engaged in fraud and deceptive practices
in connection with LX, BCI's SEC-registered alternative trading
system. The NYAG claim was settled in 2016, as previously
disclosed. The more recent claim is currently due to go to trial on
liability in October 2025 with a later trial to decide quantum
issues. Barclays is defending the claim.
General
The Group is engaged in various
other legal, competition and regulatory matters in the UK, the US
and a number of other overseas jurisdictions. It is subject to
legal proceedings brought by and against the Group which arise in
the ordinary course of business from time to time, including (but
not limited to) disputes in relation to contracts, securities,
guarantees, debt collection, consumer credit, fraud, trusts, client
assets, competition, data management and protection, intellectual
property, money laundering, financial crime, employment,
environmental and other statutory and common law issues.
The Group is also subject to
enquiries and examinations, requests for information, audits,
investigations and legal and other proceedings by regulators,
governmental and other public bodies in connection with (but not
limited to) consumer protection measures, measures to combat money
laundering and financial crime, compliance with legislation and
regulation, wholesale trading activity and other areas of banking
and business activities in which the Group is or has been engaged.
The Group is cooperating with the relevant authorities and keeping
all relevant agencies briefed as appropriate in relation to these
matters and others described in this note on an ongoing
basis.
At the present time, Barclays PLC
does not expect the ultimate resolution of any of these other
matters to have a material adverse effect on the Group's financial
position. However, in light of the uncertainties involved in such
matters and the matters specifically described in this note, there
can be no assurance that the outcome of a particular matter or
matters (including formerly active matters or those matters arising
after the date of this note) will not be material to Barclays PLC's
results, operations or cash flows for a particular period,
depending on, among other things, the amount of the loss resulting
from the matter(s) and the amount of profit otherwise reported for
the reporting period.
17. Related party
transactions
Related party transactions in the
half year ended 30 June 2024 were similar in nature to those
disclosed in the Barclays PLC Annual Report 2023. No related party
transactions that have taken place in the half year ended 30 June
2024 have materially affected the financial position or the
performance of the Group during this period.
Appendix: Non-IFRS Performance Measures
The Group's management believes
that the non-IFRS performance measures included in this document
provide valuable information to the readers of the financial
statements, as they enable the reader to identify a more consistent
basis for comparing the businesses' performance between financial
periods, and provide more detail concerning the elements of
performance which the managers of these businesses are most
directly able to influence or are relevant for an assessment of the
Group. They also reflect an important aspect of the way in which
operating targets are defined and performance is monitored by
management.
However, any non-IFRS performance
measures in this document are not a substitute for IFRS measures
and readers should consider the IFRS measures as well.
Non-IFRS performance measures glossary
Measure
|
Definition
|
Loan: deposit ratio
|
Total loans and advances at
amortised cost divided by total deposits at amortised
cost.
|
Attributable profit
|
Profit after tax attributable to
ordinary shareholders of the parent.
|
Period end tangible equity refers to:
|
Period end tangible shareholders'
equity (for Barclays Group)
|
Shareholders' equity attributable
to ordinary shareholders of the parent, adjusted for the deduction
of goodwill and intangible assets.
|
Period end allocated tangible
equity (for businesses)
|
Allocated tangible equity is
calculated as 13.5% (2023: 13.5%) of RWAs for each business,
adjusted for capital deductions, excluding goodwill and intangible
assets, reflecting the assumptions the Barclays Group uses for
capital planning purposes. Head Office allocated tangible equity
represents the difference between the Barclays Group's tangible
shareholders' equity and the amounts allocated to
businesses.
|
Average tangible equity refers to:
|
Average tangible shareholders'
equity (for Barclays Group)
|
Calculated as the average of the
previous month's period end tangible shareholders' equity and the
current month's period end tangible shareholders' equity. The
average tangible shareholders' equity for the period is the average
of the monthly averages within that period.
|
Average allocated tangible equity
(for businesses)
|
Calculated as the average of the
previous month's period end allocated tangible equity and the
current month's period end allocated tangible equity. The average
allocated tangible equity for the period is the average of the
monthly averages within that period.
|
Return on tangible equity (RoTE) refers to:
|
Return on average tangible
shareholders' equity (for Barclays Group)
|
Annualised Group attributable
profit, as a proportion of average tangible shareholders' equity.
The components of the calculation have been included on pages 90 to
91.
|
Return on average allocated
tangible equity (for businesses)
|
Annualised business attributable
profit, as a proportion of that business's average allocated
tangible equity. The components of the calculation have been
included on pages 90 to 92.
|
Operating expenses excluding
litigation and conduct
|
A measure of total operating
expenses excluding litigation and conduct charges.
|
Operating costs
|
A measure of total operating
expenses excluding litigation and conduct charges and UK regulatory
levies.
|
Cost: income ratio
|
Total operating expenses divided
by total income.
|
Loan loss rate
|
Quoted in basis points and
represents total impairment charges divided by total gross loans
and advances held at amortised cost at the balance sheet
date.
|
Net interest margin
|
Annualised net interest income
divided by the sum of average customer assets. The components of
the calculation have been included on page 24.
|
Tangible net asset value per
share
|
Calculated by dividing
shareholders' equity, excluding non-controlling interests and other
equity instruments, less goodwill and intangible assets, by the
number of issued ordinary shares. The components of the calculation
have been included on page 94.
|
Profit before
impairment
|
Calculated by excluding credit
impairment charges or releases from profit before tax.
|
Structural cost actions
|
Cost actions taken to improve
future financial performance.
|
Group net interest income
excluding Barclays Investment Bank and Head Office
|
A measure of Barclays Group net
interest income, excluding the net interest income reported in
Barclays Investment Bank and Head Office.
|
Inorganic activity
|
Refers to certain inorganic
transactions announced as part of the FY23 Investor Update designed
to improve RoTE beyond 2024.
|
Performance measures excluding the
impact of inorganic activity
|
Calculated by excluding the impact
of inorganic activity from performance measures. The components of
the calculations for Barclays Group and businesses have been
included on page 5 and on page 93.
|
Returns
|
Half year ended 30.06.24
|
|
|
Barclays UK
|
Barclays UK Corporate Bank
|
Barclays Private Bank and Wealth Management
|
Barclays Investment Bank
|
Barclays US Consumer Bank
|
Head Office
|
Barclays Group
|
Return on average tangible equity
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Attributable
profit/(loss)
|
1,063
|
248
|
151
|
1,614
|
119
|
(408)
|
2,787
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
Average equity
|
14.3
|
3.0
|
1.1
|
30.0
|
3.6
|
6.0
|
58.0
|
Average goodwill and
intangibles
|
(3.9)
|
-
|
(0.1)
|
-
|
(0.3)
|
(3.6)
|
(7.9)
|
Average tangible equity
|
10.4
|
3.0
|
1.0
|
30.0
|
3.3
|
2.4
|
50.1
|
|
|
|
|
|
|
|
|
Return on average tangible equity
|
20.4%
|
16.6%
|
29.7%
|
10.8%
|
7.2%
|
n/m
|
11.1%
|
|
Half year ended 30.06.23
|
|
|
Barclays UK
|
Barclays UK Corporate Bank
|
Barclays Private Bank and Wealth Management
|
Barclays Investment Bank
|
Barclays US Consumer Bank
|
Head Office
|
Barclays Group
|
Return on average tangible equity
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Attributable
profit/(loss)
|
1,049
|
396
|
181
|
1,610
|
131
|
(256)
|
3,111
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
Average equity
|
14.0
|
2.9
|
1.1
|
29.1
|
3.9
|
4.6
|
55.6
|
Average goodwill and
intangibles
|
(3.7)
|
-
|
(0.1)
|
-
|
(0.8)
|
(3.8)
|
(8.4)
|
Average tangible equity
|
10.3
|
2.9
|
1.0
|
29.1
|
3.1
|
0.8
|
47.2
|
|
|
|
|
|
|
|
|
Return on average tangible equity
|
20.4%
|
27.3%
|
35.2%
|
11.1%
|
8.4%
|
n/m
|
13.2%
|
|
|
|
|
|
|
|
|
Barclays Group
|
|
|
|
|
|
|
|
|
|
|
Return on average tangible shareholders'
equity
|
Q224
|
Q124
|
|
Q423
|
Q323
|
Q223
|
Q123
|
|
Q422
|
Q322
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Attributable
profit/(loss)
|
1,237
|
1,550
|
|
(111)
|
1,274
|
1,328
|
1,783
|
|
1,036
|
1,512
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Average shareholders'
equity
|
57.7
|
58.3
|
|
57.1
|
55.1
|
55.4
|
55.9
|
|
54.9
|
56.8
|
Average goodwill and
intangibles
|
(7.9)
|
(7.8)
|
|
(8.2)
|
(8.6)
|
(8.7)
|
(8.3)
|
|
(8.2)
|
(8.2)
|
Average tangible shareholders' equity
|
49.8
|
50.5
|
|
48.9
|
46.5
|
46.7
|
47.6
|
|
46.7
|
48.6
|
|
|
|
|
|
|
|
|
|
|
|
Return on average tangible shareholders'
equity
|
9.9%
|
12.3%
|
|
(0.9)%
|
11.0%
|
11.4%
|
15.0%
|
|
8.9%
|
12.5%
|
Barclays UK
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
Q224
|
Q124
|
|
Q423
|
Q323
|
Q223
|
Q123
|
|
Q422
|
Q322
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Attributable profit
|
584
|
479
|
|
382
|
531
|
534
|
515
|
|
474
|
549
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Average allocated
equity
|
14.4
|
14.3
|
|
14.1
|
14.0
|
14.2
|
13.9
|
|
13.7
|
13.5
|
Average goodwill and
intangibles
|
(3.9)
|
(3.9)
|
|
(3.9)
|
(3.9)
|
(4.0)
|
(3.6)
|
|
(3.5)
|
(3.6)
|
Average allocated tangible equity
|
10.5
|
10.4
|
|
10.2
|
10.1
|
10.2
|
10.3
|
|
10.2
|
9.9
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
22.3%
|
18.5%
|
|
14.9%
|
21.0%
|
20.9%
|
20.0%
|
|
18.7%
|
22.1%
|
|
|
|
|
|
|
|
|
|
|
|
Barclays UK Corporate Bank
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
Q224
|
Q124
|
|
Q423
|
Q323
|
Q223
|
Q123
|
|
Q422
|
Q322
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Attributable profit
|
135
|
113
|
|
59
|
129
|
239
|
157
|
|
131
|
172
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Average allocated
equity
|
3.0
|
3.0
|
|
2.8
|
2.8
|
2.9
|
2.9
|
|
2.9
|
2.9
|
Average goodwill and
intangibles
|
-
|
-
|
|
-
|
-
|
-
|
-
|
|
-
|
-
|
Average allocated tangible equity
|
3.0
|
3.0
|
|
2.8
|
2.8
|
2.9
|
2.9
|
|
2.9
|
2.9
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
18.0%
|
15.2%
|
|
8.4%
|
18.3%
|
32.9%
|
21.7%
|
|
17.8%
|
23.4%
|
Barclays Private Bank and Wealth Management
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
Q224
|
Q124
|
|
Q423
|
Q323
|
Q223
|
Q123
|
|
Q422
|
Q322
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Attributable profit
|
77
|
74
|
|
47
|
102
|
91
|
90
|
|
92
|
108
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Average allocated
equity
|
1.1
|
1.1
|
|
1.1
|
1.1
|
1.1
|
1.1
|
|
1.2
|
1.1
|
Average goodwill and
intangibles
|
(0.1)
|
(0.1)
|
|
(0.1)
|
(0.1)
|
(0.1)
|
(0.1)
|
|
(0.1)
|
(0.1)
|
Average allocated tangible equity
|
1.0
|
1.0
|
|
1.0
|
1.0
|
1.0
|
1.0
|
|
1.1
|
1.0
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
30.8%
|
28.7%
|
|
19.1%
|
41.2%
|
35.9%
|
34.5%
|
|
34.9%
|
41.7%
|
Barclays Investment Bank
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
Q224
|
Q124
|
|
Q423
|
Q323
|
Q223
|
Q123
|
|
Q422
|
Q322
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Attributable
profit/(loss)
|
715
|
899
|
|
(149)
|
580
|
562
|
1,048
|
|
313
|
847
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Average allocated
equity
|
29.9
|
30.0
|
|
28.9
|
28.8
|
29.0
|
29.1
|
|
30.9
|
31.2
|
Average goodwill and
intangibles
|
-
|
-
|
|
-
|
-
|
-
|
-
|
|
-
|
-
|
Average allocated tangible equity
|
29.9
|
30.0
|
|
28.9
|
28.8
|
29.0
|
29.1
|
|
30.9
|
31.2
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
9.6%
|
12.0%
|
|
(2.1)%
|
8.0%
|
7.7%
|
14.4%
|
|
4.0%
|
10.9%
|
|
|
|
|
|
|
|
|
|
|
|
Barclays US Consumer Bank
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
Q224
|
Q124
|
|
Q423
|
Q323
|
Q223
|
Q123
|
|
Q422
|
Q322
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Attributable
profit/(loss)
|
75
|
44
|
|
(3)
|
3
|
72
|
59
|
|
101
|
107
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Average allocated
equity
|
3.6
|
3.6
|
|
3.6
|
3.8
|
3.9
|
3.9
|
|
4.1
|
4.0
|
Average goodwill and
intangibles
|
(0.3)
|
(0.3)
|
|
(0.3)
|
(0.7)
|
(0.8)
|
(0.8)
|
|
(0.9)
|
(0.9)
|
Average allocated tangible equity
|
3.3
|
3.3
|
|
3.3
|
3.1
|
3.1
|
3.1
|
|
3.2
|
3.1
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
9.2%
|
5.3%
|
|
(0.3)%
|
0.4%
|
9.3%
|
7.5%
|
|
12.6%
|
13.9%
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures excluding the impact of inorganic
activity
|
Half year ended 30.06.24
|
|
|
Barclays UK
|
Barclays UK Corporate Bank
|
Barclays Private Bank and Wealth Management
|
Barclays Investment Bank
|
Barclays US Consumer Bank
|
Head Office
|
Barclays Group
|
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Total income
|
3,713
|
877
|
632
|
6,347
|
1,678
|
30
|
13,277
|
Inorganic activity
|
-
|
-
|
-
|
-
|
-
|
(240)
|
(240)
|
Total income excluding inorganic activity
|
3,713
|
877
|
632
|
6,347
|
1,678
|
270
|
13,517
|
|
|
|
|
|
|
|
|
Total operating expenses
|
(2,108)
|
(486)
|
(436)
|
(3,902)
|
(800)
|
(449)
|
(8,181)
|
|
|
|
|
|
|
|
|
Cost: income ratio excluding inorganic
activity
|
57%
|
55%
|
69%
|
61%
|
48%
|
n/a
|
61%
|
|
|
|
|
|
|
|
|
Attributable
profit/(loss)
|
1,063
|
248
|
151
|
1,614
|
119
|
(408)
|
2,787
|
Post-tax impact of inorganic
activity
|
-
|
-
|
-
|
-
|
-
|
(233)
|
(233)
|
Attributable profit/(loss) excluding inorganic
activity
|
1,063
|
248
|
151
|
1,614
|
119
|
(175)
|
3,020
|
|
|
|
|
|
|
|
|
Average tangible equity (£bn)
|
10.4
|
3.0
|
1.0
|
30.0
|
3.3
|
2.4
|
50.1
|
|
|
|
|
|
|
|
|
Return on average tangible equity excluding inorganic
activity
|
20.4%
|
16.6%
|
29.7%
|
10.8%
|
7.2%
|
n/a
|
12.0%
|
|
Three months ended 30.06.24
|
|
|
Barclays UK
|
Barclays UK Corporate Bank
|
Barclays Private Bank and Wealth Management
|
Barclays Investment Bank
|
Barclays US Consumer Bank
|
Head Office
|
Barclays Group
|
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Total income
|
1,887
|
443
|
320
|
3,019
|
819
|
(164)
|
6,324
|
Inorganic activity
|
-
|
-
|
-
|
-
|
-
|
(240)
|
(240)
|
Total income excluding inorganic activity
|
1,887
|
443
|
320
|
3,019
|
819
|
76
|
6,564
|
|
|
|
|
|
|
|
|
Total operating expenses
|
(1,045)
|
(235)
|
(219)
|
(1,903)
|
(410)
|
(194)
|
(4,006)
|
|
|
|
|
|
|
|
|
Cost: income ratio excluding inorganic
activity
|
55%
|
53%
|
68%
|
63%
|
50%
|
n/a
|
61%
|
|
|
|
|
|
|
|
|
Attributable
profit/(loss)
|
584
|
135
|
77
|
715
|
75
|
(349)
|
1,237
|
Post-tax impact of inorganic
activity
|
-
|
-
|
-
|
-
|
-
|
(233)
|
(233)
|
Attributable profit/(loss) excluding inorganic
activity
|
584
|
135
|
77
|
715
|
75
|
(116)
|
1,470
|
|
|
|
|
|
|
|
|
Average tangible equity (£bn)
|
10.5
|
3.0
|
1.0
|
29.9
|
3.3
|
2.1
|
49.8
|
|
|
|
|
|
|
|
|
Return on average tangible equity excluding inorganic
activity
|
22.3%
|
18.0%
|
30.8%
|
9.6%
|
9.2%
|
n/a
|
11.8%
|
Tangible net asset value per share
|
As at 30.06.24
|
As at 31.12.23
|
As at 30.06.23
|
|
£m
|
£m
|
£m
|
Total equity excluding
non-controlling interests
|
71,173
|
71,204
|
67,669
|
Other equity
instruments
|
(12,959)
|
(13,259)
|
(13,759)
|
Goodwill and
intangibles
|
(7,839)
|
(7,794)
|
(8,607)
|
Tangible shareholders' equity attributable to ordinary
shareholders of the parent
|
50,375
|
50,151
|
45,303
|
|
|
|
|
|
m
|
m
|
m
|
Shares in issue
|
14,826
|
15,155
|
15,556
|
|
|
|
|
|
p
|
p
|
p
|
Tangible net asset value per share
|
340
|
331
|
291
|
Shareholder Information
Results timetable1
|
|
|
|
Date
|
|
Ex-dividend date
|
|
|
|
15 August 2024
|
Dividend record date
|
|
|
|
16 August 2024
|
Cut off time of 5:00pm (UK time)
for the receipt of Dividend Re-investment Programme (DRIP)
Application Form Mandate
|
30 August 2024
|
Dividend payment date
|
|
|
|
20 September 2024
|
Q3 2024 Results
Announcement
|
|
|
|
24 October 2024
|
|
|
|
|
|
|
|
For qualifying US and Canadian
resident ADR holders, the half year dividend of 2.9p per ordinary
share becomes 11.6p per ADS (representing four shares). The
ex-dividend date for ADR holders is 16 August 2024. The dividend
record and dividend payment dates for ADR holders are as shown
above.
|
A DRIP is provided by Equiniti
Financial Services Limited. The DRIP enables the Company's
shareholders to elect to have their cash dividend payments used to
purchase the Company's shares. More information can be found at
www.shareview.co.uk/info/drip
|
DRIP participants will usually
receive their additional ordinary shares (in lieu of a cash
dividend) three to four days after the dividend payment
date.
|
Barclays PLC ordinary shares ISIN
code: GB0031348658
|
|
|
Barclays PLC ordinary shares TIDM
Code: BARC
|
|
|
|
|
|
|
|
|
|
|
%
Change3
|
Exchange rates2
|
30.06.24
|
31.12.23
|
30.06.23
|
|
31.12.23
|
30.06.23
|
Period end - USD/GBP
|
1.26
|
1.28
|
1.27
|
|
(2)%
|
(1)%
|
6 month average -
USD/GBP
|
1.30
|
1.24
|
1.23
|
|
5%
|
6
|
3 month average -
USD/GBP
|
1.26
|
1.24
|
1.25
|
|
2%
|
1%
|
Period end - EUR/GBP
|
1.18
|
1.15
|
1.16
|
|
3%
|
2%
|
6 month average -
EUR/GBP
|
1.19
|
1.15
|
1.14
|
|
3%
|
4%
|
3 month average -
EUR/GBP
|
1.18
|
1.15
|
1.15
|
|
3%
|
3%
|
|
|
|
|
|
|
|
Share price data
|
|
|
|
|
|
|
Barclays PLC (p)
|
208.90
|
153.78
|
153.38
|
|
|
|
Barclays PLC number of shares
(m)4
|
14,826
|
15,155
|
15,556
|
|
|
|
|
|
|
|
|
|
|
For further information please contact
|
|
|
|
|
|
|
|
|
|
|
|
|
Investor relations
|
Media relations
|
Marina Shchukina +44 (0) 20 7116
2526
|
Tom Hoskin +44 (0) 20 7116
4755
|
|
|
More information on Barclays can
be found on our website: home.barclays
|
|
|
|
|
|
|
|
Registered office
|
|
|
|
|
|
|
1 Churchill Place, London, E14
5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number:
48839.
|
|
|
|
|
|
|
|
Registrar
|
|
|
|
|
|
|
Equiniti, Aspect House, Spencer
Road, Lancing, West Sussex, BN99 6DA, United Kingdom.
|
|
Tel: +44 (0)371 384 2055 (UK and
International telephone number)5.
|
|
|
|
|
|
|
|
|
American Depositary Receipts (ADRs)
|
|
|
|
|
|
|
EQ Shareowner Services
|
P.O. Box 64504
|
St. Paul, MN 55164-0504
|
United States of
America
|
shareowneronline.com
|
|
|
|
|
|
Toll Free Number: +1
800-990-1135
|
|
|
|
|
|
|
Outside the US +1
651-453-2128
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delivery of ADR certificates and
overnight mail
|
|
|
|
|
|
EQ Shareowner Services, 1110
Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120-4100,
USA.
|
1
|
Note that these dates are provisional and subject to
change.
|
2
|
The average rates shown above are derived from daily spot
rates during the year.
|
3
|
The change is the impact to GBP reported
information.
|
4
|
The number of shares of 14,826m as at 30 June 2024 is
different from the 14,816m quoted in the 1 July 2024 announcement
entitled "Total Voting Rights" because the share buyback
transactions executed on 27 and 28 June 2024 did not settle until 1
and 2 July 2024 respectively.
|
5
|
Lines open 8.30am to 5.30pm (UK time), Monday to Friday,
excluding UK public holidays in England and
Wales.
|